The time-course of vascular adaptations following localized short term exercise training by Allen, Jason David
Louisiana State University
LSU Digital Commons
LSU Doctoral Dissertations Graduate School
2001
The time-course of vascular adaptations following
localized short term exercise training
Jason David Allen
Louisiana State University and Agricultural and Mechanical College, j.d.allen@duke.edu
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Kinesiology Commons
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please contactgradetd@lsu.edu.
Recommended Citation





THE TIME-COURSE OF VASCULAR ADAPTATIONS FOLLOWING LOCALIZED 








Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 

















Jason David Allen 
B.A., Leeds Metropolitan University, 1992 





 I would like to express my gratitude to Dr. Michael Welsch for his friendship, guidance, 
and dedication to my development, throughout my program of study.  He has served as my major 
professor and chair of my dissertation committee.  I feel extremely fortunate to be counted as one 
of his students.  I would also like to thank Drs. Steven Kamerling, Arnold Nelson, 
ChangaramVenugopal, Grover Waldrop, and Robert Wood for serving on my committees, and 
sharing their insight, knowledge and time.  Throughout, your help has always been constructive, 
beneficial, and appreciated. 
 Thank you to my colleagues who have helped me transport subjects, collect, analyze, and 
interpret data and write papers and presentations.  Particular thanks go to Jonathan Hoy and 
Micah Cating for bailing me out at crunch times on many occasions and to Tracie Parish and 
Lisa Johnson for being my friends and making work much more fun and to my friends outside 
school who make having fun much more fun. 
 Finally, my parents David and Ruth who were always there to offer me support both 
emotionally, but more often than not financially. 
 iii
PREFACE 
This dissertation documents a literature review and 3 experiments conducted in the exercise 
physiology discipline of the Department of Kinesiology at Louisiana State University and 
Pennington Biomedical Research Center, Baton Rouge, Louisiana.   
Chapter 1 outlines the issues under investigation and a brief rationale for the experiments 
presented in subsequent chapters.  Chapter 2 outlines an experiment into the stability and 
reproducibility of a technique developed to assess brachial artery flow-mediated dilation and was 
conducted over the course of 1997 and 1998.  This paper is under review for publication by the 
journal Medicine and Science in Sports and Exercise.  Chapter 3 outlines a cross-sectional study 
conducted in 1999, entitled “Influence of age and normal plasma fibrinogen levels on flow 
mediated dilation in healthy adults”.  This was published in the American Journal of Cardiology 
in 2000.  Chapter 4 outlines a prospective interventional study conducted in 2001 to investigate 
the time course of vascular adaptations following localized short-term exercise training.  Chapter 
5 is a summary of the work in the preceding 3 chapters and an attempt to give a contextual 
meaning to the studies results and conclusions. 
Appendix A is an extensive review of literature, completed over the course of 2000, and entitled 
“Human circulation: The peripheral vascular system and its regulation and adaptation to physical 
stress in health and disease”.  A section from this paper is being adapted as a review paper for the 
Journal Sports Medicine. 
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 This is a series of 3 experiments in the area of vasoreactivity.  The first study investigated 
the stability and reproducibility of brachial artery flow-mediated dilation (BAFMD). Twenty-six 
healthy volunteers underwent 3 scans on 2 days, performed by 2 ultrasonographers, and analyzed 
by 2 readers. All subjects were tested between 7 and 11am after refraining from food and 
exercise.  Average baseline diameter was 3.48+0.53mm, which increased to 3.71+0.57mm 
(6.58+4.15%) at peak dilation. ICCC’s for days, testers and readers were 0.9188, 0.9394, and 
0.8982 respectively. To detect a difference in vasoreactivity of 60% (two-tailed), e.g. 5% 
vasodilation versus 8% vasodilation, at 90% power, 23 and 10 subjects would be required for 
cross-sectional and pre-post designs, respectively.  These data indicate adequate stability and 
reproducibility of the BAFMD technique under controlled conditions. 
 The second study investigated the relation between BAFMD and normal plasma 
fibrinogen (PF) in 30 non-smoking, healthy, volunteers (41+12 yr.; range:22-57).  Results 
indicated a 6.08% increase (range:-3.58 to 17.48%) in BAFMD. Correlation analysis indicated 
significant inverse relationships for BAFMD and age r=-0.417 (p=0.02), and for BAFMD and 
PF r=-0.56 (p=0.001). Stepwise multiple regression including PF, age, total cholesterol and 
blood pressure revealed PF as the predominant predictor for BAFMD with 31% of the variance 
accounted for by BAFMD =22.61-(0.05836*PF), with no other variables entered. 
 The final study examined the time-course of changes in BAFMD in response to a 
localized exercise training protocol.  Fourteen healthy males (age: 26 + 5.7) underwent BAFMD 
assessment prior to, during and following 4 weeks (5 days per week) of 60% maximal voluntary 
contraction handgrip training of the non-dominant arm. 
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Following training, paired t-tests revealed a 62% increase in BAFMD for the trained arm (6.2 + 
3.0% to 10 + 4.1%), compared to baseline (p=0.0004), and a 100% difference (10 + 4.1% vs. 4.6 
+ 4.4%) between arms (p=0.0001).  An increase in BAFMD (6.2 + 3.0% to 8.25 + 2.4%), was 
evident following 4 days of training (p=0.015), although individual participant variability 
reduced the statistical power of these findings. There were no changes in hemodynamic, 




CHAPTER 1. INTRODUCTION 
 The purpose of this introductory chapter is to provide a brief insight into the 
underpinning theme of the doctoral work herein, and to provide structure to the subsequent 
document chapters.  Chapters 2 through 4 are articles for publication and therefore individually 
contain brief reviews of the literature to place them in context.  Additionally, a substantial review 
of the pertinent literature is provided in appendix A. 
The circulatory system is designed to cope with a variety of situations and adapts in 
numerous ways to ensure optimal perfusion of the working tissues.  The incredibly complex 
interplay of cardiovascular control mechanisms such as central, local, and reflex interactions 
render it impossible to examine this system in its entirety.  It is therefore prudent to focus on a 
specific area within the whole circulatory system and examine direct influences upon it as of 
primary concern.  Consequently, the focus of this work is the peripheral vascular system and its 
regulation and adaptation to physical stress in health and disease states.  More specifically, the 
vascular responses of the brachial artery to a hyperemic blood flow stimulus. 
The initial step into the investigative process was the development of an easily 
administered technique to provide a possible insight into the health of the cardiovascular system.  
Noninvasive evaluation of flow-mediated dilation of the brachial artery (BAFMD) appeared to be 
an good model to initially develop because it has been suggested as a potential means of identifying 
patients with early atherosclerosis[1, 2].  The theoretical basis for the study of flow-mediated 
dilation is the landmark observation by Furchott and Zawadzki [3] demonstrating the obligatory role 
of the endothelium and endothelium-derived relaxing factors in modulating vascular tone.  
Additionally, Anderson et al., and Takase et al., demonstrated a close relationship between the 
vasoactivity of the coronary and brachial arteries [4, 5].  Consequently, the evaluation of BAFMD 
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has been utilized as a non-invasive measure of vasoreactivity in many studies.  The general 
consensus of these studies indicates reduced BAFMD in the presence of independent cardiovascular 
risk factors.  For example, impaired BAFMD has been linked with cigarette smoking [6], 
hypertension [7, 8], hypercholesterolemia [9-11], hyperhomocystinemia [12], diabetes mellitus [13-
16], and aging [8, 17]. 
Many of these studies utilize external ultrasound imaging devices with high-frequency linear 
array transducers to obtain an image of the brachial artery at rest and following a period of 
forearm occlusion, with the percent change in vessel diameter used as a marker of vascular 
function.  Clearly, the appeal for using such a non-invasive, relatively painless, technique to 
possibly identify early/pre-clinical manifestations of vascular abnormalities is enormous.  
Despite this the stability and reproducibility of this technique are not yet clear.  Therefore the 
goal of the initial dissertation study was to establish the stability and reproducibility of BAFMD 
following 5 minutes of forearm occlusion and produce power calculations to aid in clinical trial 
design. 
 A second step in the research process was to investigate if the BAFMD technique would 
be able to discriminate between groups with different cardiovascular risk in a cross-sectional 
study design.  Plasma fibrinogen was chosen as a variable to investigate for two reasons.  
Primarily, elevated plasma fibrinogen[18] is associated with increased risk for atherosclerotic 
disease, acute myocardial infarction, and stroke.[18-23]  It also increases with age and may 
amplify the effects of other established cardiovascular risk factors.[22]  Although, the 
detrimental effect of plasma fibrinogen and its intermediates is not fully clear, it is thought to 
involve coagulation of platelets, leukocytes, free fatty acids and formation of thrombi.[24]  
Additionally, more recently, plasma fibrinogen has been proposed to act directly on the 
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endothelial wall,[21] causing a reduced ability to release endothelial-derived-relaxing-factors and 
decrease vasoactivity.[25]  Consequently, high plasma fibrinogen contributes to an individual’s 
acute risk of cardiovascular disease through dysregulation of the coagulation process, and to their 
longitudinal risk secondary to vascular dysfunction.  Secondly, the relationship between plasma 
fibrinogen and brachial artery flow mediated dilation (BAFMD) in asymptomatic individuals had 
not previously been investigated. 
 Finally, as an exercise physiologist it was essential to perform a study involving exercise 
stress.  Interestingly exercise training has been shown in various animal and human models to 
preserve or enhance the vasoreactivity of arteries over a four week training period.  It is 
suggested the repeated stimulus of contraction-relaxation and the need to increase the delivery of 
blood flow to active skeletal muscle, promotes a series of vascular responses allowing increased 
vascular conductance and subsequent oxygen and nutrient perfusion to working skeletal 
muscle[26] which, in turn, may eventually lead to vessel structural changes[27]. 
Despite these findings the mechanisms of improvement or the time course of these 
changes, in humans, are not clear at this point, although are in part secondary to changes in the 
smooth muscle and/or endothelial vasoreactivity[28].  Accordingly, the final study in this series 
examined the influence of physical training on vasoreactivity.  A specific aim of the study was to 
investigate the time course of changes in flow-mediated dilation of the brachial artery (BAFMD) 
in response to a 4-week localized exercise training protocol. 
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CHAPTER 2. STABILITY AND REPRODUCIBILITY OF BRACHIAL ARTERY FLOW 
MEDIATED DILATION 
 
 2.1. Introduction 
 Noninvasive evaluation of flow-mediated dilation of the brachial artery has been suggested 
as a potential means of identifying patients with early atherosclerosis [1, 2].  The theoretical basis 
for the study of flow-mediated dilation is the landmark observation by Furchott and Zawadzki [3] 
demonstrating the obligatory role of the endothelium and endothelium-derived relaxing factors in 
modulating vascular tone.  Additionally, Anderson et al., and Takase et al., demonstrated a close 
relationship between the vasoactivity of the coronary and brachial arteries [4, 5].  Consequently, the 
evaluation of BAFMD has been utilized as a non-invasive measure of vasoreactivity in many 
studies.  The general consensus of these studies indicates reduced BAFMD in the presence of 
independent cardiovascular risk factors.  For example, impaired BAFMD has been linked with 
cigarette smoking [6], hypertension [7, 8], hypercholesterolemia [9-11], hyperhomocystinemia [12], 
diabetes mellitus [13-16], plasma fibrinogen [17], and aging [8, 18]. 
 Many of these studies utilize external ultrasound imaging devices with high-frequency 
linear array transducers to obtain an image of the brachial artery at rest and following a period of 
forearm occlusion, with the percent change in vessel diameter used as a marker of vascular 
function.  Clearly, the appeal for using such a non-invasive, relatively painless, technique to 
possibly identify early/pre-clinical manifestations of vascular abnormalities is enormous.  Yet 
despite the large number of cross-sectional studies few trials have reported the effects of 
behavioral or pharmacological interventions using BAFMD as an end point measure.  In fact, the 
stability of this technique is not yet clear, and more importantly, convincing studies concerning 
the reproducibility of the technique are scarce. 
 7
 Accordingly, the purpose of this study was to establish the reproducibility and reliability 
of BAFMD following five minutes of forearm occlusion.  Specifically, this study examined the 
degree of variability of the measurement within and between test days, ultrasound testers, image 
readers, and subjects. Subsequently, the quantitative information was used to produce power 
calculations to aid in the design of simple cross-sectional, repeated measures, and prospective 
clinical trials with brachial artery flow-mediated dilation as an end-point measure. 
 2.2. Methods 
 Twenty-six non-smoking volunteers (38+13 yr.; range: 22-57) (see table 2.1), without overt 
signs of disease were recruited.  Individuals with acute medical conditions or active infection, on 
pharmacotherapy with known vascular effects (e.g. anti-inflammatory or cardiovascular 
medications), or those with Raynaud’s phenomenon, previous arm surgery or known history of 
cardiovascular or kidney disease, or diabetes were excluded.  Following explanation of the study, 
its benefits and risks, subjects signed an informed consent approved by the Pennington 
Biomedical Research Center Institutional Review Board. 
 Brachial artery assessments were obtained using high-resolution ultrasound (Toshiba 
Powervision SSA-380A with a 7.5-MHz linear array transducer) prior to, during, and following 
five minutes of forearm occlusion.  Prior to the experiment subjects were instructed to fast and 
refrain from exercise for 12 hours and alcohol for 48 hours.  Baseline ultrasound images were 
obtained following 15 min of supine rest.  Ultrasound images were obtained in longitudinal view, 
approximately four cm proximal to the olecranon process, in the anterior/medial plane.  With the 
image depth initially at 4cm, gain settings were adjusted to provide an optimal view of the 
anterior and posterior walls of the artery.  Once settings were optimized they were kept constant 
throughout the experiment.  All imaging was performed on the non-dominant arm with the  
 8






Range Minimum Maximum 
Age 
(yr.) 
37 13 35 22 57 
Height 
(cm) 
173 8 25 160 185 
Weight 
(kg) 
72 13 43 48 91 
Body Mass Index 
(Weight/Height2) 
24 4 10 19 29 
Heart Rate 
(beats/min) 
63 12 46 34 80 
Systolic Blood Pressure 
(mmHg) 
118 13 54 104 158 
Diastolic Blood Pressure 
(mmHg) 
76 8 32 64 96 
Total Cholesterol 
(mg/dL) 
178 37 171 113 284 
Low Density Lipoprotein 
(mg/dL) 
102 33 141 48 189 
High Density Lipoprotein 
(mg/dL) 
54 14 52 27 79 
Baseline Artery Diameter 
(mm) 
3.48 0.54 1.89 2.74 4.64 
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subject in the supine position and forearm extended and slightly supinated.  Forearm occlusion 
consisted of inflation of a blood pressure cuff, positioned approximately one cm distal to the 
olecranon process, to 240mmHg for five min. Brachial artery images were recorded on super-
VHS videotape for 30sec at baseline, and continuously from the final 30sec of occlusion until 
5min post release.  Throughout the brachial imaging procedure blood pressures were measured in 
the contra-lateral arm in order to account for any variation in central cardiovascular responses to 
the testing protocol. 
 All subjects were tested between the hours of 7 and 11am in an attempt to control for any 
diurnal variations in brachial artery vasoreactivity [19].  Additionally, blood draws were 
performed immediately following vessel imaging in all participants at all visits. Blood samples 
were examined for lipids, total protein, fibrinogen, glucose, electrolytes, viscosity factors, and 
homocysteine levels to ensure no significant changes occurred between visits. 
 Digital still images captured during diastole, as defined by the onset of the QRS complex, 
were subsequently analyzed (in a blinded fashion) using specialized imaging software (Media 
Cybernetics, Image-Pro Plus).  Arterial diameters (mm) were calculated as the mean distance 
between the anterior and posterior wall at the vessel-blood interface. 
 To address intra and inter-day reproducibility 15 subjects were examined on three 
occasions.  Intra-day assessments were separated by approximately one hour.  The inter-day 
assessment was performed one week later.  To examine technician effect on brachial artery 
assessment two ultrasonographers evaluated 10 participants on two separate occasions.  Testers 
were randomly assigned to each participant.  The effects of image reader bias on the brachial 
artery assessment, two image analysts evaluated a total of 82 images on separate occasions as 
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described above. Finally, to determine intra-analyst variability one analyst re-examined all 82 
images, with the order of images randomized. 
 Statistical analyses were performed using SPSS for Windows (9.0) and SAS. Interclass 
correlation coefficients with confidence intervals were determined for Days, Tester, and Reader. 
Subsequent analysis to determine the magnitude of the variance components was performed 
using the SAS MIXED procedure using the REML for an unbalanced design.  Tests were 
deemed significant at the p<0.05 level. 
 Variance component estimates from model were then used for power calculations for 
three different study designs.  The first of these was a simple cross-sectional approach to 
distinguish between groups (e.g. healthy and diseased).  The second power calculation was 
designed for a simple pre/post longitudinal design (before and after an intervention). 
 2.3. Results 
 Brachial artery diameters, hemodynamic, and hematological data for all subjects at 
baseline on visit one, are shown in Table 2.1.  The average baseline brachial artery diameter for 
the whole data set (across visits) was 3.48+0.53mm (range: 0.52 to 4.66mm).  This increased to 
3.71+0.57mm (range: 0.57 to 5.04 mm) at peak dilation (within 90sec of forearm cuff release), 
representing an increase of 6.58+4.15% (range: -6.51 to 17.48%).  The average baseline blood 
pressures and heart rates for the entire data set was 118+12 over 75+8mmHg at 63+11 beats/min, 
respectively.  There were no significant changes in blood pressure or heart rate from baseline 
during the period of forearm occlusion and immediately following cuff release 
 Within and between day, tester, and reader comparisons.  There were no significant 
changes in baseline brachial artery diameters, blood pressures or heart rates between the three 
visits (Day 1a, Day 1b and Day 2).  Furthermore, no significant changes in hematological 
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variables including, lipids, total protein, fibrinogen, glucose, electrolytes, and homocysteine 
levels were noted from Day 1 to Day 2. 
 The average mean percent difference in BAFMD between days (n=15*3 days) and 
between testers (n=10*2 testers) was 1.91 + 1.07%, with an ICCC of 0.9188 (95%CI = 0.7255-
0.9823; p=0.0001) and 1.40 + 0.97%, with an ICCC of 0.9394 (95%CI = 0.7562-0.9850; 
p=0.0001) respectively.  Additionally the mean absolute difference in BAFMD between readers 
was 0.21 + 0.014mm, with an ICCC of 0.8982 (95%CI = 0.7650-0.9615; p=0.0001). 
 One objective of this study was to determine if there were significant differences between 
different testers and/or readers as this may have important implications for the design of clinical 
trails.  When these were considered as fixed effects there was a significant difference for testers 
(p= 0.0215) but not readers (p= 0.5660).  The REML procedures produced estimates of the 
incomplete model variance components (all random effects) and these are shown in figure 2.1. 
 The database allowed for the fitting of a separate variance component for tester within 
subject by day.  The estimate of this component was zero (see figure 2.1) indicating that although 
there maybe a significant (main effect) difference between testers the difference was consistent 
across the period of study. 
 The results of the power calculations for each of the two study designs are shown in 
figures 2.2 and 2.3.  In a cross-sectional design (i.e. smokers versus non-smokers) it is calculated 
that to detect a brachial artery vasoreactivity difference of 60% (two-tailed), e.g. 5% vasodilation 
versus 8% vasodilation, at 90% power, 23 subjects would be required.  Using an interventional 
design the ability to detect a pre-post difference of 60% (two-tailed) in brachial artery reactivity 
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Figure 2.2. Power Contours for a Cross-sectional Research Design 
To detect a 60% (two-tailed) difference in brachial artery vasoreactivity (e.g. 5% vasodilation 
versus 8% vasodilation) in a cross-sectional study design (i.e. smokers versus non-smokers) at 



































Figure 2.3. Power Contours for an Interventional (parallel) Research Design 
To detect a 60% (two-tailed) difference in brachial artery vasoreactivity (e.g. 5% vasodilation 




 2.4. Discussion 
 Since early work establishing blood flow-dependent increases in brachial artery dilation 
[4, 7, 20], several groups have used this technique as a surrogate marker of cardiovascular risk.  
Obviously if non-invasive evaluation of vasoreactivity is a marker of cardiovascular risk this 
technique could hold great clinical promise.  However, prior to incorporation into clinical trials 
and eventually practice, it is essential the reproducibility and limitations of the technique be 
established. 
 Several laboratories, using similar techniques, have performed studies to assess the 
validity of the BAFMD model.  Evidence of the validity of the measure has not been firmly 
established.  However, evidence of criterion validity stems from studies linking the degree of 
BAFMD following occlusion to coronary vasoreactivity [21] and carotid intima-media thickness 
(a marker of atherosclerosis progression) [22].  Furthermore, given the plethora of studies 
indicating reduced vasoreactivity in individuals with established cardiovascular risk factors 
compared to healthy controls [6-9, 11, 13, 17], suggests the technique also has a high degree of 
construct validity.  Unfortunately, there is a scarcity of published work to determine the 
predictive validity of the measure. 
 Relatively few studies addressed these issues, and of these few, none have controlled for 
factors known to influence vasoreactivity.  It is therefore not surprising there is little consensus 
on the reproducibility of the measurement technique.  For example Hardie and colleagues [14], 
tested 19 healthy young subjects on two separate occasions, approximately 3 months apart.  
Using one ultrasound technician for all scans and two readers for image analysis, they 
demonstrated a mean difference in BAFMD within-observers of 0.13+2.07%, between-observers 
0.06+2.17% and between-studies of 0.57+6.83%.  Hardie et al. concluded that the reproducibility 
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of BAFMD measured by ultrasound was poor and likely to render the measurements inaccurate 
for clinical research. In fact, using the mean values provided by Hardie et al. BAFMD would 
have to improve by approximately 13.7% (e.g. from 3% to 16.7%), to be able to detect a change 
in a pre-post design. Such a change is twice the between study variation. 
 One of the limitations of Hardie et al. was the lack of control for variables know to 
influence BAFMD such as testing time of day, recent meals, caffeine or exercise.  With this in 
mind, it is interesting that Deanfield’s group [1, 23] did find adequate reproducibility in 
BAFMD, despite also not controlling for many of the factors known to influence vasoreactivity.  
In their initial study, they showed, in 21 subjects on two different days, an average difference in 
FMD of 2.8+2.3% with a coefficient of variation of 2.3%.  In 1995 they extended this work in 40 
healthy subjects over four visits in a 4-month period.  The fact flow-mediated dilation was 
calculated as the average of the values obtained by two observers may have acted to reduce 
measurement variability.  Nevertheless, using their measures of reproducibility they estimated 
sample sizes for interventional, trials (treatment vs placebo). Their power calculations suggested 
an improvement in BAFMD of 3% (for example 5% vasodilation versus 8% vasodilation) could 
be detected with 80% power with a sample size of approximately 25 subjects in each group [23, 
24].  The findings of the present study suggest the ability to detect differences in pre and post 
designs using smaller sample sizes. The improvements in power calculations compared to 
Deanfield’s group could be related to two factors; the stricter control of variables known to 
influence arterial vasoreactivity and possible differences in the accuracy of the measurement 
device. 
 Known hematological variables shown to influence arterial vasoreactivity include lipids 
[5, 11], homocysteine [12, 25], fibrinogen [17], and blood glucose [26].  Additionally, blood 
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pressure also has been shown to affect BAFMD. In the present study, many of these variables 
were monitored at each test and were not found to differ within subjects.  Etsuda, et al. [19] 
showed a significant diurnal variation in BAFMD within subjects, demonstrating the importance 
of standardizing the assessment time of day.  Additionally, Title et al. (2000) and Plotnick et al., 
(1997) have demonstrated an attenuated response in BAFMD following a glucose or fat load [26, 
27].  These transient reductions lasted for up to 3 and 4 hours respectively.  Clearly, this 
indicates the importance of the timing of meals prior to testing.  The present reproducibility 
study is the only one to have accounted for these confounding factors by standardizing the time 
of day of testing (between 7 and 10am) and requiring a 12 hour fast. 
 In any study the precision of the measurement tool affects accuracy and limits the ability 
to detect a change following perturbations or interventions.  The resolution of the brachial 
images in the current study allowed a caliper accuracy of 0.028mm.  In contrast Deanfield’s 
group were limited to a caliper accuracy of 0.065mm. 
 The limitations of the present study are related to the unbalanced nature of the statistical 
design.  An a-priori decision was made to account for major variance components encountered 
with this technique.  Consequently the study used a limited number of ultrasonographers (three) 
and image readers (two). In addition, between day variability was limited to only two visits 
scheduled, one week apart. 
 Considerations for the application of this technique in future studies are limited by the 
recency of the protocol itself.  For example there are no current normative data available to 
indicate boundaries between “impaired” and “normal” brachial artery vasoreactivity.  
Furthermore, the current literature has largely focused on peak BAFMD at the 60 and 90-second 
post occlusion time points to identify “dysfunction”.  Careful study of the time course of vessel 
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changes following forearm occlusion is needed to arrive at a more complete understanding of the 
flow-mediated response.  Recognizing the importance of strictly controlled conditions and the 
current limitations, it does appear the next step in the development of this tool is to tie in 
modifications of cardiovascular risk factors with changes in arterial vasoreactivity and to 
ultimately develop a link between arterial vasoreactivity and clinical outcomes. 
 These data indicate adequate stability and reproducibility of the BAFMD technique under 
strictly controlled conditions.  Importantly, to ensure high reproducibility it is recommended 
study designs incorporate a single tester, or block on ultrasonographer to ensure subjects are 
scanned by the same individual each visit.  Additionally, these results provide a series of power 
curves for the estimation of sample size for both cross-sectional and pre-post experimental 
designs using the BAFMD technique as an end-point.  However, the usefulness of this technique 
to examine individuals on a prognostic basis is as yet, unclear. 
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*CHAPTER 3. INFLUENCE OF AGE AND NORMAL PLASMA FIBRINOGEN LEVELS ON 
FLOW-MEDIATED DILATION IN HEALTHY ADULTS 
 
 3.1. Introduction 
Elevated plasma fibrinogen [1] is associated with increased risk for atherosclerotic disease, acute 
myocardial infarction, and stroke [1-6].  Additionally, fibrinogen increases with age and may 
amplify the effects of other established cardiovascular risk factors [5].  The detrimental effect of 
plasma fibrinogen and its intermediates is not fully clear, but is thought to involve coagulation of 
platelets, leukocytes, free fatty acids and formation of thrombi [7].  Recently, plasma fibrinogen 
has been proposed to act directly on the endothelial wall [4], causing a reduced ability to release 
endothelial-derived-relaxing-factors and decrease vasoactivity. Impaired endothelium-dependent 
vasodilation has shown to be an early event in atherogenesis, preceding the formation of plaque 
[8] and occlusive vascular disease in both primate models [9] and humans [10].  Consequently, 
high plasma fibrinogen contributes to an individual’s acute risk of cardiovascular disease through 
dysregulation of the coagulation process, and to their longitudinal risk secondary to vascular 
dysfunction. Given fibrinogen’s role in vascular dysfunction we hypothesized an inverse 
relationship between plasma fibrinogen and brachial artery flow mediated dilation (BAFMD) in 
asymptomatic individuals. Accordingly, this study (1) examined the relation of plasma 
fibrinogen and age, and (2) evaluated the role of plasma fibrinogen on BAFMD using high-
resolution ultrasonography. 
 3.2. Methods 
 Thirty non-smoking volunteers (41+12 yr.; range:22-57), without overt signs of disease 
and normal plasma fibrinogen (283+43mg/dl; range:174-341) were recruited. Individuals with 
acute medical conditions or active infection, on pharmacotherapy with known vascular effects 
                                                 
* Reprinted by permission of “The American Journal of Cardiology” 
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(e.g. anti-inflammatory or cardiovascular medications), or those with Raynaud’s phenomenon, 
previous arm surgery or known history of cardiovascular or kidney disease, or diabetes were 
excluded. Following explanation of the study, its benefits and risks, subjects signed an informed 
consent approved by the Pennington Biomedical Research Center Institutional Review Board.  
 Brachial artery assessments were obtained using high-resolution ultrasound (Toshiba 
Powervision SSA-380A with a 7.5-MHz linear array transducer) prior to, during, and following 
5min of forearm occlusion. Prior to the experiment subjects were instructed to fast and refrain from 
exercise for 12hr and alcohol for 48hr. Baseline ultrasound images were obtained following 15min 
of supine rest. Ultrasound images were obtained in longitudinal view, approximately 4cm proximal 
to the olecranon process, in the anterior/medial plane. With the image depth initially at 4cm, gain 
settings were adjusted to provide an optimal view of the anterior and posterior walls of the artery. 
Once settings were optimized they were kept constant throughout the experiment. All imaging was 
performed on the non-dominant arm with the subject in the supine position and forearm extended 
and slightly supinated. Forearm occlusion consisted of inflation of a blood pressure cuff, positioned 
approximately 1cm distal to the olecranon process, to 240mmHg for 5min. Brachial artery images 
were recorded on super-VHS videotape for 30sec at baseline, and continuously from the final 30sec 
of occlusion until 5min post release. Immediately following the vessel imaging blood draws were 
performed. Digital still images captured during diastole, as defined by the onset of the QRS 
complex, were subsequently analyzed using specialized imaging software (Media Cybernetics, 
Image-Pro Plus). Arterial diameters (mm) were calculated as the mean distance between the 
anterior and posterior wall at the vessel-blood interface. Reproducibility of this technique in our 
laboratory yielded average mean difference in brachial artery diameter change for days, testers, 
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and readers of 1.91%, 1.40%, and 0.21mm respectively, with intra-class correlation coefficients 
of 0.92, 0.94, and 0.90, respectively. 
 Statistical analysis was performed using SPSS for Windows (version 9.0). Group values 
are expressed as mean + SD. Pearson product moment correlation was used to examine 
relationships between brachial artery diameter percent change (BADPC) and age and between 
BADPC and plasma fibrinogen.  An independent sample t-test was used for comparison between 
participants separated by age (younger < 50yr. > older) for plasma fibrinogen levels and 
BADPC. Finally, stepwise multiple regression with BADPC as the dependent variable and 
plasma fibrinogen, age, total cholesterol, and blood pressure as the independent variables was 
performed.  Alpha level of p<0.05 was required for statistical significance. 
3.3. Results 
Baseline data for subjects are shown in Table 3.1. Plasma fibrinogen were all within the 
normal range. Brachial artery diameter increased from 3.60+0.71mm at baseline to 
3.82+0.74mm at peak dilation (within 90 sec of cuff release), representing a 6.08% increase 
(range:-3.58 to 17.48%). Correlation analysis indicated significant inverse relationships for 
BADPC and age r=-0.417 (p=0.02), and for BADPC and plasma fibrinogen r=-0.56 (p=0.001) 
(Figure 3.1). Comparison between the younger and older groups showed significant differences 
in BADPC, (younger: 7.65+3.97% and older: 2.93+3.93%, p=0.005) and plasma fibrinogen 
(younger: 269+45mg/dl and older: 311+23mg/dl, p= 0.002), but not for blood lipid or 
hemodynamic variables (Table 3.2). 
Stepwise multiple regression analysis including plasma fibrinogen, age, total cholesterol 
and blood pressure revealed plasma fibrinogen as the predominant predictor for BADPC with  
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Table 3.1. Baseline participant characteristics 
 
 Mean SD Range Minimum Maximum
Age 
(yr.) 
42 12 35 22 57 
Height 
(cm) 
170 8 28 157 185 
Weight 
(kg) 
76 15 55 48 103 
Heart Rate 
(beats/min) 
63 11 50 34 84 
Systolic Blood Pressure 
(mmHg) 
120 13 54 104 158 
Diastolic Blood Pressure 
(mmHg) 
76 8 32 64 96 
Total Cholesterol 
(mg/dL) 
195 39 171 113 284 
Low Density Lipoprotein 
(mg/dL) 
114 34 141 48 189 
High Density Lipoprotein 
(mg/dL) 
56 15 64 27 91 
Triglyceride 
(mg/dL) 
116 59 275 33 308 
Plasma Fibrinogen 
(mg/dl) 
283 43 167 174 341 
Baseline Artery Diameter 
(mm) 
3.60 0.71 2.62 2.55 5.17 
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Brachial Artery Diameter 
Change (%) 
7.65+3.97 2.90+3.93 3.08 0.005* 
Age 
(yr.) 
36+11 53+3 -6.49   < 0.001* 
Plasma Fibrinogen 
(mg/dl) 
269+45 311+23 -3.33 0.002* 
Peak Blood Flow Velocity 
(cm/sec) 
178+36 169+55 0.533 0.59 
Heart Rate 
(beat/min) 
61+11 66+12 -0.98 0.336 
Systolic Blood Pressure 
(mmHg) 
117+11 127+15 -1.98 0.57 
Diastolic Blood Pressure 
(mmHg) 
76+6 76+10 0.67 0.95 
Total Cholesterol 
(mg/dL) 
189+42 208+33 -1.28 0.21 
Low Density Lipoprotein 
(mg/dL) 
112+37 118+25 -0.46 0.65 
High Density Lipoprotein 
(mg/dL) 
54+14 59+7 -0.82 0.42 
Triglyceride 
(mg/dL) 
112+62 125+52 -0.55 0.59 
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Figure 3.1. Relationship between BADPC and Plasma Fibrinogen 
BADPC = brachial artery diameter percent change from baseline 
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31% of the model variance accounted for by the equation BADPC =22.61-(0.05836*PF), with no 
other variables entered into the model. 
 3.4. Discussion 
 The unique finding of this study is the inverse relation between normal plasma fibrinogen 
levels and BAFMD. This finding indicates elevated plasma fibrinogen may decrease arterial 
responsiveness to certain vasodilatory signals such as shear stress. Given the link between 
impaired flow mediated dilation and cardiovascular disease [1, 5, 6, 11, 12] this suggests an 
additional important role for fibrinogen in maintaining chronic vascular integrity/function. In 
fact, multivariate analysis revealed plasma fibrinogen to be the predominant predictor for 
BADPC when age, total cholesterol and blood pressure were included in the model. The 
mechanisms of action of fibrinogen on vasoreactivity are not fully understood but may involve 
alterations in blood viscosity and/or chemistry causing ensuing chronic elevated stress on the 
artery wall with gradual depletion of endothelial derived relaxing factors. This may subsequently 
contribute to a loss in vasoactivity and render the vessel vulnerable to prothrombic factors and 
ultimately proliferation of vascular smooth muscle and possibly cardiovascular disease.  The fact 
plasma fibrinogen is modifiable by exercise [2, 13, 14], diet [15, 16], and drug treatment 
warrants further study to determine if a decrease in plasma fibrinogen results in improved 
vascular function. 
In summary, this study shows an inverse association between age-related normal plasma 
fibrinogen levels and brachial artery flow-mediated dilation, in 30 healthy non-smokers.  Given 
the links between impaired flow-mediated dilation and cardiovascular disease this indicates an 
important role for fibrinogen in maintaining chronic vascular integrity/function, in addition to the 
risk for thrombus formation. 
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CHAPTER 4. THE TIME-COURSE OF VASCULAR ADAPTATIONS FOLLOWING 
LOCALIZED SHORT-TERM EXERCISE TRAINING 
 
 4.1. Introduction 
Selye’s theory of stress-response-adaptation, when applied to the vascular system 
suggests; exercise stress leads to changes in vascular responses, followed by adaptations in the 
vasculature itself[1].  In this case, the stress induced by exercise results in an increased delivery 
of blood flow to active skeletal muscle.  This repeated stimulus promotes a series of vascular 
responses allowing increased vascular conductance and subsequent oxygen and nutrient 
perfusion to working skeletal muscle[2] which, in turn, may eventually lead to vessel structural 
changes[3].   
Increased vasoreactivity following a chronic increase in blood flow was first 
demonstrated by Miller and colleagues in canine femoral arteries following the opening of an 
arteriovenous anastamosis[4, 5].  In 1992, Lash and Bohlen, found large and intermediate sized 
arterioles of the spinotrapezius in aerobically trained rats (8-10 weeks treadmill exercise) 
exhibited greater dilation than controls, to 1-8Hz stimulation[6].  Similar responses following 8-
10 weeks of exercise training have been reported in various segments of animal vasculature such 
as the coronary arteries,[7-10] thoracic and pulmonary arteries and arterioles,[11] the abdominal 
aorta[12-14] and arterioles and capillary beds of skeletal muscle[6, 15-18].  Few human studies 
have examined the influence of physical training on vasoreactivity.  However, recent work 
utilizing localized resistance training programs have been shown to support an intensity 
independent 4-week adaptation in the forearm in the absence of central hemodynamic and 
sympathetic modulations[19-22].  Despite these findings the mechanisms of improvement or the 
time-course of these changes, in humans, are not clear.  However, they appear to be, in part, 
secondary to changes in the vascular smooth muscle and/or the endothelium[14]. 
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Accordingly, the purpose of this study was to examine the influence of physical training 
on vasoreactivity.  A specific aim of the study was to investigate the time-course of changes in 
flow-mediated dilation of the brachial artery (BAFMD) in response to a 4-week localized 
exercise training protocol.  It was hypothesized significant increases in peripheral conduit artery 
responsiveness would occur within the training period as represented by an increase in BAFMD. 
 4.2. Methods 
 Fifteen healthy, sedentary volunteers (age 26 + 5.7 yr.) were recruited to participate in 
this study.  Smokers, those with renal impairment or proteinuria, hepatic impairment, gout, 
anemia, hypercholesterolemia, hypertension, diabetes, acute medical/congestive conditions, 
active infection, Reynaud’s phenomenon, or previous arm surgery were excluded from this 
study.  Additionally, participants currently on pharmacotherapy with known vascular effects (e.g. 
anti-inflammatory or cardiovascular medications) were excluded.  Each participant was required 
to complete an informed consent approved by the Institutional Review Boards of Pennington 
Biomedical Research Center and Louisiana State University. 
 The study was a prospective design consisting of a 4-week non-dominant arm (TR) 
training protocol.  The protocol was localized to the forearm and the participant’s dominant arm 
(UTR) served as the study control.  Brachial artery flow-mediated dilation, defined as the 
absolute and percent vessel diameter change from rest, following hyperemia were the major 
endpoints of this study.  Additionally, blood variables known to influence vasoreactivity were 
also examined. 
 Participants forearm circumferences and handgrip maximal voluntary contraction (MVC) 
were assessed at baseline (taken as the average of 3 consecutive trials) and on a weekly basis during 
training to enable the workout intensity to be adjusted appropriately.  The exercise training involved 
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20 minutes of handgrip exercise (using a Stoelting dynamometer), at an intensity of 60% MVC and 
a contraction rate of 1 contraction every 4 seconds for 5 consecutive days of each week for a 4-week 
period[22].  Assessments of BAFMD in both the TR and UTR were made twice per week during 
the training period. 
 Blood samples were drawn before and after the training period and examined to ensure 
all subjects were within normal ranges, and that no significant changes occurred in variables 
(lipids, total protein, fibrinogen, glucose, electrolytes, and viscosity factors) known to influence 
BAFMD.  Finally, anthropometric measures including, height, weight and 3-site skinfolds[23] 
along with a symptom-limited maximal arm ergometer test[24-26] were performed prior to and 
following the training. 
 The arm ergometer test consisted of the participant, in a seated position, turning an arm 
ergometer at a speed of 50 rpm and initial resistance of 0.5kp for 2 minutes. The resistance was 
then increased by 0.25kp every 2 minutes until the subject could not maintain the pedal cadence, 
or requested to stop. 
 Brachial artery assessments were obtained using high-resolution ultrasonography (with a 
7.5-MHz linear array transducer) prior to, during, and following 5min of forearm occlusion.  Prior 
to each experiment the subjects were instructed to fast and refrain from exercise for 12hr and 
alcohol for 48hr. Baseline ultrasound images were obtained following 15min of supine rest.  
Ultrasound images were obtained in longitudinal view, approximately 4cm proximal to the 
olecranon process, in the anterior/medial plane.  With the image depth initially set at 4cm, gain 
settings were adjusted to provide an optimal view of the anterior and posterior walls of the artery.  
Once settings were optimized they were kept constant throughout the experiment.  All imaging was 
performed with the participant in the supine position and their forearm extended and slightly 
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supinated.  Forearm occlusion consisted of inflation of a blood pressure cuff, positioned 
approximately 1cm distal to the olecranon process, to 240mmHg for 5min.  Brachial artery images 
were recorded on super-VHS videotape for 30sec at baseline, and then continuously from the final 
30sec of occlusion until 5min post release.  Digital still images were captured during diastole, as 
defined by the onset of the QRS complex, and subsequently analyzed using specialized imaging 
software (Media Cybernetics, Image-Pro Plus).  Arterial diameters (mm) were calculated as the 
mean distance between the anterior and posterior wall at the vessel-blood interface.  This 
procedure was repeated for the UTR.  Reproducibility of this technique in our laboratory has 
previously yielded average mean differences in brachial artery diameter change for days, testers, 
and readers of 1.91%, 1.40%, and 0.21mm respectively, with intra-class correlation coefficients 
of 0.92, 0.94, and 0.90, respectively[27]. 
 All statistical analyses were performed using SPSS for Windows (version 10.0) and SAS 
(version 8.1).  Repeated measures t-tests were used to detect changes pre- and post-training for 
absolute and percent BAFMD change, forearm circumferences, MVC, maximal arm ergometer 
time, hemodynamic variables (SBP, DBP, HR), autonomic balance (SDNN), and hematological 
factors (total cholesterol, LDL, HDL, TGL, Glucose, K+, and Fe+). 
The differences between arms and across the training protocol for absolute and percent 
BAFMD were subjected to repeated measures t-tests followed by a 9 (time) * 2 (arms) analysis 
of variance (ANOVA) and orthogonal polynomial contrasts (linear and quadratic) used to test for 
trends/deviations over time.  Subsequently, brachial artery responses were grouped as pre (prior 
to the initiation of training) and post (all measures following the initiation of training), and 
subjected to a 2x2 repeated-measures analysis of variance (ANOVA), blocked on subject.  Alpha 
was set a priori at p<0.05 for all statistical analyses. 
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 4.3. Results 
 The initial number of participants was 16, however one was excluded for non-compliance 
and one subject voluntarily removed himself from the study.  Participant baseline characteristics 
are shown in table 4.1. 
 All subjects completed at least 18 of 20 handgrip training sessions over the 4-week 
period.  Repeated measures t-tests revealed forearm circumference increased by 1.24% 
(p=0.001) in the TR compared to 0.06% in the UTR (p=0.858) following training (see table 4.2).  
Additionally, MVC increased by 6.32% (p=0.005) in the TR compared to 4.71% (p=0.126) in 
the UTR following training (see table 4.2). 
 The results of repeated measures t-test for pre- and post-training measures for maximal 
arm ergometer time, cardiovascular hemodynamics (SBP, DBP, HR) and autonomic balance 
(SDNN), and hematological profiles (total cholesterol, LDL, HDL, TGL, Glucose, K+, and Fe+) 
can be seen in table 4.3.  There were no significant differences in any of the variables measured. 
The TR and UTR vascular measures over the course of the training regimen are shown in 
tables 4.4a and 4.4b respectively.  Paired sample t-tests to determine the effects of training on the 
TR revealed no change in brachial artery resting diameters and velocities, hyperemic blood 
velocity (peak rel vel), or post hyperemic diameter (peak diam).  The percent (p=0.0004) and 
absolute (p=0.007) brachial artery changes were significantly higher following training.  
Additionally, a subsequent paired t-test revealed a significant difference between arms following 
training for the percent (p=0.0001) (see figure 4.1) and absolute (p=0.0007) brachial artery 
changes. 
 The time-course of changes in vascular reactivity following training for each participant 
can be seen in figure 4.2.  Despite 12 of the 14 subjects showing an increase in absolute and  
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Table 4.1. Participant Characteristics 
Variable Mean + SD 
Age (yr.) 26 + 5.7 
Ht (cm) 177 + 8.1 
Wt (kg) 68 + 10 
BIA (%) 17 + 4.4 
BMI 22 + 1.7 
Waist/Hip 0.88 + 0.05 
SBP (mmHg) 115 + 15 
DBP (mmHg) 75 + 6 
HR (bt/min) 68 + 10 
Physical Activity Score 7.19 + 0.8 
 
(BIA = bio-electrical impedance; BMI = body mass index) 
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Table 4.2. Forearm circumference and Handgrip MVC pre and post training 
Variable Non-Dominant (trained arm) 
(n=14) 
Dominant (untrained arm) 
(n=14) 
 Pre 
Mean + sd 
Post 
Mean + sd 
%change 
Mean + sd 
Pre 
Mean + sd 
Post 





42.88+8.7 45.64+9.9 6.32+6.1* 46.42+9.7 48.54+10.7 4.71+10.4 
Arm Circ 
(cm) 
25.77+1.7 26.09+1.8 1.24+1.1* 26.53+1.8 26.55+1.7 0.06+1.2 
(* = p<0.05 as compared to pre values) 
(MVC = maximal voluntary contraction; Arm Circ = forearm circumference)
 37
Table 4.3. Hemodynamic, Autonomic, and Hematological values pre and post training 
Variable Pre 
Mean + sd 
Post 
Mean + sd 
p-value 
Max Arm Crank (min) 7.09 + 3.6 7.09 + 3.8 1.0 
SBP (mmHg) 115 + 15 111 + 8 0.269 
DBP (mmHg) 75 + 6 75 + 5 0.887 
HR (beat/min) 68 + 10 64 + 5 0.320 
SDNN (ms) (n=7) 54.25 + 20.38 52.13 + 19.47 0.959 
TC (mg/dl) 173.38 + 25.9 170.15+ 24.5 0.412 
LDL (mg/dl) 104.22 + 23.3 102.5 + 20.3 0.609 
HDL (mg/dl) 46.69 + 8.8 45.92 + 10.9 0.545 
TGL (mg/dl) 112.93 + 61 108.69 + 61.7 0.808 
GLU (mg/dl) 94.84 + 5.5 94.69 + 7.6 0.942 
K+ (mmol/l) 4.06 + 0.2 4.16 + 0.4 0.408 
Fe+ (ug/dl) 108.53 + 47.6 95.08 + 37.4 0.108 
 
(Max Arm Crank = maximal arm crank time; SDNN = heart rate variability; TC = total 
cholesterol, LDL = low density lipoprotein; HDL = high density lipoprotein; TGL = 
triglycerides; GLU = glucose; K+ = potassium; Fe+ = iron) 
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 Table 4.4a. Non-dominant (TR) arm brachial artery dynamics during the 4-week training regime 
 
 (rest diam = artery diameter at rest;  rest vel = blood flow velocity at rest;  peak diam = artery 
 diameter at peak dilation;  peak rel vel = peak hyperemic blood velocity immediately following 
 occlusion;  absol chg = arterial diameter change from baseline to peak dilation; 




















































































































































 Table 4.4b. Dominant (UTR) arm brachial artery dynamics during the 4-week training regime 
 
 (rest diam = artery diameter at rest;  rest vel = blood flow velocity at rest;  peak diam = artery 
 diameter at peak dilation;  peak rel vel = peak hyperemic blood velocity immediately following 
 occlusion;  absol chg = arterial diameter change from baseline to peak dilation; 









































































































































































Figure 4.1. Mean values for % change in BAFMD before and following treatment 




































Figure 4.2. Non-dominant (TR) arm peak hyperemic flow-mediated dilation values for all 
subjects 
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percent BAFMD from pre to post training a 9 (time) by 2 (arm) analysis of variance (ANOVA), 
along with orthogonal polynomial contrast statistics failed to reveal any significant differences or 
patterns across the training period (see figure 4.2). 
 Subsequently, to provide greater statistical power for the analysis and account for inter-
participant variation, the absolute and percent BAFMD means for all the post-training time 
points were pooled to represent a post-training measure.  A 2x2 repeated-measures analysis of 
variance (ANOVA) for baseline and post-training (all time points pooled), blocked on subject, 
revealed significant differences between arms (p=0.0157) and an interaction effect (p=0.0477).  
Post-hoc LSD analysis results revealed no significant differences in baseline BAFMD between 
arms or between baseline and post training BAFMD in the UTR arm.  However BAFMD in the 
TR arm was significantly elevated post-training (see figure 4.3). 
To strengthen this finding paired t-test analysis revealed a significant increase in peak 
absolute (p=0.005) and peak percent (p=0.015) BAFMD following one week of training (see 
figures 4.4a and 4.4b).  Furthermore, there were no significant differences for the TR between 
week 2b and the remainder of the trial. 
 Combined, these results indicate there was a significant increase in whole group BAFMD 
in the TR as compared to the UTR.  Additionally, the pooled ANOVA and repeated measures t-
tests suggest this change occurred by the end of the first week of training. 
 4.4. Discussion 
 This study examined the influence of physical training on vasoreactivity and specifically 
considered the time-course of vascular adaptations following localized short-term exercise 
training.  The findings indicate that BAFMD was significantly elevated by approximately 62% 


































Figure 4.3. Results of 2 * 2 ANOVA (pooled post time points) 

























Figure 4.4a. Group mean values for peak percent BAFMD across the training regimen 
(* = p < 0.05 as compared to baseline; # = p < 0.1 as compared to baseline) 



































Figure 4.4b. Group mean values for peak absolute BAFMD across the training regimen 
(* = p < 0.05 as compared to baseline; # = p < 0.1 as compared to baseline) 










are in agreement with previous whole body training studies reporting improvements of 77% in 
the brachial (2.2% dilation at baseline to 3.9% following 10 weeks of training) and 58% in the 
radial (8.6% dilation at baseline to 13.6% following 4 weeks of training) in healthy and heart 
failure populations respectively[28, 29].  These similarities are despite the fact, whole body 
studies do not account for adaptations in central cardiovascular control mechanisms and its 
influence on vasoreactivity. 
A unique contribution of this study is the unilateral training design and measurement of 
brachial vasoreactivity in both the TR and UTR arms.  Previous, studies utilizing similar designs 
but different assessment techniques found improvements of 30%, 23% and 20.6% in healthy 
young subjects forearm blood flow, following 4 weeks of handgrip training at workloads of 70%, 
75% and 75% MVC respectively[19, 20, 22].  These studies utilized strain gauge 
plethysmography which may provide an accurate measure of blood flow at the tissue bed 
resistance arterioles.  The present study extends the current knowledge to show a unilateral 
change in a large conduit vessels following training using ultrasonography.  Although the 
comparison between whole tissue bed and single vessel adaptations are not direct ones, it is 
noteworthy that the directions of changes are the same. 
 The next logical step for this work was to demonstrate a differentiation of vasoreactivity 
improvements specific to the training stimulus.  In 1993, Katz et al., demonstrated a regional 
specificity of training adaptations following 8 weeks of lower extremity aerobic training.  They 
showed an increase in acetylcholine-mediated dilation in the trained lower extremity but not in 
the untrained upper extremity in normal subjects[30].  The current study demonstrated a post 
training unilateral improvement in vasoreactivity limited to the TR as compared to the UTR of 
100.3% (10% vs 4.6%).  These results are in agreement with the plethysmography work of 
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Sinoway et al., Green et al., and Alomari et al., who showed differences between arms of 25%, 
17%, and 10%, respectively[19, 20, 22]. 
This aspect of the study design allows us to postulate that the improvement in 
vasoreactivity is a locally mediated phenomenon.  The basis of this argument is two-fold; 
primarily, the increases in vasoreactivity were limited to only the TR and additionally, these 
results occurred without any alterations in central hemodynamics, autonomic balance or 
hematological profile.  A physiological explanation for this localized improvement could involve 
either mechanical or chemical stimuli.  For example, repetitive mechanical muscle contractions 
initiate rhythmical modulations in blood flow and vessel shear stresses may mediate an up 
regulation of the nitric oxide, and/or prostacyclin enzyme pathways[8, 31], inhibition of 
norepinephrine release from adrenergic nerves[32], decreased sensitivity of the α2–adrenergic 
receptor mechanism to norepinephrine[12, 13], or smooth muscle sarcoplasmic reticulum 
calcium unloading[33, 34].  The location of these changes is currently unclear.  Several studies 
report increases in vasodilator mRNA and proteins at the site of the conduit vessel itself[11, 12, 
14] while more recently the same laboratory suggest these changes occur in smaller distal 
vessels[35].  Alternatively, local accumulations of metabolites and vasoactive substances in 
distal tissue beds could play a role in these adaptations.  In fact, previous studies have shown an 
increase in oxidative enzyme activity may precede the increases in vasoresponsiveness[14].  The 
differences in these finding could in fact be related to the duration of the training stimulus.  
Conduit artery protein upregulation may occur early in the exercise-adaptive process and return 
to normal later in the training period[35].  Interestingly, the differences in magnitude of the 
improvements observed between plethysmography and ultrasonography could eventually provide 
us with a window into the order of this vascular signaling or adaptations in response to training. 
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Although this idea needs further refinement it is interesting that flow-mediated dilation 
examinations of vascular responsiveness have consistently reported increases, whereas 
pharmacological approaches to vascular responsiveness and exercise training are less consistent.  
In fact, Joyner et al., suggests that pharmacological infusions given via the brachial artery in 
humans may actually reflect events at the resistance arteries rather than the conduit vessels[36].  
If we consider this in conjunction with Laughlin’s schema of non-uniform vasomotor 
responsiveness and adaptation of the arterial tree, albeit in the coronary vasculature,[3, 37] it is 
possible that different locations or receptors/pathways are being measured with different 
techniques.  For example during pharmacological interventions the stimulus to dilate may 
precede the increase in blood flow, activating ß2 or muscarinic receptors in the smaller distal 
vessels, whereas flow-mediated interventions target stretch-activated potassium channels and/or 
some form of endothelial cytoskeleton which transduces the signal into the cell and appears to be 
relatively more important in the larger proximal conduit arteries[38]. 
The final and unique aspect of this study is the examination of the time-course of 
vascular adaptations following short-term exercise training.  Initially, a 9*2 analysis of variance 
and orthogonal polynomial contrasts did not reveal any significant differences or patterns across 
the training period.  Figure 4.2 illustrates that although 12 of the 14 participants showed increase 
in vasoreactivity, there is a large degree of variability in the individual plots and consequently an 
inability to establish a standard time-course of changes for all participants.  This could be 
attributed to several factors.  Obviously, it is possible different subjects display different time-
courses of adaptation and that no ‘standard curve’ exists.  Additionally, some participants may be 
hyper or hypo responders to various vascular influences which could cloud the data.  Although 
each ultrasound scanning session was standardized as much as possible, the fact that participants 
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were required to attend 8 post training sessions over the course of the study lends itself to day by 
day variations in subject responses and variations in external influences known to effect 
vasoreactivity.  For example time of day[39], mental stress[40-42], diet[43, 44] and the relation 
of food consumption to testing[45, 46] have all been shown to influence conduit artery 
vasoreactivity.  It is also feasible that the BAFMD technique itself currently lacks the 
specificity/sensitivity to differentiate between individuals and is more suited to differentiating 
between small groups[27]. 
In order to examine the group time-course adaptations to the exercise training stimulus 
and reduce the influence of individual participant variations, the values for all the post-training 
time points were pooled and subjected to a 2*2 repeated measures ANOVA for arm and pre vs. 
post-training blocked on subject.  This revealed a unilateral vasoreactivity improvement.  This 
combined with a paired t-test analysis suggests this change occurred after only 4 days of training 
(see figures 4.3 and 4.4). 
To the author’s knowledge there is only one other published investigation involving the 
time-course of vasoreactivity improvements with exercise training.  In 1997, Delp and associates 
treadmill ran rats at 30m/min on a 15% incline for 1hr/day, for 5days/week, and subsequently 
sacrificed them after 1 day, and 1, 2, 4, and 10 weeks.  Aortic segments were then tested within 
24hrs of the last exercise bout.  To measure vasodilation the aortic segments were first treated 
with norepinephrine, which induced a similar tension in all groups.  A single dose of 
acetylcholine was then used to induce endothelial-mediated vasodilation.  The percent dilation in 
sedentary rats (61%) was similar to that in ring segments from animals in the 1 day, 1 week and 
2 week training groups.  However, the percent relaxation of the vessel rings was greater in the 4 
week (72%) and 10 week (79%) trained rats[14]. 
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The differences between Delp’s findings and the current study can be attributed to many 
factors including species and arterial bed differences, or the fact that one study is in an intact in 
vitro model treated pharmacologically, whilst the other is in vivo stimulated by reactive 
hyperemic blood flow.  Nevertheless, both studies show a time point differentiation in group 
responses.  Interestingly, to add strength to the current findings, in 1993 Wang et al., reported an 
increase in nitric oxide mediated dilation response in the dog circumflex coronary artery in vivo, 
to both acetylcholine and hyperemia, following 7 days of treadmill exercise training[10]. 
Given the current understanding of the pathogenesis of atherosclerosis, which proposes 
that vascular dysfunction may be an initiating event[47], in conjunction with animal and human 
studies which consistently demonstrate vascular dysfunction in disease models, the importance 
of a treatment to increase vasoreactivity is tremendous.  Regular exercise training may not only 
provide a mechanism to combat atherosclerosis by the modification of established risk factors, 
but may also exert a direct influence on the vascular wall itself. 
In conclusion, 4-weeks of unilateral handgrip training enhanced vascular reactivity in the 
trained limb as compared to the control limb.  The time-course of this adaptation appeared to 
occur following the first 4 days of training although individual participant variability reduced the 
statistical power of these findings.  Given the relative modernity of this research area and the 
lack of published work addressing the questions of vascular stress adaptation it becomes obvious 
that the vasculature tone involves a complex interplay of many factors and additional work is 
required to fully differentiate the physiological mechanisms involved. 
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CHAPTER 5. SUMMARY 
 The purpose of this final chapter is to summarize and tie together the findings and 
conclusions from this body of work.  It must be appreciated that although this is a literal 
presentation of completion of requirements for a degree there are several other projects along the 
same theme which unfortunately did not make the cut but still exerted an influence into the 
design, application, and therefore the results and conclusions of these studies.  These findings 
must also be viewed in context to the wider literature in this field, which is touched upon in 
Appendix A.  Given the exploding nature of the volume of studies in this field this whole 
document can barely scratch the surface and is also outdated at the time of final printing.  Taking 
these things into consideration, the findings of these three studies hopefully make a meaningful 
contribution to the field and will be significant in the direction and design of other peoples work. 
 The initial study (chapter 2) investigating the stability and reproducibility of brachial 
artery flow-mediated dilation indicated adequate stability and reproducibility of the technique 
under strictly controlled conditions.  Importantly, to ensure high reproducibility it is 
recommended study designs incorporate a single tester, or block on ultrasonographer to ensure 
subjects are scanned by the same individual each visit.  Additionally, the results provided a series 
of power curves for the estimation of sample size for both cross-sectional and pre-post 
experimental designs using the brachial artery flow-mediated dilation (BAFMD) technique as an 
end-point.  However, the usefulness of this technique to examine individuals on a prognostic 
basis is as yet, still unclear. 
 The second study (chapter 3) investigating the influence of age and normal plasma 
fibrinogen levels on flow-mediated dilation in healthy adults was a cross sectional study and 
utilized the validated technique from study 1.  This work revealed an inverse relation between 
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normal plasma fibrinogen levels and BAFMD.  Therefore, elevated plasma fibrinogen may 
decrease arterial responsiveness to certain vasodilatory signals such as shear stress. Given the 
link between impaired flow mediated dilation and cardiovascular disease [1-5] this suggests an 
additional important role for fibrinogen in maintaining chronic vascular integrity/function. In 
fact, multivariate analysis revealed plasma fibrinogen to be the predominant predictor for 
BAFMD when age, total cholesterol and blood pressure were included in the model. The 
mechanisms of action of fibrinogen on vasoreactivity are not fully understood but may involve 
alterations in blood viscosity and/or chemistry causing ensuing chronic elevated stress on the 
artery wall with gradual depletion of endothelial derived relaxing factors. This may subsequently 
contribute to a loss in vasoactivity and render the vessel vulnerable to prothrombic factors and 
ultimately proliferation of vascular smooth muscle and possibly cardiovascular disease.  The fact 
plasma fibrinogen is modifiable by exercise [6-8], diet [9, 10], and drug treatment warrants 
further study to determine if a decrease in plasma fibrinogen results in improved vascular 
function. 
 Following the identification of group difference using BAFMD it was important as an 
exercise physiologist to investigate the effects of an exercise intervention on the vasculature and 
its responses to stress.  Although we know exercise has an indirect effect on vascular health by 
modifying hemodynamic, autonomic and hematological variables, it may also have a direct 
effect on the vasculature itself and if so over what period of time.  Therefore the final study was 
a localized handgrip exercise intervention study investigating the time-course of vascular 
adaptations following localized short-term exercise training. 
 The findings of this work were unique in two ways.  Initially, this was the first study to 
demonstrate 4-weeks of unilateral handgrip training enhanced vascular reactivity in the trained 
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limb as compared to the control limb.  Secondly, the time-course of this adaptation appeared to 
occur following the first 4 days of training. 
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APPENDIX A. HUMAN CIRCULATION: THE PERIPHERAL VASCULAR SYSTEM AND 
ITS REGULATION AND ADAPTATION TO PHYSICAL STRESS IN HEALTH AND 
DISEASE 
 
 A.1. Physical Characteristics of Circulation 
 A discussion of the circulatory system can be organized according to several different 
classifications that relate to the duties or tasks performed.  The primary tasks of the circulatory 
system are the transport of oxygen and carbon dioxide.  Accordingly, the most liberal 
discrimination deals with the exchange of gases at the lungs as a separate entity to the exchange 
of gases at the tissues; pulmonary and peripheral circulation respectively.  Within these 
groupings the nature of the tissue and its specific demands for blood flow delivery and removal 
are reflected in the structure of the carrying vessels.  For example, peripheral circulatory arteries 
during supine rest, are responsible for receiving approximately 80 ml of blood per second in a 
pulsatile manner, from the left ventricle, with pressures ranging from around 80 to 120 mmHg.  
They are also responsible for delivering and evenly distributing approximately 0.02-0.05ml/gram 
of blood to muscle tissue at pressures of around 17 mmHg.  Obviously the aorta, which initially 
receives the blood, is very different in structure and function from the arterioles and capillaries, 
which finally deliver it. 
 “The blood flow to each tissue of the body is almost always precisely controlled in 
relation to the tissues needs” [1] 
 
The structure and function of the circulatory system allow exercise increases in tissue 
demand of up to 30 times resting levels, to be accommodated.  The heart, however, can only 
increase its output approximately 5 fold.  Therefore, integral changes in vascular control at the 
vessels themselves allow for the redirection and the matching of blood demand and supply.  To 
this end, the arteries act as pressure and direction controllers while the veins act as capacitors to 
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keep the heart supplied with blood, ensuring cardiac output.  In this chapter the structure and 
function of the peripheral or systemic vascularture will be examined. 
  A.1.1. The Physical Anatomy of Circulation 
The wall structure of almost the entire vascular system consists of three layers, an intima, 
a media, and an adventitia.  The very thin capillaries contain only an intima.  The intima is 
defined as consisting of a single layer of endothelial cells lining the vascular wall.  In large 
vessels these are attached to a thin basal lamina which in turn, is connected to a sub-endothelial 
layer comprised of collagenous bundles, elastic fibrils, smooth muscle cells and fibroblasts [2].  
The media is the middle layer of the vascular wall and consists of smooth muscle cells arranged 
within layers of elastic sheets and bundles of collagenous fibers.  Finally, the outermost layer or 
adventitia consists of dense fibroelastic tissue without smooth muscle cells (except longitudinal 
bundles in large veins).  It provides stability to the vessel and connects it to surrounding tissues.  
The adventitia also contains the vasa vasorum, for nutrition to the media, and nerves for vascular 
control.  The exact composition of each of the three layers varies for different types of vessels 
and is generally related to the tasks each vessel performs.  For a complete review of the 
architecture of vascular tissues please refer to [2]. 
   A.1.1.1. Arteries 
Essentially arteries can be classified as either elastic or muscular.  Elastic arteries are 
large and initially receive blood from the heart under pressure.  They act as low resistance 
pathways (conducting arteries) carrying blood to the medium sized muscular arteries, which flow 
in to even smaller arterioles, then capillaries and finally return to the heart via the venous system. 
The aorta is a good example of an elastic artery.  It has a diameter of approximately 15 
mm and very little nervous innervation.  The walls consist of both smooth muscle and elastic 
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laminae (40 to 60 fenestrated layers in the aorta) to enable them to resist the constant fluctuations 
in volume and pressure during the cardiac cycle.  A major functional advantage of this is an 
ability to stretch during systole and “rebound” during diastole thereby helping to reduce these 
fluctuations and propel blood forward more “smoothly” to the delicate vessels further along the 
vascular tree. 
Muscular arteries are immediately distal to the elastic arteries and have a diameter 
ranging from 10mm to 3mm, decreasing progressively away from the heart.  The walls are less 
elastic and contain predominately smooth muscle cells.  The brachial and femoral arteries are 
good examples of muscular arteries.  Wall thicknesses of these vessels also decrease distally 
until they become arterioles. 
Arterioles have a diameter of approximately 0.3mm to 10µm and a wall that often 
consists of just an endothelial lining and a muscular layer.  Several factors can influence 
arterioles to change their lumen diameter including, nervous innervation, locally released 
metabolites and, blood-borne products. 
The smallest blood vessels are capillaries with a diameter of approximately 8 to 10µm, 
which is just large enough for single erythrocytes to flow through.  These vessels are responsible 
for the exchange of gases, nutrients at the tissue beds and are therefore, very permeable in most 
tissues.  Essentially the walls are just endothelial cells, with clefts between them, held together 
on a basal lamina.  The type of endothelial cells and clefts varies depending on tissue type. 
Capillaries can be categorized into two types, true capillaries and metarterioles.  
Metarterioles act as a direct “through-way” from arterioles to venules.  Surrounding this route 
are networks of true capillaries forming a capillary bed to better supply the adjacent tissues.  
True capillaries have a sphincter muscle situated at each branch point from the metarteriole, 
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which can be open or closed depending on the needs of the tissue.  True capillaries then drain 
back into the metarteriole.  This system allows exact matching of blood supply and demand at 
the local level. 
   A.1.1.2. Veins 
 Veins carry blood away from the tissues and back towards the heart.  The smallest of 
these vessels are the post-capillary venules, which are essentially the distal end of the capillaries 
and generally have walls of one to two cells thick.  Post capillary venules join and flow into 
larger venules, which in turn, join to form veins.  The lumens of veins are generally larger than 
those of corresponding arteries yet the walls are thinner and contain less elastin.  The distinction 
between the intima, media, and adventitia in veins is less clear than in arteries.  The walls consist 
of a relatively weak media with, circularly arranged, plate-like bundles of smooth muscle, and an 
adventitia with some longitudinally arranged smooth muscle cells.  Overall, the veins are less 
muscular and more collagenous in nature, relative to similar sized arteries [2].  The pressures 
endured by veins are relatively low and, in fact, they act as capacitance vessels usually 
containing approximately 2/3 of the body’s total blood volume.  To prevent backward flow of 
blood at such low pressures the veins possess one-way valves formed from intimal layer “cusp-
like” infoldings and the muscular ability to constrict their diameter and so help ensure bloods 
return to the heart. 
  A.1.2. The Functional Anatomy of Circulation 
   A.1.2.1.Pressure and Volume 
The anatomy of circulation must be viewed in relation to its function.  The heart is simply 
a muscle, which acts as a gradient pump to ultimately propel whatever volume of blood it 
receives from the vena cava at 0mm Hg to the aorta at an average of 100 mmHg.  The heart is 
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influenced by several external factors such as local metabolites and nervous or humoral 
stimulation but the basic principle remains (see figure A.1).  “the heart cannot pump what it does 
not receive” [3]. 
Blood pressure is the product of cardiac output (Q) and total peripheral resistance (TPR).  
The parallel arrangement of organ blood supply coupled with the ability of the arteries, 
arterioles, and capillaries to increase or constrict their diameters, creates an effective system to 
control pressures and perfusions to individual tissues.  The largest fall in pressure occurs at the 
arterioles and capillaries (see figure A.2).  Pressure can also be viewed as the product of volume 
of blood (Q) and cross sectional area of the vessel (TPR).  If we assume the volume of blood 
pumped per minute is unchanged then pressure becomes inversely proportional to cross sectional 
area of the vessels.  The cross sectional area of the arteries increases from 20cm2 in the small 
arteries to 40cm2 and 2500cm2 respectively for the arterioles and capillaries.  Blood pressures 
have a corresponding fall from approximately 100mmHg in the large arteries to 35mmHg at the 
arterial end of the capillaries and only 15mmHg at the venules. 
The zero pressure of returning blood at the right atria occurs primarily, due to the high 
capacitance of the venous system.  Veins have ability to substantially increase the volume of 
blood they hold without a large increase in system pressure.  A vein generally holds about 3 
times as much blood as a corresponding artery and is approximately 8 times as distensible, that 
is, a given rise in pressure causes about 8 times as much extra blood to fill a vein.  Therefore, as 
compliance is the product of distensibility and volume, a veins are approximately 24 times more 
compliant than corresponding arteries [1]. 
If we consider the effects of gravity on the upright human it becomes obvious that certain 








Figure A.2. Blood Pressures Across the Vascular System [3]. 
The pathways are shown for the example of an increase in the transmural pressure. 
Symbols: framed text = established factor, unframed text = hypothetical factor 
Arrows; bold arrow = well described link, normal arrow = link which needs further confirmation, dotted arrow = 
hypothetical link, dotted arrow with ? = unknown link 
Abbreviations; AA = arachidonic acid, CYT P-450 = cytochrome P-450, Kca = calcium activated potassium channel, 
MP = membrane potential, SAC = stretch-activated cation channel, VOC = voltage-operated calcium channel, TK = 
tyrosine kinase, MLCK = myosin light chain kinase.  
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that is the pressure in the system after blood flow has been stopped by clamping the large blood 
vessels at the heart [1], is approximately 7mmHg.  This is the driving pressure for venous return.  
Unfortunately, the force of gravity can overcome this, and in a human standing absolutely still 
the hydrostatic pressure or weight of the blood itself would create a pressure at the feet of 
approximately 90mmHg.  This column of blood is prevented from forming by the action of the 
valve system incorporated in veins.  Every time an individual constricts muscles in the leg it 
pushes blood to the heart and the one-way valve system prevents gravity dragging the blood back 
to the feet. 
The circulatory system is designed to cope with a variety of situations.  If pressures need 
to be increased, nervous stimulation can cause vasoconstriction of veins to reduce compliance, 
aiding venous return.  Additionally, splanchnic and cutaneous vascular beds serve as large blood 
reservoirs, which can be mobilized to increase the volume in the circulatory system when 
needed.  Artery beds can be dilated or constricted on a systemic or individual basis to ensure 
optimal perfusion of the working tissues. 
The complex interplay of cardiovascular control mechanisms such as central, local, and 
reflex interactions render it impossible to examine this system in its entirety.  While numerous 
studies have attempted to investigate individual control mechanisms, or manipulated one control 
system to examine its effects upon other variables (for a detailed review of these modulations see 
[4]).  Unfortunately, many of these studies still fail to overcome the problems presented by 
redundant mechanisms or the effects across several systems, which add variability to the model 
(especially in disease).  Additionally, may experimental designs create artificial environments in 
which may add outcome variability to the model.  In recent years, spectral analysis and “chaos 
theory” have been utilized to “tease-out” system influences but even these techniques cannot 
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encompass the variety of possible interactive factors.  It is therefore prudent to focus on a 
specific area within the whole circulatory system and examine direct influences upon it as of 
primary concern.  Consequently, the focus of this literature review is the peripheral vascular 
system and its regulation and adaptation to physical stress in health and disease states.  Details of 
more removed or secondary influences will be reviewed only in the context of the literature 
focus. 
 
 A.2. General Principles of Vascular Control 
The previous section has indicated the importance of radius on the distribution of volume 
and pressure within the vascular tree.  Poiseuilles Law best encompasses the relative influences 
of radius and other contributors to blood flow through arteries1… 
     Q = π ∆P r4 
  8 ηl 
…whereby, Q is blood flow, ∆P is the pressure difference over the vessel length, r is the radius 
of the vessel, l is the vessel length, and η is the viscosity of the blood. 
From this equation it is obvious radius has the greatest effect upon flow.  In fact, this 
effect is such that a 4-fold increase in vessel radius causes a 256-fold increase in blood flow.  
Radius becomes an even more important contributor to flow when we consider the length of the 
vascularture and blood viscosity does not change transiently.  It is essential therefore, to examine 
the factors, which impact radius. 
                                                 
1 The Casson equation developed for printing inks may account for viscosity to a greater extent 5. Gow, B.S., 
Circulatory correlates: vascular impedance, resistance, and capacity, in Handbook of Physiology: Section 2: The 
Cardiovascular System, S.R. Geiger, Editor. 1980, American Physiological Society: Bethesda, Maryland. p. 353-
408.. 
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Additionally, the body must maintain adequate blood pressure and flow to supply the 
needs of the tissues.  The best ways to do this are to manipulate cardiac output and total 
peripheral resistance.  Since a derivative of Ohm’s Law states… 
∆P = Q * R…. 
…whereby, ∆P = the change in pressure across a system or vessel, Q = cardiac output or flow, 
and R = resistance to flow.  Although the relationship between Q and R may not be linear in 
human vessels, it is apparent the most efficient way to increase pressure in a system or vessel is 
to increase the driving pressure of the fluid, increase the resistance to flow, or preferably both.  
In fact, a balance between these two variables is how the body regulates blood pressure and 
tissue perfusion. 
 Resistances along the cardiovascular system at rest are related to an inherent property or 
‘basal tone’ within vascular smooth muscle. 
“Basal tone may be considered as a conceptual reference point on which various 
vasomotor influences, both neural and hormonal, and local metabolic are expressed” [3]. 
 
That is vasoconstrictors can be used to increase basal tone and resistance to flow for the 
whole system or at a local level.  Likewise vasodilators can be used to reduce vascular resistance. 
This section will outline major systemic mechanisms underlying Poiseuilles Law and 
central blood flow/pressure regulation.  The major focus will be devoted to local circulatory 
regulation, with an emphasis on the contributions of the intima, media and, adventitia to flow 
regulation including, myogenesis, sympathetic stimulation or inhibition, flow, and humoral 
influences including, local metabolites, endothelin, vasopressin, bradykinin, prostaglandins, and 
endothelium-derived nitric oxide [6, 7]. 
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  A.2.1. Systemic Blood Pressure Control 
The most influential control mechanism for short-term blood pressure regulation is the 
baroreflex or pressoreceptor (for a comprehensive review see [8].  These consist of stretch 
receptors in most of the large arteries of the thorax and neck (especially the aortic arch and 
carotid sinus), which respond to changes in pressure and rate of change in pressures between 60 
and 180 mmHg for the carotids and 90 and 210 mmHg in the aorta.  Increases or increasing 
pressures cause nerve transmission to the tractus solitarius in the medulla of the brainstem and 
subsequent inhibition of the vasoconstrictor center with concomitant excitation of the vagal 
center.  The resulting cardiovascular responses are vasodilation of the peripheral arterioles and 
veins with decreased heart rate and force of contraction.  Subsequently, blood pressure falls.  
Conversely, a fall in arterial pressure results in withdrawal of baroreceptor signals to the 
medulla, an increase in cardiopulmonary receptor stimulation and the reverse effects.  The 
importance of the peripheral arteries vasoconstrictor response is most evident in arterial pressure 
decreases subject to conditions which limit ventricular filling pressures (e.g. upright posture, heat 
stress) and prevent a rise in cardiac output [3]. 
Medium-term (hours) and long-term (days or weeks) blood pressure control is 
predominantly controlled by a process of adjusting the rate of water intake and the rate of solute-
free water excretion by the kidney and by vasoconstriction of the vascularture (for a complete 
review see [9]).  Vasopressin is the major hormone involved in medium-term water retention 
during hypovolemia/hypotension or during an increase in plasma osmorality.  During these 
conditions the hypothalamiconeurohypophyseal system stimulates a release of vasopressin from 
the posterior pituitary gland.  Vasopressin acts to increase the permeability to water of the kidney 
collecting ducts via V2 receptors and the adenylate cyclase/cyclicAMP pathway.  To a lesser 
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extent vasopressin stimulates a pressor response consisting of vascular smooth muscle (and other 
tissue) contraction via V1 receptors and G-protein/arachidonic acid pathway. 
Chronic decreases in pressure or flow to the kidneys create a cascade of events, known as 
the renin-angiotensin system, designed to restore normal perfusion.  This process starts with the 
release of the kidney hormone renin.  Renin is synthesized, stored and secreted into the renal 
arterial circulation by the juxtaglomerular cells in the afferent arterioles as they enter the 
glomeruli.  Renin has a half-life of approximately 15-min.  Specifically, renin can be stimulated 
via three mechanisms… 
(i) Macula densa pathway. 
The macula densa is situated adjacent to the juxtaglomerular cells and is composed of specialized 
columnar epithelial cells located in the wall of that portion of the cortical thick ascending limb 
that passes between the afferent and efferent arterioles.  A decrease in NaCl reabsorption by the 
macula densa stimulates renin release (using adenosine), conversely an increase causes the 
opposite effect of renin inhibition (via prostaglandins) [10]. 
(ii) Intrarenal baroreceptor pathway 
Increases and decreases in preglomerular vessel blood pressures inhibit and stimulate renin (via 
prostaglandin) release respectively. 
(iii) β-adrenergic receptor pathway 
This mechanism is mediated by the release of norepinephrine from postganglionic sympathetic 
nerve terminals.  The activation of the juxtaglomerular cells β-adrenergic receptors enhances 
renin release. 
 An increase in renin causes an increase in angiotensin II, which, in turn, inhibits renin 
release by effecting subtype 1 receptors on the juxtaglomerular cells in a short-loop negative 
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feedback system.  Additionally, there is a long-term mechanism of negative feedback via the 
angiotensin II effect of systemic blood pressure elevation and thereby, reducing sympathetic β-
adrenergic juxtaglomerular cell stimulation. 
 The substrate for renin is angiotensinogen, which is continuously produced, primarily in 
the liver but also by areas of the central nervous system and the kidney.  Glucocorticoids, thyroid 
hormone and angiotensin II stimulate angiotensinogen production.  Renin cleaves 
angiotensinogen between amino acids 10 and 11 (the leucine-valine bond), to create angiotensin 
I, which is a mild vasoconstrictor.  It is usually quickly converted to angiotensin II by 
angiotensin-converting-enzyme (ACE) which is bound to the endothelial cells in the vascular 
system.  Angiotensin III is also produced from angiotensin I, via a minor pathway.  ACE cleaves 
dipeptide units from substrates with amino acid sequences in a non-specific manner.  
Angiotensin II and III have vasoconstrictor effects on the peripheral vasculature, but angiotensin 
II is considerably more potent.  In fact, angiotensin II is considered to be approximately 40 times 
more potent than norepinephrine in this regard [10].  Angiotensin II activates AT1 receptors on 
the vascular wall and has two major effector pathways… 
(i) Smooth muscle constriction occurs via guanine nucleotide-binding regulatory (G) 
proteins, which facilitate activation of phospholipases C-β and eventually lead to an opening of 
sarcoplasmic reticular stores and calcium channels and an increase in intra-cellular calcium 
levels.  Calmodulin sequesters calcium ions and forms calmodulin-calcium complexes that 
subsequently activate ATPase-kinases and muscle contraction occurs. 
(ii) Phospholipase A2 is stimulated at the receptor and it metabolizes phosphatidylcholine to 
arachidonic acid.  Arachidonic acid can then modify cellular responses by conversion to 
prostaglandin and thromboxane A2 or by activation of it’s own receptors.  AT1 receptors may 
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also stimulate cell growth, especially cardiac and vascular muscle cells, via the MAP kinase 
pathway and increased expression of proto-oncogenes, particularly c-fos and c-jun. 
 The major effects of angiotensin II are the rapid pressor response via altered peripheral 
resistance, the slow pressor response via altered renal function, and the long term vascular and 
cardiac hypertrophy and remodeling. 
(i) The rapid pressor response 
“When a single moderate dose of angiotensin II is injected intravenously, systemic blood 
pressure begins to rise within seconds, rapidly reaches maximum, and returns to normal within 
minutes” [10]. 
 
The main contributor to this response is an elevation of total peripheral resistance by vascular 
smooth muscle AT1 receptor stimulation and contraction.  Angiotensin II may also enhance 
peripheral noradrenergic neurotransmission by augmenting norepinephrine release and inhibiting 
its uptake at sympathetic nerve terminals and by enhancing the vascular response to 
norepinephrine.  Interestingly the angiotensin II molecule itself may have some neurotransmitter 
or modulator effects on the central nervous centers. 
(ii) The slow pressor response 
The slow pressor response is mediated predominantly by an alteration of renal function via 
increased retention of Na+ and water coupled with an increase excretion of K+.  This occurs 
through several mechanisms including a direct angiotensin II effect on the proximal tubule, a 
modification of glomerular flow rate by vasoconstriction of renal arterioles, and stimulation of 
the adrenal cortex to release aldosterone.  The overall effect of angiotensin II on the kidney is to 
move the pressure natriuresis curve to the right. 
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(iii) The vascular and cardiac remodeling response 
Angiotensin II has been shown to cause hypertrophy and remodeling of cardiovascular tissues 
including; increased blood vessel wall-to-lumen ratios, vessel intimal thickening and both 
eccentric and concentric cardiac hypertrophy.  This is attributed to the hypertension and the 
increased proto-oncogene expression. 
  A.2.2. The Adventitia: - Neural Control 
 The sympathetic vasomotor system is the most pervasive influence in neural regulation of 
circulation.  It carries a tremendous number of vasoconstrictor fibers and only a few vasodilator 
fibers.  Their anatomy is such that they leave the spinal cord through all the thoracic and the first 
two lumbar spinal nerves.  This system innervates the entire vascular arterial tree down to the 
arterioles.  Capillaries, precapillary sphincters, and metarterioles are not innervated.  The 
sympathetic postganglionic fibers are usually nonmyelinated and form two plexuses in the tunica 
adventitia.  The outer or primary plexus is usually present in the middle or outer third of the 
adventitia and its fibers ramify and terminate more distally in the vascular bed.  The inner or 
terminal plexus is typically restricted to the adventitio-medial junction, and transmitter release 
here leads to changes in vascular smooth muscle tone [11].  The sympathetic neurons are 
predominately adrenergic, releasing norepinephrine, which binds at lipoprotein α receptors on 
the cell membrane, where the vasoconstrictor response is initiated [3]. 
The neuroeffector junction is a dynamic balance between norepinephrine release and 
uptake or diffusion, and can be influenced by other vasoactive substances such as angiotensin II, 
nitric oxide, and local metabolites.  The synthesis of norepinephrine from tyrosine is a complex 
process involving several intermediates (see [11, 12]).  A vast majority (approximately 80%) of 
the norepinephrine released is reincorporated into the releasing nerve terminal via α2 receptors, 
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and a small amount spills over into the circulation.  It must be noted here, in the adrenal medulla 
there are two distinct catecholamine containing cell types: one with norepinephrine (as in 
neuroeffector junctions) and one with primarily epinephrine, synthesized by 
phenylethanolamine-N-methyltransferase from norepinephrine.  Epinephrine (0.2 µg/kg/min) 
and norepinephrine (0.05 µg/kg/min) are released by the adrenal medulla directly into the blood 
stream and contribute significantly to basal vascular tone.  Interestingly, epinephrine and 
norepinephrine have different effects at the vasculature compared with the heart.  Epinephrine 
affects both α and β receptors similarly whereas, norepinephrine has a much greater effect on α 
receptors. 
The parasympathetic system releases acetylcholine via the vagus nerve and in general has 
the opposite effect to sympathetic stimulation.  For example, parasympathetic discharge at the 
myocardium causes a decrease in heart rate and force of contraction.  However, the 
parasympathetic system has little or no effect on peripheral resistance at the vasculature.  
Vanhoutte (1980), suggested parasympathetic discharge close to the adrenergic nerve ending 
may cause a hyperpolerization effect and create a resistance to activation and a subsequent 
dampened norepinephrine release [13]. 
 Having examined the vasoconstriction response it is necessary to detail the theories of 
vasodilation.  The existence of sympathetic cholirnergic vasodilators is established in muscle 
tissues of some species.  Their effect is transient at best and an understanding of the rationale for 
these mechanisms is unclear.  In human skeletal muscle the evidence for cholirnergic 
vasodilators is not strong [3].  Other neurogenic vasodilator mechanisms have been proposed but 
in humans peripheral vascular resistance and blood pressure are maintained by alterations in 
basal tone and sympathetic vasoconstrictor withdrawal. 
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 Further strata in the complexity and co-ordination of vascular behavior are the varying 
degrees of responsiveness of select tissues to sympathetic stimulation and the degree or manner 
of discharge of the system.  Under certain circumstances such as fright or pain a mass 
sympathetic discharge occurs.  In exercise or heat regulation specific areas can be constricted 
while others undergo dilation to produce optimal blood flow to the working tissues or skin [14].  
Additionally, there are significant regional variations in the responses of arterioles to a similar 
sympathetic stimulation and the density of α-adrenergic innervation differs greatly.  Arterioles 
supplying skin, skeletal muscle, splanchnic organs, kidneys, and adipose tissue are richly 
innervated.  Innervation in the veins is variable from very low deep in limb tissue to very high in 
the splanchnic and cutaneous tissues [3].  Additionally, the receptor themselves may be slightly 
varied in different locations.  Finally, the norepinephrine release-reuptake balance may vary with 
location. 
  A.2.3. The Media: - Myogenesis (The Bayliss Effect) 
 Autoregulation of blood flow is the tendency for flow to remain the same despite changes 
in arterial pressure [15].  This behavior, termed the myogenic response, is inherent to smooth 
muscle and independent of neural, metabolic, and hormonal influences [16].  Interestingly, there 
appears to be an inverse relationship between vessel size and myogenic responsiveness [17], 
although this response may also differ in different types of tissues [18].  It is most pronounced in 
the arterioles (for a comprehensive review of myogenesis please refer to [15, 17]) and may act as 
a protective mechanism to avoid over-perfusion of the capillary beds.  This effect was first 
noticed in 1902 by William Maddock Bayliss in dog the hind limbs following release of brief 
aortic occlusions [19].  Folkow’s work with denervated preparations established myogenesis as a 
pressure dependent, non-neural mechanism [20].  Currently, the stimulus for the myogenesis is 
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unclear but is believed to be a response to tension changes on the vessel wall and/or to stretch on 
the myofibrils.  Part of the reasons for this uncertainty are the differing magnitudes, time courses 
and directions of stimuli in isometric contractions of vascular rings/strips compared with isobaric 
contractions of cannulated arterioles and arteries [21]. 
 The wall tension theory has recently gained support through mechanistic studies 
demonstrating alterations to agonist sensitivity only occurs with changes in wall tension.  
Additionally, events implicated in myogenic signal transduction such as intracellular calcium 
concentration and myosin light chain phosphorylation are significantly correlated with vessel 
wall tension, not vessel diameter [22].  Additionally, physics supports the wall tension theory.  
The law of La Place dictates wall tension (T) is a function of transmural pressure across the 
vessel wall (Pt) and radius (r). 
T = Pt * r 
Therefore, if wall tension increases due to a rise in pressure inside the vessel, a reduction in 
radius can counteract this increased wall tension and create a homeostatic feedback loop. 
 The actual sensor of pressure is as yet unclear.  Stretch activated cation channels, voltage 
dependent calcium channels, and the extracellular matrix have all been proposed as mechanisms 
[18], but conclusive evidence is still lacking.  The structural component of the vessel involved in 
myogenesis appears to be the smooth muscle itself.  Removal of the vascular endothelium has 
led to contrasting results mainly between physical removal, which led to an altered response, and 
chemical removal, which did not.  Further analysis of these studies leads to the conclusion that 
myogenesis in the brain may be more endothelium dependent, as may some of the larger conduit 
arteries which, also endure greater flow velocities [23].  Interestingly, removal of tonic nervous 
influence by chemical blockade caused no alteration of myogenic response.  Consequently, 
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myogenesis is believed to be predominately a reaction of the smooth muscle cells in the vessel 
walls of small arteries and arterioles, independent of either nerves or endothelium. 
 An increase in blood pressure causes an increase in vessel wall tension and in turn, 
initiates depolarization of the smooth muscle cell membrane and a cascade of second messenger 
pathways resulting in contraction (figure A.3).  From figure A.3 it is established that an increase 
in calcium in the smooth muscle cytosol accompanies myosin light chain phosphorylation.  The 
concentration of calcium necessary to initiate contraction is unclear.  It may be possible that 
auxiliary pathways alter calcium the sensitivity of the smooth muscle contractile apparatus. 
Unfortunately, in vivo external influences pervade myogenesis.  For example, blood flow 
is pulsatile not static.  Additionally, nervous stimulation of the smooth muscle tissue may 
enhance the myogenic response, which is in direct contrast to some endothelially released 
relaxing factors or local tissue metabolites, which may antagonize the response.  It is therefore 
difficult to generalize from in vitro responses to stimuli to intact animal autoregulation. 
 In conclusion, the myogenic response is a reaction to a change in wall tension and is 
demonstrated in a variety of tissue beds to varying degrees.  It involves smooth muscle cell 
depolarization and an influx of calcium ions.  Furthermore, it appears not be dependent upon the 
endothelium or on nervous stimulation yet in-vivo can be modified by both of these. 
  A.2.4. The Intima : - Endothelial Control 
 The unique anatomical position of the endothelium, at the interface between the lumen 
and media of blood vessels, lends itself to multiple roles in the maintenance of vascular tone 
[24].  The importance of the vascular endothelium to arterial vasomotion was first demonstrated 
by Furchgott and Zawadski, (1980), whereby, the presence of a healthy endothelium was 




Figure A.3. A Model of the Main Pathways Suggested to be involved in the Myogenic Response 
The pathways are shown for the example of an increase in the transmural pressure. 
Symbols: framed text = established factor, unframed text = hypothetical factor 
Arrows; bold arrow = well described link, normal arrow = link which needs further confirmation, dotted arrow = 
hypothetical link, dotted arrow with ? = unknown link 
Abbreviations; AA = arachidonic acid, CYT P-450 = cytochrome P-450, Kca = calcium activated potassium channel, 
MP = membrane potential, SAC = stretch-activated cation channel, VOC = voltage-operated calcium channel, TK = 
tyrosine kinase, MLCK = myosin light chain kinase [15]. 
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changes in homodynamic forces, or blood-borne signals, by membrane receptor mechanisms and 
respond to physical and chemical stimuli by synthesis or release of a variety of vasoactive and 
thromboregulatory molecules and growth factors [26].  These include endothelial-derived 
relaxing factor/nitric oxide [25, 27], endothelial-derived hyperpolarizing factor [28], prostacyclin 
[29-31], bradykinin, thromboxaine, endothelin [32], and tissue-type plasminogen activator [33, 
34]. 
Endothelial structure and function have been established through in vitro culture studies 
and through in-vivo animal [35] and human studies [36].  These findings have led to the 
development of cascade models for stimulation and reaction of the endothelium (Figure A.4).  
Bradykinin, substance P, serotonin, adenosine diphosphate and adenosine triphosphate all 
depend upon the presence of the endothelium for their relaxant action [37].  Two general classes 
of stimuli elicit an endothelial-dependent response.  The first of these is pharmacological stimuli 
such as norepinephrine, acetylcholine, and bradykinin via specific endothelial cell receptors.  NE 
stimulates α2 receptors, bradykinin stimulates β2 receptors, and acetylcholine (although it is 
doubtful humoral levels would be sufficiently high enough under normal conditions) stimulates 
muscarinic receptors.  Specific G proteins activate phospholipase C (PLC) which leads to the 
hydrolysis of phosphatidyl inositol bisphosphate into two intracellular second messengers: 
inositol triphosphate (IP3) and diacyglycerol (DAG).  Consequently IP3 triggers calcium release 
from intracellular stores [38]. 
Additionally, flow induced shear stress is believed to increase intracellular calcium 
concentration via stretch activated potassium channels and/or some form of endothelial cell 
cytoskeleton which transduces the signal into the cell [16].  Shear stresses range between 10 and 
70 dyne/cm2 at different points in the arterial vascular network [40].  Changes in these shears  
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Figure A.4. A simplified model of receptor-signal transduction processes in endothelial cells 
leading to the release of putative endothelium-derived prostacyclin (PGI2), endothelium-derived 
hyperpolarizing factors (EDHF), and endothelium-derived relaxing factor, nitric oxide (EDRF-
NO). Vasoactive substances (hormone) such as: norepinephrine, UK14304, acetylcholine, 
bradykinin, and substance-P, bind to their specific endothelial cell membrane receptor that is 
coupled by a G protein to phospholipase C (PLC). Activation of PLC leads to hydrolysis of 
phosphatidyl inositol bisphosphate producing two intracellular second messengers: inositol 
trisphosphate (IP3) and diacylglycerol (DAG). IP3 signals calcium release from intracellular 
stores. Increased intracellular free calcium ([Ca2+]i) activates three processes: 1) phospholipase 
A2 to release arachidonic acid (AA) which is converted to prostacyclin by cyclooxygenase; 2) 
nitric oxide synthase (NO synthase) to produce EDRF-NO; and 3) release of unidentified EDHFs 
by as yet to be established pathways (?).As illustrated, flow-induced vasodilation results from 
increased shear stress which induces increased [Ca2+]i via stretch activated channels (SAC) or 
G-protein mediated mechanisms. PGI2 is believed to signal relaxation of vascular smooth 
muscle by stimulating adenylate cyclase which produces cAMP(adenosine 3'-5'-monophosphate) 
from ATP (adenosine triphosphate). EDRF-NO is believed to signal relaxation in vascular 
smooth muscle by stimulating guanylate cyclase which produces cGMP(guanosine 3'-5'-cyclic 
monophosphate) from GTP (guanosine 5'-triphosphate). As illustrated by the?'s, the process 
whereby EDHF is produced and mechanism by which EDHF causes hyperpolarization are not 
established [39]. 
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have been shown to influence vessel diameter responses.  Higher shear stress caused from higher 
flow or viscosity leads to an increase in internal vessel radius.  Conversely lower shear stress 
leads to decreased internal vessel radius.  It is suggested that the response of endothelial  
mediated compensatory changes are to maintain shear stresses in the range of approximately 15 
to 20 dyne/cm2 [41, 42].  Rat studies in which shear stress is acutely altered by aortocaval shunt 
results in upregulation of cGMP [43] along with NOS messenger mRNA.  These changes are 
accompanied by vessel structural expansion and could be blocked by L-NMMA (see below). 
Intracellular calcium concentration is believed to be the key mediator for vasodilation by 
activation of three mechanisms; NO, prostaglandin and endothelial-derived hyperpolarizing 
factor. 
(i) NO –GTP to cGMP 
NO is the most discovered and influential contributor to vascular tone under normal conditions.  
There are several isoforms of NO released endothelially.  Constitutional NO contributes to 
vascular basal tone by inhibiting contraction of the underlying smooth muscle, whereas inducible 
NO is released in response to stimuli.  NOS is the enzyme responsible for NO production and 
also exists in both constitutive (basal) and inducible isoforms.  NOS converts the substrate L-
arginine to L-citrulline and NO in the endothelial cells.  This can be blocked by arginine 
analogues, of which NG-monomethyl-L-arginine (L-NMMA)is the most widely utilized [44].  
The vasodilator activity of NO occurs in the vascular smooth muscle, due to its interaction with 
the iron atom of heme in guanylate cyclase,[45] causing its activation as the enzyme to produce 
cyclic guanosine 3’-5’-monophosphate (cGMP) from guanosine 5’-triphosphate (GTP) [38].  
cGMP activates several protein kinases causing calcium extrusion from the cell, increased uptake 
by the sarcoplasmic reticulum and subsequent dilation.  NO also displays some hyperpolarizing 
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characteristics.  It is capable of activating calcium-dependent potassium channels and ATP-
dependent potassium channels indirectly, by increasing intracellular cGMP. 
(ii) PGI – ATP TO cAMP 
The increased endothelial intra-cellular calcium concentration activates phospholipase A2 to 
release arachidonic acid (AA), which is converted by the enzyme cyclooxygenase to prostacyclin 
(PGI2) [46].  This pathway can be inhibited by cyclooxygenase blockade.  PGI2 itself has 
antithrombic and antiplatelet properties.  It’s vasodilatory capacity in vascular smooth muscle is 
by the activation of the enzyme adenylate cyclase to convert adenosine triphosphate (ATP) to 
adenosine 3’-5’-monophosphate (cAMP), with subsequent activation of protein kinases.  PGI2 
may also demonstrate some hyperpolarizing characteristics by activation of smooth muscle cell 
ATP-dependent channels through the secondary rise in cAMP after binding to the corresponding 
cell surface receptor. 
(iii) EDHF 
 The hyperpolarizing characteristics of both NO and PGI2 have created difficulties in 
identifying the mediator for EDHF.  In fact, it’s relaxing effect can only be revealed following 
combined blockade of NO and PGI2 [28, 47].  Relaxation attributed to this factor occurs 
secondary to smooth muscle cell hyperpolarization and is blocked by membrane depolarization 
[28].  In most vascular beds calcium dependent potassium channel inhibitors inhibit this 
response.  A cytochrome P450-derived arachidonic acid metabolite has been suggested as EDHF 
for human coronary circulation [48], but it is possible different factors are responsible in 
different vascular beds. 
EDHF may only become a significant contributor to vasodilation when NO and PGI2 are 
inhibited in arteriosclerotic, hypercholesterolemic, or ischemic conditions, possibly as a 
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compensatory or reserve mechanism [47].  This is supported by EDHF’s apparent insensitivity to 
superoxide anions. 
  A.2.5. Metabolic Dilation 
 The relative importance of metabolic control increases with decreasing vessel size, from 
large capacitance vessels to smaller precapillary resistance vessels [39].  Vasodilator substances 
(e.g. adenosine, adenine nucleotides, carbon dioxide, PO2, potassium, phosphate ions, lactate, 
Krebs cycle intermediates, and various polypeptides), which, are released from active muscle 
fibers, diffuse thought the interstitial space to act on the smooth muscle cells of arterioles [3, 49].  
Several theories have postulated many different substances be “the” controlling vasodilator.  
This seems unlikely because, individually these metabolites have modest effects, but when 
combined they elicit a greater vasodilatory response.  In fact, in 1972, Lundvall, hypothesized 
that the total osmolarity of all particles released by the active tissue was the cause of vasodilation 
[50].  In fact, total osmolarity of venous blood increases in proportion to organ oxygen 
consumption and blood flow.  Additionally, in resting tissues blood flow can be raised to 
exercise levels by infusions, which appropriately increase osmolarity [3].  Unfortunately, this 
matching effect only lasts for a few minutes and then becomes complicated by increased blood 
flow to the tissue that reduces metabolite interstitial concentrations.  It is interesting to note that 
distal vasodilation causes a reduction in distal total peripheral resistance and thereby encourages 
increased flow in the proximal conduit arteries and consequent endothelial flow-mediated 
dilation, which may in turn create an increase in blood flow to those distal tissue beds [51]. 
 Arteriolar PO2 has been investigated as a vasodilator influence.  It is logical that as 
smooth muscle needs O2 for contraction, reduced levels will initiate relaxation.  Unfortunately, 
although low venous PO2 is associated with vasodilation the relationship does not track each 
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other except in conditions of extreme hypoxia [49].  Arterial PO2 must fall below 40 to 50 
mmHg before flow is affected, thus the sensitivity required for oxygen tension to regulate flow 
appears not to exist [3].  It is possible CO2 and hydrogen ion fluctuations have a direct effect on 
vascular smooth muscle and flow over a narrow range.  This relationship is established in 
cerebral vessels but currently, not in other tissue beds. 
It is possible, with recent development in the understanding of endothelial function, that 
hypoxic status could cause a release of local vasodilators such as adenosine derivatives and 
prostaglandins [52].  Adenosine itself, unlike its nucleotides, crosses cell membranes easily and 
its interstitial concentration should give a relatively good parallel of cellular metabolism.  
Unfortunately, adenosine is an unsuitable candidate for vasodilatory regulator due to the low 
levels in the venous blood and the rapidity of its conversion to inactive compounds. 
 Another local influence on vasoregulation is temperature.  Cutaneous vessels have unique 
responses to temperature changes.  For example, cooling creates greater sensitivity to 
sympathetic simulation [13].  In contrast deeper vessels loose some myogenic activity and are 
less sensitive to vasoconstrictor stimuli.  Warming tends to decrease adrenergic sensitivity and 
thereby reduce vasoconstriction 
In conclusion, the difficulty in acquiring accurate interstitial concentration measures and 
because different influences may effect vasoactivity at different times in the course of dilation or 
exercise.  A further complication is the possibility of redundant systems capable of regulating 
blood flow when primary mechanisms are inhibited.  It is interesting to consider theses different 
influences on vasocontrol acting in parallel to each other homogenously throughout the vascular 
network.  However, this does not appear to be the case, at least in the coronary arterial tree 





Figure A.5. Schematic illustrating the relationship between the relative responsiveness of 
segments of the coronary arterial tree to vascular control systems and the diameter of each 
arterial segment. The top panel illustrates the coronary arterial tree and the second panel reflects 
changes in diameter observed on progression from the conduit coronary arteries down to the 
resistance arteries and arterioles. The last four panels illustrate the relative responsiveness of the 
segments of the arterial tree respectively to: myogenic reactivity, flow-induced vasodilation, 
metabolic vasodilator signals, and sympathoamines [39].  
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“micro-domains” [54].  Each micro-domain is conceived to be primarily under the control of 
specific regulatory mechanisms, for example myogenesis along with metabolic control appear to 
be of greatest importance in small resistance arteries and very small arteries respectively (Figure 
A.5).  Conversely, the larger conduit arteries are more responsive to flow and sympathetic 
stimulation.  Overall the micro-domains of the coronary tree are then proposed to be integrated 
by interactions between metabolic, myogenic, and flow dependent control processes [54], with 
different ones serving as the dominant influence and others as redundant systems in different 
micro-domains and presumably under different physiological conditions. 
 
A.3. Assessment Methods for Peripheral Circulation 
 There are several recognized methods of assessing peripheral circulation.  Some methods 
are more applicable for basic and animal research while others are regularly employed in clinical 
assessments.  Several techniques have been developed to enable blood flow estimates to be made 
of the arterial inflow, venous outflow, or local blood flow within the muscle [55].  Regional 
techniques include electromagnetic flow meters, plethysmography, indicator methods 
(thermodilution and indocyanine green dye infusion), Doppler Ultrasound, and magnetic 
resonance imaging.  Local blood flow techniques include Xenon-133 clearance, microdialysis, 
near infrared spectroscopy, positron emission tomography.  As some techniques continue to 
evolve they may be used for both regional and local flow detection (near infrared spectroscopy 
coupled with indocyanine green dye).  This review will describe several of these techniques and 
discuss their strengths, limitations and applications.  Particular emphasis will be placed on the 
popular non-invasive techniques of venous occlusion plethysmography and the recent 
 86
development of Doppler Ultrasonography.  Additionally, as it is most pertinent to the author’s 
field of study Doppler ultrasonography will form the major concentration of this section. 
  A.3.1. Regional Blood Flow Measures 
   A.3.1.1. Electromagnetic Flow Meters 
The principle behind electromagnetic flow meters is based on the fact that blood is a 
conductive liquid.  Consequently, any induction of voltage change will be proportional to the 
blood flow through the vessel being tested [56, 57].  Therefore… 
electromotive force = B * L * u 
…whereby, B represents the magnetic flux density (Torr), L represents the distance between the 
electrodes (m), and u is the instantaneous blood velocity (m/s) [55].  Blood flow can then be 
calculated from the mean blood flow velocity and the cross-sectional area of the vessel.  The 
flow probe is mounted around a particular blood vessel in an invasive procedure.  The probe 
itself generates a strong electromagnetic field to detect voltage deflections.  Advantages of this 
system include the ability to calculate instantaneous volumetric pulsatile flow.  Additionally the 
equipment is relatively inexpensive to purchase and operating costs are low.  Unfortunately, this 
procedure is too invasive for use as a standard method for measures in healthy human subjects 
and is therefore mainly limited to animal research. 
   A.3.1.2. Plethysmography 
 Plethysmographs record a biological change in volume or other dimension (such as light 
reflectance) in a portion of the body associated with cardiac contractions, respiration, or in 
response to pneumatic venous occlusion [58].  A variety of transducers are available including 
air, photocell, and the most popular strain gauge.  These allow this technique to be employed in 
the detection of peripheral-vascular disease, venous disease, and carotid artery disease. 
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 Complete coverage of all aspects of plethysmography is beyond the scope of this review.  
Venous blood flow detection utilizing strain gauge venous occlusion plethysmography will be 
the focus here. 
 “For measuring total limb blood flow, the most useful and almost certainly the most 
reliable method, in skilled hands, is venous occlusion plethysmography.”[59] 
 
This technique involves stopping venous return for a few seconds without disturbing arterial 
inflow.  Continuous recordings of whole limb (or isolated segment thereof) volume changes are 
made.  The initial rate of swelling is the apparent rate of arterial inflow (assumed to be the same 
as before venous occlusion).  The arm should be at or above the level of the heart and tilted to 
ensure venous drainage.  Interestingly, application of a wrist cuff (one minute prior to venous 
occlusion was shown to provide lower forearm flows than in when the hand was not occluded 
[60].  Presumably, when the hand is not occluded, some of the arterial inflow to the hand may 
accumulate in the veins of the forearm. 
 The mathematical principle behind strain gauge plethysmography is that the percentage 
change in volume of a cylinder of fixed length is approximate to twice the percent change in its 
circumference.  This approximation also applies to sub-cylindrical objects of non-uniform cross-
section, if the changes are in uniform proportion at all levels along the fixed axial length.  The 
linear relationship between changes in volume and circumference may therefore be expected to 
apply to a segment of human limb [59].  Criticisms of this technique come from the derived 
volume change rather than a measured one as with the water plethysmograph.  Direct 
comparisons show that values obtained by both techniques, under controlled conditions are 
similar [61], although others have observed the water technique recorded flows approximately 
9% higher than the strain gauge technique [62].  These differences may be related to Hiatt and 
colleagues findings that inflation of a venous occlusion cuff during strain gauge measurements 
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reduced radial arterial diameter and blood flow velocity, observed using Doppler 
ultrasonography [63].  Nevertheless, strain gauge plethysmography does appear to be 
reproducible for serial measurements following reactive hyperemia [64-66], and following 5 
minutes of forearm occlusion coupled with handgrip exercise [64, 66].  Interestingly, 
reproducibility of resting blood flows is less clear.  Mahankali et al. showed only correlation 
coefficients of approximately r=0.55 for resting forearm flows between and with days [64]. 
 The benefits of strain gauge plethysmography over other techniques is the ability to 
measure total blood flow (including primary and collateral vessels) to a distal extremity, as 
opposed to ultrasonography which is a better measure of single vessel anatomy and function.  
Additionally, strain gauge plethysmography is relatively inexpensive, light and easy to use, and 
requires minimal training for proficiency [61]. 
   A.3.1.3. Indicator Methods 
 Several different types of indicators have been used in this technique.  They can generally 
be divided into intravascular indicators (e.g. indo-cyanine green dye, Evans-blue, labeled 
microspheres, and labeled albumin), freely-diffusible indicators that pass through cell 
membranes (e.g. 133Xe, heat, N2O and H2 gas), as well as small hydrophilic extracellular 
indicators (e.g. sucrose, insulin) which distribute in the interstitial space via small pores in 
capillary walls [55].  For an indicator to be indicative of blood flow it must not be retained or 
metabolized, and must fully mix with the blood.  For thermodilution adequate mixing and heat 
transfer must occur, and for dye dilution the dye must bind to a carrier prior to distribution in the 
capillary network.  Additionally, all these methods must be performed at steady state to allow 
accurate measures and injection of the perfusate must not interfere with this [67]. 
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 A distinction in indicator techniques is made between dilution (e.g. thermodilution and 
dye dilution) and perfusion techniques (e.g. 133Xe clearance). Washout techniques are addressed 
under local blood flow techniques.  Here I will outline dye- and thermo-dilution. 
 Dye dilution is based upon the principle that the concentration of an indicator is 
dependent upon the volume of blood flow through the artery [67].  This technique was originally 
developed for measurements of cardiac outputs but has been adapted for use in peripheral limbs.  
It is performed by infusion of a known concentration of dye at a specific rate followed by 
determination of the dye concentration (using a photo-densitometer) in blood sample withdrawn 
downstream.  To remain valid it is assumed there is no recirculation of the mixture or samples 
are also drawn form a bi-lateral limb (working at the same level of activity) and the sample 
values adjusted accordingly.  This technique is limited to steady state exercise but can be used 
during incremental exercise up to maximal intensities.  The major disadvantages with this 
technique include, the invasive nature, the involvement of blood handling, and the possible need 
to replace fluids lost due to repeated sampling. 
Thermodilution techniques are based upon a thermodynamic heat balance relationship, 
and knowing the specific heats of the blood, the infusate as well as the masses of the blood and 
the infusate [68].  Blood flow is determined from the temperature change in the investigation 
vessel during continuous infusion of cold saline.  The temperature deflection is proportional to 
the temperature, rate of infusion, and rate of blood flow [55].  Measurements are taken from a 
thermostat inserted proximally in the artery from a catheter.  This technique was also originally 
developed to measure cardiac output and adapted for peripheral measures.  Bolus and continuous 
infusion techniques can be used at rest but the changes in intra muscular pressures during 
exercise (steady state) make only continuous infusions useful.  The advantage of this technique is 
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that recirculation effects can be ignored and measures can be made more frequently than with 
dye dilution techniques.  Although there are no alterations in blood volume, care must be taken 
to avoid overcooling of the measurement tissues.  This technique is relatively inexpensive to 
purchase or to operate. 
   A.3.1.4. Doppler Ultrasound 
 For clinicians, the Doppler ultrasound probe has revolutionized investigations of 
peripheral vascular disease and blood flow.  The underlying principle of the technique is that the 
frequency of reflected ultrasound waves is dependent upon the speed of flow of the blood from 
which the waves have been reflected [69].  Until 1970, Doppler ultrasound only provided 
information about blood flow rates.  The introduction of pulsed Doppler allowed “ultrasonic 
arteriography” to be utilized [70].  This technique added depth to the information obtained in the 
returning signal.  A short-burst of ultrasound is emitted and the crystal used to detect the 
returning ‘echo’ is only activated for a brief moment – a ‘time gate’.  Depending upon the length 
of time between signal emission and receiver activation, the depth of the structure from which 
the returning signals enter the gate can be estimated.  As this length is varied, a three 
dimensional map of the vessel can be constructed [69]. 
Duplex scanning is a more recent addition to Doppler’s capabilities.  It combines real 
time ultrasonic imaging with Doppler flow measurements which have undergone sound spectrum 
analysis for visual display [71].  Even more beneficial is the development of color duplex 
scanning in which flow is represented on a real time image by a color scale, which can show 
velocity and direction.  Additionally, as this technique became more widely utilized, waveform 
pattern recognition and subsequent analysis have also become commonplace. 
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 In recent years external ultrasound imaging devices with high-frequency linear array 
transducers have been used to examine conduit arteries of the peripheral vasculature and their 
responses to various physical and physiological stimuli.  Many of these studies utilize Doppler 
ultrasonography to obtain an image of the brachial artery at rest and following a period of 
forearm occlusion.  The percent change in vessel diameter between the two is used as a marker 
of vascular function and may be a potential means of identifying patients with early atherosclerosis 
[6, 72].  Clearly, the appeal for using such a non-invasive, relatively painless, technique is 
enormous.  Consequently, hundreds of papers have been published over the last 5 years using 
Doppler ultrasonography in this manner. 
 Despite the large number of cross-sectional studies the stability of this technique is not 
clear, and more importantly, convincing studies concerning the reproducibility of the technique 
are scarce.  Several factors have been shown to influence arterial vasoactivity including time of 
day of testing [73], relationship to meals [74] and several hematological factors (see section 6).  
Satisfactory reproducibility has been shown in some studies despite no attempts to control for 
these factors and on limited variance components [6, 75, 76], along with unsatisfactory 
reproducibility found by others [77]. 
 In an attempt to address these deficiencies our lab undertook a reproducibility study on 
26 (41+12yr: range22-57) individuals without overt signs of disease, acute medical conditions or 
on pharmacotherapy with known vascular effects.  The experiments on these individuals were 
done under highly controlled conditions.  Prior to the experiment subjects were instructed to fast 
and refrain from exercise for 12hr and alcohol for 48hr.  Additionally, all ultrasound images 
were obtained at the same time of day, following 15min of supine rest in a quiet environment.  
Blood pressures were measured in the contralateral arm during the technique and blood draws 
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were performed immediately following vessel imaging in all participants at all visits.  
Subsequently, blood samples were examined for lipids, total protein, fibrinogen, glucose, 
electrolytes, viscosity factors, and homocysteine levels to ensure all subjects were within normal 
ranges and that no significant changes occurred between visits.  No significant changes occurred 
between visits for blood pressures or for any of the hematologic variables.  The study design was 
an incomplete model whereby intraclass correlation coefficients and covariance parameter 
estimates could be made for between and within days, ultrasound technicians, image readers and 
subjects.  Average mean percent artery dilation difference for days was 1.91 + 1.07%, with an 
intraclass correlation coefficient (ICCC) of 0.9188 (95%CI = 0.7255-0.9823; p=0.0001).  
Average mean percent difference artery dilation for testers was 1.40 + 0.97%, with an ICCC of 
0.9394 (95%CI = 0.7562-0.9850; p=0.0001).  Mean absolute difference in artery dilation for 
readers was 0.21 + 0.014mm, with an ICCC of 0.8982 (95%CI = 0.7650-0.9615; p=0.000).  
When components were combined days, testers, readers and subjects accounted for 14%, 19%, 
0% and 43% of the total amount of variation, respectively. Although inter-reader image analysis 
proved to be the largest source of controllable variation, these data indicate adequate accuracy 
and reproducibility of this ultrasound technique under strictly controlled conditions [78] 
 In summary, it appears ultrasound duplex scanning and color-flow mapping represent the 
most accurate and versatile of all noninvasive vascular diagnostic techniques.  The major 
limitations to these devices are their cost, complexity, and the relative lack of portability [79]. 
   A.3.1.5. Magnetic Resonance Imaging 
Recently, developments in magnetic resonance imaging phase contrast velocity mapping 
techniques have lead to the ability to calculate vessel diameters, blood flow volumes, and shear 
stresses in many different arteries [80].  This technique is based on the principle that hydrogen 
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nuclei in blood moving through a magnetic-field gradient accumulate a phase shift proportional 
to their velocity [81]. 
The advantages of this technique are that it is non-invasive, does not require the injection 
of any tracer, and may be especially useful in determining local blood flow in deep single vessels 
[82].  The technique has good image temporal and spatial resolution, but unfortunately it is very 
expensive to purchase and operate.  An additional disadvantage is that the equipment is very 
cumbersome and therefore limits the type and intensity of exercise, which can be studied [55]. 
  A.3.2. Local Blood Flow Techniques 
   A.3.2.1. Isotope Clearance 
 This technique is based upon the simple tenant that, clearance of a molecule or ion is 
purely dependent upon flow [83].  A tracer is injected intramuscularly and the washout clearance 
rate can then be observed as a measure of muscle perfusion [67].  Muscle blood flow can be 
calculated from the slope of the washout curve.  The typical tracer for this technique is 133Xe, 
which due to its lipophilic nature cannot become stored in fat tissue.  Unfortunately, a problem 
with this technique is the non-linear relationship between the wash-out curves and actual blood 
flow.  These errors could be contributed to different solubility constants of muscle, connective 
tissue and fat, isotope exchange between arterioles and veins and/or injection trauma [84].  
Consequently, isotope clearance techniques may result in the underestimation of blood flow by 
up to 50%.  A further problem is that due to the isotope injection trauma, it is recommended an 
interval of 10 minutes be undertaken prior to data acquisition.  A further confounder is that, 
different blood flow values may be obtained by using different mathematical equations to 
convert the flow curves to empirical values [84].  In conclusion, this technique appears to have 
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value for measures of relative or serial changes in blood flow but considering the high costs of 
purchase and operation other options appear preferable. 
   A.3.2.2.Near-Infrared Spectroscopy 
 In 1977, Francis Jobsis demonstrated the feasibility of near-infrared spectroscopy (NIRS) 
to access the adequacy of oxygen delivery and utilization in living tissues [85].  More recently, 
using indocyanine green as a tracer, Colacino et al. were able to quantify blood flow through an 
area of duck brain [86].  Since this time the technique has developed to examine skeletal muscle 
blood flow at rest and during exercise.  Comparisons of human forearm blood flow using NIRS 
and venous occlusion plethysmography show good correlation [87].  Recently, Boushel et al. 
used NIRS to measure muscle blood flow in the calf muscle during dynamic plantar flexion 
exercise and in the quadriceps muscles during knee extension and cycling [88-90]. 
 NIRS is based upon the principle that near-infrared light (700-1000nm) passes through 
tissues with relative ease.  The amount of light recovered after illuminating the tissue depends 
upon the degree of scattering by the tissues and the amount of absorption by chromospheres in 
the tissue.  Currently, only hemoglobin, myoglobin and cytochrome-c oxidase are know to effect 
near-infrared light absorption.  Using tracers, which absorb near-infrared light, it is possible, 
using the Fick principle, to produce flow estimates.  The rate of accumulation of a tracer in a 
tissue is the rate of inflow minus the rate of outflow.  Indocyanine green is an ideal tracer 
because it is non-toxic, soluble, has a relatively short half-life, and binds 95% to plasma proteins 
[91].  Indocyanine green is introduced rapidly into the venous circulation, where it is assumed to 
be evenly-mixed during passage through the heart and lungs, before entry into the arterial and 
tissue microcirculation.  Blood can then be drawn from an artery to record an ICG curve.  When 
the amount of tracer and blood flow in the injection artery are known, the blood flow in the 
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tissue region of interest can be estimated from the peak of the recorded dye curves.  When the 
curve reaches maximum height, the measured tracer concentration will reflect blood flow in that 
region [91]. 
 NIRS is sensitive for detecting progressive changes in tissue perfusion introduced by 
incremental exercise and for assessing perfusion differences between tissue regions [90].  In fact, 
an advantage of this system is the ability to track and differentiate blood flows and oxygen 
saturation’s in different areas of microcirculation in the same muscle/limb [92].  Additionally, 
the ease of application, real time measures, and good signal integrity during movement also 
make this technique useful.  Drawbacks to NIRS include the high cost of the equipment and the 
current limitation of a trade-off between light penetration to deeper tissues and spatial resolution.  
Improvements in the accuracy of this technique can be expected as NIRS technology continues 
to improve. 
   A.3.2.3. Microspheres 
 In 1969, the Rudolph and Heymann developed the microsphere technique to detect the 
distribution of blood flow within organs/tissues [93].  Since that time it has become the “gold 
standard” for measures of microcirculatory perfusion [94].  Since its inception, microspheres 
have been used in almost every field of cardiovascular research, and in a wide range of species 
and preparations varying from isolated organs to chronically instrumented animals on treadmills 
[95].  Additionally, microspheres is the only viable technique for measuring the distribution of 
blood flow among and within muscle of conscious animals during exercise [96]. 
 The idea behind this technique is relatively simple.  Radiolabeled spheres of 10-25µm 
diameter are infused into the left heart or aorta so they mix with the cardiac output and are 
distributed throughout the body in proportion to the flow rates of the individual tissues [97].  The 
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microspheres are just the right size to travel all the way to the arteriolar level and then get lodged 
in the small arterioles or capillaries.  Under most conditions very few spheres return to the heart 
in the large veins, so most are trapped in the tissues on the first pass through.  At the same time 
as infusion, a second catheter placed in the arterial tree distal to the infusion catheter is used to 
withdraw arterial blood at a known rate.  This withdrawal is then used as a ‘ghost organ’ for 
calculating flows to various tissues by comparing its radioactivity to that of dissected organs 
after the experiment.  Major technical assumptions which must be met are that the spheres are 
mixed freely and evenly distributed in the circulation and also that they become lodged in the 
tissues at the first pass.  Additionally, care must be taken to ensure the microsphere mix and the 
drawing of blood samples does not interfere with the normal circulation [96].  The major 
disadvantage of this technique appears to be that the animal has to be harvested at the end of the 
trial to allow tissue dissection.  Other disadvantages of this technique are the considerable 
expertise and facilities needed to administer the microspheres, the limited number of samples 
which can be drawn, and the possible changes in blood flow distribution caused by the technique 
itself [98].  Recently, non-radioactive techniques such as colored or fluorescent microspheres 
have been introduced, thereby reducing technician radiation exposure during repeated testing 
[95].  Despite these limitations the microsphere technique provides a powerful experimental tool 
for studying the distribution of blood flow within and among the muscles and other tissues 
during exercise [96]. 
   A.3.2.4. Positron Emission Tomography 
 Due to the large number of tracers available for use with positron emission tomography, 
this technique can be utilized for non-invasive quantification of muscle perfusion, glucose 
utilization, fatty acid uptake and oxidation.  It therefore represents an important tool to bridge the 
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gap between blood flow and metabolism [99].  Positron emission tomography measurements are 
based on the imaging of biochemical processes in vivo following the infusion of “natural” 
substrates labeled with short-lived positron emitting isotopes, and detection of γ-rays resulting 
from interactions between positrons and electrons [100].  Tracers such as 82Rb and 13NH3 have 
been used for blood flow measurements although H213O is most widely used [100].  H213O is an 
ideal tracer because it is freely diffusible and inert with respect to changes in tissue metabolism, 
and has a half-life of approximately 2 minutes.  Using positron emission tomography blood flow 
mapping can be done using 2 methodologies, autographic or steady state.  The autographic 
method uses radioactivity decay curves to mathematically determine blood flows and has been 
validated against plethysmography [101].  The steady state method involves the continuous 
administration of H213O to achieve a radioactivity equilibrium, whereby tracer administration is 
in balance with tracer washout.  The major benefits of this technique are the ability to link blood 
flow and metabolism, along with a greater ability to image possible heterogeneity of these 
distributions.  The major disadvantages of positron emission tomography are the costs of 
purchase and operation of the equipment.  Additionally, restrictions in imaging and data retrieval 
limit the type and intensity of exercise for which it may be utilized [55]. 
 
 A.4. Circulatory Adjustments to Dynamic Exercise 
At rest, blood flow to the human forearm and calf muscles is approximately 3-5 
ml/100gtissue/min but may be 10 to 15 times higher immediately following intense muscle 
activity [102], demonstrating a huge increase in vascular conductance within these tissues.  
Additionally, considering limb skeletal muscle constitutes approximately 40% of the total body 
mass, central cardiovascular control mechanisms must ensure 1.2 liters/min of blood at rest, 
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increase to 20-25 liters/min at maximal dynamic exercise [102].  Once again the Fick equation 
forms a reference point for understanding the adaptations accompanying dynamic exercise. 
VO2peak = HRpeak * SVpeak * a-v O2diffmax 
Although it would be negligent to omit central cardiovascular changes in any review of 
cardiovascular adjustments to an acute bout of dynamic exercise, many authors have already 
comprehensively covered this topic.  Therefore, the major focus of this chapter will address the 
adjustments occurring in the peripheral vasculature. 
  A.4.1. Central Adaptations 
 Central adjustments traditionally refer to heart rate, stroke volume, and the ability to 
provide driving pressure for tissue blood flow.  This section will therefore mainly focus on the 
distribution of blood flow during dynamic exercise. 
(i) Cardiac Output 
 Normal values for cardiac output at rest are approximately 5 l/min.  This increases to 
approximately 25 l/min in healthy adults [103].  Cardiac output is the product of stroke volume 
and heart rate. 
(ii) Stroke Volume 
 Stroke volume is the largest determinant between individuals VO2peaks and cardiac 
outputs.  On average it ranges from approximately 70ml during upright rest to as high as 140ml 
during exercise.  In elite endurance athletes however, exercise stroke volumes can be as high as 
200ml.  These increases occur despite the reduction in diastolic filling time from 0.55 sec at rest 
(70 beats/min) to 0.12 sec during maximal exercise (195 beats/min) [3]. 
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In any review of the cardiovascular system it is essential to include the major factors 
which influence stroke volume.  These include intrinsic factors such as cardiac contractility and 
extrinsic factors such as preload and afterload. 
Increases in cardiac contractility can be attributed to an increase in heart rate, by a 
reduction in the diastolic relaxation phase and thereby reducing the time available for calcium 
clearance from the cell.  Additionally, increased activity of cardiac sympathetic nerves and 
increases in plasma NE and Epi may also increase cardiac intropy. 
 Ventricular filling pressure or preload is the degree of stretch on the muscle fibers of the 
ventricular wall prior to systole.  According to the Frank-Starling mechanism this is positively 
correlated with stroke volume, because as a muscle fiber is stretched it causes and increase in 
tension and the ability to exert force. 
 Aortic pressure is the pressure to be overcome by the left ventricle in order for blood to 
be pumped out of the heart.  This is known as afterload and determined largely by the 
compliance of the peripheral vasculature. 
(iii) Heart Rate 
 In dynamic exercise heart rate increases with exercise intensity and oxygen consumption 
[104].  Typically, heart rates range from 70 beats/min at rest to approximately 200 beats/min at 
VO2peak.  These increases are controlled by a combination of parasympathetic nervous 
withdrawal and sympathetic nervous stimulation. (Figure A.6). 
Most of the initial heart rate response (up to approximately 100 beats/min) is attributable 
to a reduction in vagal tone.  Above 100 beats/min sympathetic activity becomes increasingly 
important [3].  This point of increased sympathetic activity is also important in alterations of 




Figure A.6. Circulatory Adjustments to Dynamic Exercise [3]. 
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  A.4.2. Peripheral Adaptations 
(i) Arteriovenous Oxygen Difference 
In dynamic exercise whole body arteriovenous oxygen difference (a-v O2diff) increases 
with exercise intensity and oxygen consumption.  Typically, a-v O2diff ranges from 5 
mlO2/100mlblood at rest to approximately 15 mlO2/100mlblood at VO2peak.  These values are 
dependent upon many factors such as the concentration of hemoglobin in the blood, the oxygen 
binding capacity, alveolar PO2, pulmonary diffusion capacity, and alveolar ventilation [3].  
During vigorous exercise hemoconcentration occurs due to increases in arterial pressures and a 
plasma volume shift in to the interstitium. 
Arterial oxygen content of approximately 20mlO2/100mlblood does not change with 
increasing exercise intensity but venous content falls considerably until approximately 85% of 
the oxygen is extracted at VO2peak.  Contributors to increased oxygen extraction include the 
redistribution of blood flow away from the splanchnic and visceral tissues in favor of working 
muscle (see below) which allows maintenance of a high oxygen extraction gradient between the 
blood and the non-working tissues.  In fact, splanchnic tissues have been found to have 
extraction rates greater than 90% during prolonged exercise [105].   
The working tissues also become more effective at extracting oxygen during exercise.  At 
rest a small percentage of the total capillaries in a given tissue are open at any time.  
Consequently, the muscle fiber to capillary ratio is low, as is the mean transit time of the red 
blood cells through each open capillary, and oxygen diffusion distances to feed the muscle fibers 
are relatively high.  These conditions are advantageous at rest because a high diffusion gradient 
for oxygen from the blood to the tissue is maintained. 
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During dynamic exercise the increase in muscle metabolism and oxygen demand causes a 
fall in tissue PO2, and a greater diffusion gradient from blood to the tissues.  Although this 
contributes to increased tissue oxygen extraction the major determinants are an enormous 
increase in the number of open capillaries, providing a greater muscle fiber to capillary ratio and 
lower diffusion distances, along with higher red blood cell transit times. 
(ii) General Redistribution of Blood Flow 
To sustain physical activity for more than a few seconds requires dramatic circulatory 
adjustments to ensure adequate perfusion of the exercising skeletal muscle as well as of vital 
organs such as the heart and brain [106].  In fact, the demands of exercise in a large volume of 
muscle mass can approximate maximal cardiac output [107].  This increased demand presents a 
significant challenge to blood pressure regulation.  The cardiovascular system must co-ordinate 
these opposing demands to produce an optimal pattern of vasodilation and constriction designed 
to maximize performance while defending blood pressure. 
As yet, the exact mechanisms involved in this integrated process are not entirely known.  
It is established that hemodynamic adaptations are mediated by a decrease in parasympathetic 
and an increase in sympathetic outflow controlled both by feed-forward from increased central 
drive and by feed-back arising from mechanically and metabolically sensitive afferent nerve 
endings in the contracting skeletal muscles. 
 A relatively easy and widely utilized method to approximate sympathetic nervous activity 
is plasma norepinephrine.  The relationship between plasma NE and HR is relatively linear 
above 100 beats per minute.  Additionally, the relationship between plasma NE and the decrease 
in splanchnic (Figure A.7) and renal blood flow is close and relatively predictable [109].  This 




Figure A.7. The Relationship between Splanchnic Blood Flow as Percent of Resting Values and 
Heart Rate during Exercise and Other Stresses [108]. 
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with regression lines derived from approximately 200 observations during supine rest combined 
with lower body negative pressure or heat stress [108, 110], and approximately 500 observations 
during exercise, exercise plus heat stress, and exercise before and after physical conditioning 
[111].  Interestingly, the effects of parasympathetic withdrawal on splanchnic blood flow are 
poorly documented. 
An examination of blood flow distributions to other tissues was performed using 
radioactive microspheres by Horimer et al. (1983), during mild dynamic leg exercise in 5 chair 
restrained baboons (Figure A.8) [112].  Blood flow to the exercising leg muscles increased by 
585 (+ 338)% and decreased by 38 (+ 4)% to the torso, by 38 (+ 6)% to the limb skin, by 30 (+ 
10)% to the non-exercising muscles, by 16 (+ 2) to the kidneys, and by 21 (+ 9)% to the 
splanchnic region.  Hohimers conclusion was during short dynamic exercise blood flow was 
redistributed away from skin, fat, non-working muscles and visceral organs to supply the needs 
of exercising muscles [112]. 
  A.4.3. Peripheral Adaptations of Blood Flow at the Onset of Dynamic Exercise. 
Much of what is known about skeletal muscle blood flow is taken from studies performed 
at rest or during steady state exercise [113].  Interestingly, the key time period to be examined 
maybe the transition form rest to steady state when central and peripheral control mechanisms 
often compete for vascular control.  The prevailing view of skeletal muscle exercise hyperemia is 
that it is primarily mediated by local control mechanisms and that central control systems are 
superimposed on the dominant local control systems (Figure A.9) [114, 115]. 
 Figure A.9 outlines the major established factors involved in peripheral skeletal muscle 
blood flow (q).  These mechanisms include mechanical (top row) and non-mechanical (bottom 










Figure A.9. The Major Established Factors Involved in Peripheral Skeletal Muscle Blood Flow 
Limb blood flow (q) is determined by the interplay between several mechanical (top row) or 
nonmechanical (bottom row) factors that act directly on vascular smooth muscle to reduce (-) or 
increase (+) limb vascular conductance (VC). Limb flow will also increase if the pressure 
gradient ([DELTA]P) across the capillary bed following contraction is enhanced by activation of 
the muscle pump (MP) or by an increase in perfusion pressure (PP). Further, VC can be altered 
by the sympathetic nervous system (SNS) following integration of opposing reflex signals 
arising from the baroreflex (BR) and chemoreflex (CR) and from higher brain centers; the role of 
central command in blood flow control is not clearly defined. In turn, some factors may act 
indirectly by augmenting ([black small square]) or attenuating ([white circle]) the effect of other 
regulatory agents (dotted lines). The combination of these factors results in a net change in limb 
blood flow. CNS, central nervous system; PG, prostaglandins; NO, nitric oxide; [beta]AR, beta-
adrenergic receptor; [alpha]AR, alpha-adrenergic receptor; Pi, inorganic phosphate; La-, lactate; 
K+, potassium ion; ACh, acetylcholine [113]. 
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conductance (VC).  Limb blood flow is also dependent upon the pressure gradient (*P) across 
the capillary bed following contraction.  This is enhanced by activation of the muscle pump (MP) 
or by an increase in perfusion pressure (PP).  The sympathetic nervous system can also influence 
VC, following the integration of opposing reflex signals originating from the baroreflex (BR) 
and chemoreflex (CR) and from higher brain centers.  Some factors may act indirectly by 
augmenting ( ) or attenuating (() the effect of other regulatory agents (dotted lines) [113].  
Unfortunately, each of these factors may have a different proportional contributions to VC across 
the time course of the rest to work transition and, to complicate the issue further, at different 
points in the vascular tree [38, 39].  This section will attempt to summarize the current literature 
in these areas to provide a clearer picture of peripheral skeletal muscle blood flow during 
dynamic exercise. 
 It is apparent that the time course of rest to work peripheral blood flow transition is 
biphasic, with a tremendous increase during the initial 7 seconds (phase 1) followed by a slower 
rise occurring about 20 seconds until steady state is achieved (Figure A.10).  The phase 1 rise is 
so rapid it argues against the influence of non-mechanical factors. 
   A.4.3.1.Mechanical Contributions 
i) The Muscle Pump 
 Mechanical interactions between contracting and relaxing skeletal muscle and blood 
vessels may augment blood flow to these tissues in several ways [116].  Blood flow is 
determined by the interaction of the total energy gradient driving blood and the impedance of the 
vascular network (Figure A.9).  The pressure gradient (*P) is the product of perfusion pressure 
(PP) (arterial minus venous pressure) and the resistance to flow.  In most tissues mean arterial 





Figure A.10. The Rapid Biphasic Increase in Limb Blood Flow at the Onset of Exercise 
Limb blood flow increases rapidly at the onset of exercise in a biphasic manner. An initial 
plateau following 5-7 s of exercise (Phase 1) gives way to a more slowly increasing segment 
following ~20 s (Phase 2) toward a new steady-state level [113]. 
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is accomplished by variations in vascular resistance which result from changes in the caliber of 
resistance vessels [117].  Skeletal muscle contraction causes dramatic effects upon the caliber of 
the vessels within muscle tissue and the term “muscle pump” refers to contraction-induced, 
rhythmic propulsion of blood from skeletal muscle vasculature, which facilitates venous return to 
the heart and perfusion of skeletal muscle [115].  The muscle pump is proposed to act via two 
mechanisms [117, 118].  Firstly, the contraction phase of skeletal muscle causes compression of 
the veins, which imparts kinetic energy to the blood, causing it to move out of the compressed 
segments.  Due to the valve orientation in the venous system, blood can only flow towards the 
heart.  The refilling of this pump mechanism occurs at muscle relaxation as blood refills the 
veins [117-119].  Secondly, the muscle pump alters the pressure gradient (*P) across capillaries 
by lowering venous pressure in the venules and deep small veins during the relaxation phase of 
the contraction cycle [117, 118].  The veins are attached to the muscle tissue that surrounds them 
and are therefore pulled open when this muscle relaxes.  Pressure is lowered by this increase in 
venous volume and by the fact that it should already be empty from the previous contraction 
[118].  Interestingly Folkow et al. demonstrated that arterial inflow occurred throughout the 
relaxation period, yet there was no femoral venous outflow during relaxation, suggesting venous 
segments may not refill instantaneously [119, 120].  This could be interpreted as sequential 
filling of venous compartments following contraction, from the first venous valves in the small 
veins to the systemic veins.  If the next contraction is sufficiently delayed the venous bed will 
completely refill.  If not, venous pressures will remain decreased for the next relaxation phase 
[117].  The two actions of the muscle pump are only effective during rhythmic contractions, 
whereas tetani results in an increase in resistance to flow [115, 117, 118]. 
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 Early research supporting the muscle pump hypothesis demonstrated blood flow in a 
maximally dilated forearm at rest could be doubled during rhythmical contractions [121, 122].  
This work was confirmed by Laughlin et al, (1987), during treadmill exercise in rats where they 
estimated up to 30% of the total perfusion of the soleus and up to 60% of the red portion of the 
gastrocnemius muscles respectively was due to the muscle pump [118]. 
 In an effort to distinguish the contributions of the various stages of the muscle pump 
Folkow et al. examined the calf muscle blood flow during heavy plantar flexion exercise in 
individuals in supine or upright postures.  This logic was a larger venous pressure prior to a 
contraction would lead to a larger change in the pressure gradient and flow following 
contraction.  Blood flow was 60% higher in the upright position illustrating the contribution of a 
positive hydrostatic pressure (or venous suction) on the efficiency of the muscle pump [119]. 
 Sheriff et al. ran instrumented, conscious dogs on a treadmill and found if they 
maintained a constant cardiac output or mean arterial pressure, the rate of muscle contraction 
was more important than workload per-se in the early blood flow adaptation phase.  Workload 
became more influential after approximately 10 sec of work, indicating a possible metabolite 
influence [123]. 
 Leyk et al. challenged this theory in human subjects using Doppler ultrasound to measure 
femoral blood flow during calf contractions.  Their work showed a greater hyperemic response 
when the participant was seated upright than when they were positioned with the legs above the 
head [124].  This supports the muscle pump hypothesis because if the limb is above the heart 
venous volume is reduced as blood flows back to the heart due to gravity.  Leyk et al. also 
claimed the magnitude of venous and hemodynamic pressure changes between positions could 
not completely account for the changes in limb blood flow.  Unfortunately, they didn’t account 
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for changes in central hemodynamics brought about by positional manipulations [113].  In 1998, 
Shoemaker et al, examined forearm flows 5 sec after initiating rhythmic contractions [125].  
They observed a 40% increase in hydrostatic pressure when the arm was positioned below 
compared to above the heart, and a 50-100% increase in flow.  Additionally, they reported a 
matching of the time course of blood flow to the absolute work rate when workload and 
contraction rate were manipulated.  This was interpreted as evidence of a coupling of flow to 
metabolic needs and/or fiber recruitment patterns. 
 As described above the contribution of the muscle pump in the early phase of blood flow 
increases in exercise is well documented.  It remains the major contributor to ensure tissue beds 
receive adequate blood to meet the needs of increased workload.  Unfortunately, two major 
issues remain unclear.  Firstly, what is the contribution of vasodilator influences to these early 
changes?  Secondly, how does this overall system vary between different muscle types? 
 Shoemaker et al. [125] was not the first investigator to hint at a possible metabolite effect 
to cause phase 1 vasodilation.  In 1996 Tschakovsky et al.[126] used a mechanical forearm 
pneumatic cuff which could be rapidly inflated for 1 sec and deflated versus a single dynamic 1 
sec forearm contraction.  In addition, the experiments were performed with the arm above or 
below the level of the heart.  Blood flow was measured on a beat by beat basis using Doppler 
ultrasound.  During the cuff inflation/deflation, blood flow only increased when the arm was 
positioned below the heart, whereas during voluntary contraction blood flow increased in both 
conditions.  Additionally, the arm below the heart blood flow response was greater with the 
contraction condition than with the cuff [126].  The authors concluded that this suggests the 
influence of other non-mechanical factors.  Another possible explanation could lie in differences 
between the pumping efficiencies of the cuff compared to muscle. 
 112
ii) Myogenesis 
 Any influence other than the muscle pump mechanism must have the ability to influence 
vascular smooth muscle fast enough during the contraction phase of this dynamic exercise to 
allow greater dilation during the relaxation phase.  This theory is appealing, as it would allow for 
a more efficient matching of flow to the working muscle fibers even in the same muscle bed.  
Due to this rapidity of the effect the mechanical nature of myogenesis would appear to be a 
possible candidate.  Unfortunately, this theory has received little experimental support.  In 1981, 
Bachus et al. found that rhythmically changing the extravascular pressure on in canine gracilis 
muscle, in vitro, failed to produce changes in vascular response [127].  This work was confirmed 
by Sheriff et al. by manipulating arterial pressure in exercising dogs.  The initial increase in 
hindlimb vascular conductance after the initiation of running was unaffected by both increases 
and decreases in transmural pressure [123].  These findings in conjunction with Tschakovsky’s 
work [126] appear to negate a myogenic contribution to Phase 1 increases in blood flow. 
   A.4.3.2. Other Contributors 
i) Neurogenic Influences 
 An attractive alternative to myogenic influences, given the time constraints, is some kind 
of neurally controlled vasodilation.  After all, β-adrenergic and muscarinic receptors are present 
on the skeletal muscle arterial vascularture [128], and blood flow to muscle can increase, as part 
of an anticipatory response, prior to exercise activity [129] (which must be prior to metabolic or 
mechanical influences).  The sympathetic nervous system could initiate skeletal muscle 
hyperemia through an increase in sympathetic cholinergic nerve activity or a withdrawal of 
sympathetic adrenergic stimulation [115]. 
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 The existence of sympathetic cholinergic-mediated vasodilation in the skeletal muscle 
vasculature is an attractive hypothesis because not only would direct stimulation cause dilation, a 
possible acetylcholine spillover effect from the neuromuscular junctions of active tissue would 
provide a link between muscular contraction and blood flow [130].  Studies using β-blockade 
have show some conflicting results.  Unfortunately, those demonstrating a reduction in blood 
flow tended to use non-selective β-blockade, causing a systemic reduction of heart rate and 
blood pressure, thus making it impossible to attribute limb blood flow reductions to local 
mechanisms [128, 131-133].  Studies finding no effect of β-adrenergic blockade are more 
numerous and appear to be more valid.  As early as 1969, Bolme and Novotny administered 
atropine (a cholinergic muscarinic receptor blocker) to conditioned treadmill running dogs.  The 
atropine administration obliterated the anticipatory response (to a verbal cue), but did not effect 
the magnitude of muscle hyperemia at the onset of exercise [134].  In 1998, Buckwalter et al. 
followed up their earlier studies by trying to differentiate whether β-adrenergic or muscarinic 
receptors were involved in skeletal muscle vasodilation at the onset of exercise [130].  Using 
instrumented mongrel dogs running on a treadmill they infused via the femoral artery either; (a) 
1mg of propranolol (a non-selective β-antagonist); (b) 500 µg atropine (a muscarinic antagonist); 
(c) both 1mg of propranolol and 500 µg atropine or; (d) a control saline solution.  Immediately 
prior to exercise the appropriate solution was infused into one leg.  The dogs then ran on a 
motorized treadmill at 3mph/0% grade.  Blood pressure and blood flow were monitored in both 
the infusion and control legs.  The advantage this study had over its predecessors was the use of 
a local infusion of small doses of solutions creating a functionally isolated limb, coupled with the 
continuous recordings of blood flow using locally located flow probes.  No changes in the time 
course or magnitude of blood flow responses were observed, indicating neither β-adrenergic nor 
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muscarinic receptors are required for immediate skeletal muscle vasodilation at the onset of 
exercise [130]. 
 The rejection of a neural mechanism is also supported by lumbar sympathectomy studies 
in rats [135], where initial hyperemic responses were similar to control animals.  Interestingly, 
steady state blood flows were actually higher in the sympathectomized animals. 
 Finally, in 1990, Joyner et al. used posture to alter sympathetic nerve activity in humans.  
They found no difference in forearm hyperemia at the onset of exercise in the upright posture 
(when sympathetic nerve activity is high) compared to the supine position where nerve activity is 
low [136]. 
ii) Metabolites 
 Having considered mechanical (muscle pump and myogenesis) and nuerogenic 
contributions to phase 1 blood flow increases we must now consider substances released from 
the tissues or blood which could initiate vasodilation.  A variety of substances with vasodilator 
properties are released from active skeletal muscle.  These include ions, metabolites, and gases 
such as carbon dioxide, or oxygen, and more recently nitric oxide [116].  The mechanisms for 
metabolic dilation must involve either a direct effect on vascular smooth muscle tone or by 
interference with adrenergic constrictor influences [113].  The obvious attraction to this theory is 
the again the matching of blood flow to the working, metabolite producing fibers/tissue.  Indeed, 
in longer duration work metabolites are undoubtedly major contributors in this matching process. 
iii) Potassium 
The most likely culprit for metabolite induced phase 1 increases in blood flow is 
potassium ions (K+), which are known to cause vasodilation at relatively low concentrations 
[137].  K+ is released into the interstitial fluid as a result of skeletal muscle repolarization 
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following contraction and its accumulation can mirror hyperemia to that muscle.  In twitch 
contractions a dilatory threshold can be reached in approximately 10-20 seconds and peak levels 
occur at about the 2-minute point [115].  Unfortunately, the effect on the smooth muscle 
membrane Na+-K+ ATPase pump, which mediates the K+ effect, takes considerably longer.  
Smooth muscle relaxation occurs via a reduction of the Ca2+ content of the cell.  This can occur 
by a reduction in Ca2+ influx into the cell or by an increase in Ca2+ efflux via the Na+- Ca2+ 
exchange pump.  This process can take up to 15 seconds from time Na+ reaches dilatory 
threshold concentrations [138, 139]. 
Experimental evidence questioning the role of K+ in early vasodilation comes from Chen 
et al. (1972).  They measured canine hind limb perfusion pressures as an index of vascular tone, 
during contractions prior to and following treatment with ouabain.  Ouabain treatment had no 
effect on the magnitude of fall in resistance with contractions [140].  In addition, Hnik et al, 
(1976) found twitch and tetanic stimulation of the cat gastrocnemius caused substantial 
hyperemia with only small elevations in interstitial K+ levels during the initial 10 to 20 sec of 
exercise [141].  Wilson et al. (1994) confirmed these findings in the contracting human forearm, 
whereby substantial hyperemia occurred with only small increase in venous K+ concentration 
[142]. 
iv) Hydrogen Ions 
 Hydrogen Ions (H+) production is another potential mediator of early hyperemia.  
Unfortunately, animal and human experiments [143] have demonstrated an initial increase in 
muscle pH at the onset of contractions.  Although this is followed by an eventual decrease in pH, 
the time course is too slow to implicate H+ in phase 1 blood flow changes [143, 144]. 
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v) Adenosine 
 Adenosine is a byproduct of the hydrolysis of ATP and as a result accumulates in the 
interstitium.  Skeletal muscle concentrations of adenosine during early exercise are usually 
relatively low (when compared to cardiac tissue).  This is probably related to the presence of 
adenosine deaminase, which is much higher in skeletal muscle tissue [145].  However, while 
adenosine is predominantly formed in type I fibers during sub-maximal exercise, dilation also 
occurs in type II fibers [146]. 
vi) Other Metabolites 
 Oxygen and carbon dioxide can also be eliminated as possible candidates for early 
vasodilators.  Arterial O2 content of the blood appears, under most circumstances, to be in excess 
of metabolic needs[147] and experiments that manipulate the partial pressure of O2 appear to 
have little impact on hyperemia [148].  Additionally, CO2 produced by contracting muscle is 
unlikely to accumulate to a sufficient partial pressure to account for their dilation [102]. 
 In conclusion, it is unlikely that the early dilatory response is related to the metabolism of 
the recruited fibers [113].  The blood flow hyperemia response can be dislocated from the 
metabolic demand by alterations in workload [146], and by paralyzing the muscle with curare 
[149, 150].  In addition, exercise training may also disassociate this relationship.  Short-term 
endurance training results in faster conduit artery blood flow response[151] and tighter metabolic 
coupling[152, 153] when it should also reduce the production of metabolites at the onset of 
contractions. 
  A.4.4. Increases in Hyperemic Blood Flow from Phase II to Steady State 
 The current consensus suggests the phase II increase in blood flow at the onset of 
exercise begins approximately 15-20 sec after onset and is predominately feedback regulated, 
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unlike phase I [113].  The principal regulatory mechanisms involved are central command and 
peripheral feedback [154].  They defend systemic blood pressure and provide adequate blood 
flow to working tissue via increases in cardiac output and venous return, increases in vascular 
resistance in inactive tissues, and by decreases in vascular resistance in the active skeletal 
muscles [84, 155].  The purpose of this section of the literature review is to examine the 
influence of these factors at the peripheral vasculature up to and including steady state exercise. 
   A.4.4.1. Sympathetic Control 
 Central cardiovascular control mechanisms are primarily for the maintenance of systemic 
perfusion whereas local vascular control mechanisms are primarily for the maintenance of tissue 
homeostasis.  During rest sympathetic tone is relatively high and contributes to basal vascular 
resistance, yet in exercise sympathetic outflow increases dramatically and would increase 
resistance if not mediated at the local level.  An example of this at low exercise intensity was 
shown by Peterson et al, (1988) in rat himdlimbs after undergoing acute lumbar sympathectomy 
[135].  Increases in blood flow were observed indicating mediation of sympathetic 
vasoconstriction by local control mechanisms possibly including, metabolites, endothelium 
derived factors, propagated signals and the muscle pump effect [156].  This phenomenon can 
also be observed in humans with autonomic failure as they cannot maintain arterial blood 
pressure during light supine exercise [157]. 
 The concept that muscular activity may alter the responsiveness of the vasculature to 
vasoconstrictor substances was referred to as ‘functional sympatholysis’ by Remensnyder et al. 
(1962) [158].   
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“In essence, the term ‘functional sympatholysis’ describes the interaction between a 
vasoconstrictor stimulus (i.e. sympathetic activation) and a vasodilator stimulus (i.e. muscle 
contraction).  The net effect of this interaction or the degree of sympatholysis, will vary 




 Differences in the degree of sympatholysis between arteries of different caliber have 
advanced the concept of heterogeneity of distribution of α1 and α2 receptors within the 
microcirculation.  Large resistance arterioles are served by both α1 and α2 receptors whereas 
small nutrient arterioles are served by predominantly α2 receptors [159].  This becomes more 
intriguing when we consider the α2 receptors are much more sensitive to metabolic inhibition 
than the α1 receptors.  Therefore the response to sympathetic nerve stimulation [160, 161] and 
the susceptibility of sympathetic vasoconstriction to inhibition by muscle fiber activity (appears 
greatest in distal versus proximal arterioles. 
 Additionally, animal studies have demonstrated discrepancies between muscle fiber type 
responses to sympathetic stimulation.  For example, Thomas et al. (1994), showed preserved 
sympathetic vasoconstrictor response to nerve stimulation during maximal contractions of the rat 
soleus, but not the gastrocnemius-plantaris.  At rest and during low intensity work, stimulation 
reduced blood flow to both tissue beds.  When the stimulation was doubled to the maximally 
contracting gastrocnemius-plantaris, partial attenuation of blood flow occurred [162].  These 
findings demonstrate that the net vascular response is dependent upon the tissue type, the 
strength of the sympathetic stimulus and the degree of metabolic stress placed upon the tissue by 
muscle contraction [106]. 
 The evidence for exercise induced sympatholysis in humans is somewhat conflicting.  
These discrepancies can be related to the different assessment methodologies used to examine 
the microcirculation, but more realistically upon the complex nature of factors contributing to the 
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sympatholytic response.  These include the mode, intensity and duration of the activity, the 
active muscle(s) fiber type composition and the nature and intensity of the sympathetic stimulus 
[106]. 
Nevertheless, near infrared spectroscopy has revealed a differentiation in tissue 
oxygenation between active and inactive tissues during high-intensity handgrip exercise.  
Additionally, at 20-33% MVC handgrip exercise manipulation of the sympathetic stimulus 
(using lower body negative pressure) had no effect upon the oxygenation status of the active 
tissues but reduced oxygenation in the inactive tissues.  This preservation of oxygenation was 
abolished when handgrip work was less than 10-20% MVC.  These results can be interpreted as 
different intensities are needed to activate sympathetic vasoconstriction (10-20% MVC) than 
those required to initiate metabolic sympatholysis (>33% MVC) [163].  Attenuated 
noradrenaline-induced vasoconstriction of the brachial artery has also been reported during 
handgrip exercise using magnetic resonance imaging [164]. 
   A.4.4.2. Metabolic Control  
 The metabolic hypothesis proposes tissue metabolism and arteriolar smooth muscle 
constitute a local control system that provides the coupling between blood flow and tissue energy 
and nutritional requirements [114].  Metabolites from active skeletal muscle diffuse into the 
interstitium and resistance arteries, causing vasodilation and capillary recruitment.  The 
increased blood flow and oxygen extraction that result from metabolic vasodilation increase 
oxygen supply to a level compatible with tissue oxygen demand [156].  Vasoactive substances 
proposed to be involved in this dilation include H+, K+, Pi+, CO2, adenosine, adenosine 
nucleotides, lactate, TCA intermediates, vasoactive peptides and prostaglandins [84, 165].  The 
difficulty in identifying the contribution of each of these metabolites individually to the 
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vasodilative and steady state flow is that different factors may have greater influence at different 
states of exercise and in different locations in the vascular tree.  In fact, in 1975, Skinner pointed 
out that they work in an interactive, non-additive way so that the combined effects outweigh any 
single effect [166], which obviously confounds the reductionist nature of most conventional 
approaches. 
 Without the time constraints of phase 1 dilation non-mechanical mechanisms appear to 
have a much more feasible influence on vasodilation.  A good amount is known about the long 
term angiogenic adaptations to muscle metabolism under conditions such as physical training, 
hypoxia and altitude exposure, yet after more than 100 years of research the chronic mediators of 
dilation are not known [167].  This section will review the major substances involved in this 
process. 
i) Potassium Ions 
 Potassium ions may play a role in early phase II vasodilation due to skeletal muscle 
depolarization but appears to be less important as exercise continues because the arterio-venous 
difference for K+ diminishes [116, 156].  Additionally, inter-arterial infusions of K+ necessary to 
invoke forearm vasodilation also cause pain, which does not occur in mild exercise [168]. 
ii) Adenosine 
 Adenosine is a potent dilator when given exogenously to skeletal muscle and with a very 
short half-life would appear to be ideal as a key metabolite for blood flow regulation.  
Unfortunately this makes it difficult to quantify in the interstitium in terms of its ability to reach 
and bind to purinergic receptors [116].  Experimental reports in animals are often conflicting.  
For example, Klabunde (1988) found infusions of adenosine deaminase into rats did not alter 
skeletal muscle blood flow or perfusion at rest or during low intensity treadmill running [169].  
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In contrast, Metting et al. (1986), found impairment in exercising canine hindlimb vasculature to 
adapt to decreases in perfusion when adenosine receptors were blocked [170].  During leg 
exercise in humans, sufficient to raise femoral blood flow to 5-6 L·min-1, a further infusion of 
adenosine (and inflation of a cuff below the knee) enhanced blood flow by a further 2-3 L·min-1 
[171]. 
Furthermore, research utilizing dypridamole (an inhibitor of adenosine uptake by tissues) 
showed differences in skeletal muscle fiber type dilation, with greater blood flows in slow twitch 
fibers during sub-maximal exercise [172].  Schwartz and McKenzie (1990), using adenosine 
deaminase in exercising felines, supported this theory of differential release of adenosine during 
sub-maximal exercise.  They reported diminished hyperemia in the soleus but not in the gracillis 
[173].  In humans, it appears all fiber types may produce adenosine during exercise intensities 
above VO2peak or at constant or limited blood flow perfusion [169, 172, 174]. 
 It is apparent adenosine fulfills the criteria to be a dilator in voluntary contraction.  It is 
produced in the interstitium in functionally significant amounts in relation to exercise intensity.  
Thus it could be the link between muscle contraction, metabolic rate and vasodilation.  This does 
not mean it has to be the only link between these processes.  In a inventive experiment devised to 
investigate the contribution of adenosine to vasodilation Hester et al. (1982), infused adenosine 
into an isolated canine hindlimb model at super-physiologic doses for prolonged periods in an 
attempt to ‘saturate’ the adenosine-mediated dilator system.  A marked rise in flow occurred, 
which despite continued administration of adenosine, returned slowly to baseline.  Interestingly, 
there was still a rise in blood flow and dilation when contractions were superimposed upon the 
adenosine infusion [175].  Therefore, vasodilation during muscle contraction can also occur 
independent of adenosine mediated mechanisms. 
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  A.4.4.3. Nitric Oxide and Prostaglandins (Endothelial control) 
 The discovery of the vascular endothelium and endothelial derived relaxing factors [25], 
has lead to a plethora of research revealing its importance in the regulation of vascular smooth 
muscle tissue and peripheral blood flow control [37, 39, 115, 176, 177].  In fact, the endothelium 
is implicated in constricting and dilating influences as well as, structural adaptations of the 
vasculature and is responsive to both physical (shear stress) and chemical stimuli (NE, 
acetylcholine, bradykinin, vasopressin) in the vascular tissue and in the blood [113, 156, 178].  
Other possible stimulators of nitric oxide release include metabolites (which trigger specific 
receptors) [179], and sympathetic cholinergic nerves [180].  Also nitric oxide may be released 
directly by nitroxidergic nerves [181], hemoglobin (see figure A.11) and from tissues, such as 
skeletal muscle [182].  Vasoactive substances currently understood to be released by the 
endothelium include nitric oxide (NO) [183], prostacyclin (PGI2) [184], and endothelial derived 
hyperpolarizing factor (EDHF) [185]. 
 The most investigated of the endothelial relaxing factors is nitric oxide.  It appears Ca2+ is 
an essential cofactor to the enzyme nitric oxide synthase, which converts the amino acid L-
arginine to citrulline and nitric oxide.  Nitric oxide diffuses through to the underlying smooth 
muscle cells and activates the enzyme guanylate cyclase to convert guanylate tri-phosphate to 
cyclic-guanylate mono-phosphate [186].  Cyclic-guanylate mono-phosphate performs many 
cellular functions by activating specific protein kinases that result in relaxation [187].  These 
actions include increased Ca2+ extrusion from the cell, increased Ca2+ uptake into the 
sarcoplasmic reticulum, and activation of ion channels which hyperpolarizes the smooth muscle 
cell [37, 187].  This results in vasorelaxation and dilation of the arterial vasculature.  The 





Figure A.11. Mechanisms of Nitric Oxide Release [179] 
 
 124
basic of which is constitutive-NOS (cNOS) because it is freely expressed and needs free cellular 
calcium.  This form also responds to shear stress and antagonists in contrast to the inducible form 
(iNOS).  INOS is induced by cytokines and appears to be always tightly bound to calcium and 
calmodulin [32, 178].  Further distinctions have been made based upon chronological order and 
the tissue in which the enzyme was first isolated [188].  For the purpose of this review, although 
cNOS is probably the most applicable, we will not distinguish between isoforms because the 
literature is currently unclear in its definitions. 
Our understanding of NO production mechanisms has led to several methods of 
investigation of the role of NO in arterial vascular control.  For example, guanylate tri-phosphate 
can be activated directly by the vasodilators nitroglycerin and sodium nitroprusside.  
Additionally, several varieties of L-arginine analogues have been developed to competitively 
inhibit nitric oxide synthase the most popular of which is NG-monomethyl-L-arginine (L-
NMMA) [179].  L-arginine supplementation has also been employed. 
 Although the majority of research in this domain is focused on NO it is important to 
briefly review the role of prostacyclin and EDHF in vascular control during exercise.  PGI2, like 
NO can be stimulated by a variety of factors and is derived from the action of cyclooxygenase on 
arachidonic acid.  Its release by the endothelial cell causes a relaxation in the smooth muscle via 
and increase in cyclic adenosine monophosphate (cAMP) which, in turn, activates specific 
protein kinases [189].  Koller et al, [184] demonstrated the importance of PGI2 to arteriole 
vasodilation, following an increase in blood flow, in a series of isolated rat preparations [184].  
In humans, pretreatment with 1200mg/dl of ibuprofen for 2 days reduced PGI2 synthesis but had 
no effect on brachial flow response to 15 seconds of handgrip exercise.  Therefore, PGI2 may not 
be essential in establishing the magnitude or time course of blood flow in the rest to exercise 
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transition [190].  The nature of EDHF is not yet clearly understood.  It appears to be released by 
the stimulation of endothelial M1-muscarinic receptors and probably acts via the activation of a 
K+ channel [30]. 
 Research techniques to investigate the role of NO in peripheral blood flow have 
employed several different types of preparations ranging from isolated arterioles to whole animal 
studies [186].  The literature consensus is that NO plays and important role in blood flow at rest.  
In isolated preparations King et al. reported a decrease of approximately 25% in hindlimb blood 
flow with the inhibition of NO in dogs [191].  Similar findings are reported in cats hindlimbs 
[192] and human forearm muscles [44]. 
 The influence of NO during dynamic exercise is less clear.  For example, Persson et al. 
found no effect of L-NMMA on isolated rabbit tenuissimus muscle during twitch contractions 
[193].  Similarly, Barclay and Woodly, reported no effect on blood flow in canine gastrocnemius 
muscle during twitch contraction, despite an effect at rest [194].  In humans, Wilson and Kapoor, 
found identical blood flow responses to exercise before and after NO blockade [195]. 
There appear to be three points of contention, which cloud the issue and prevent any clear 
interpretations for the role of NO.  Firstly, the caliber of the arteriole may impact the effect of 
NO.  For example, Hester et al. presented evidence that NO is important in the 1-minute 
hyperemic response and dilation of first and second but not third order arterioles during twitch 
stimulation of the hamster cremaster muscle [196]. 
Secondly, the intensity of the balance between the degree of the blockade and the 
exercise stimulus appears to be important in determining the role of NO.  For example, Gilligan 
et al. found human forearm blood flow response to handgrip exercise, at 45% MVC, was 
significantly reduced following NO blockade by up to 26%.  More interestingly, the degree of 
 126
reduction in flow was related to the degree of NO blockade [197].  Additionally, O’Leary et al. 
measured blood flow through the terminal aorta of the dog during treadmill running before and 
after L-NMMA.  They found significantly reduced flows at rest and following moderate exercise 
but no difference at higher workloads [198]. 
Finally, the composition of the muscle in which the artery serves may have an influence 
on the blood flow response elicited.  For example, Shen et al. accidentally discovered differences 
in blood flow reductions in three locomotorary muscles in exercising dogs with the infusion of L-
NMMA [199].  Subsequently, Hirai et al. found a linear relation between attenuation of exercise-
induced hyperemia and the fiber composition in rats during moderate intensity treadmill running.  
Muscles with the highest content of high oxidative (slow and fast twitch) fibers exhibited the 
greatest reductions in blood flow [200].  They concluded that NO contributes to skeletal muscle 
blood flow response to a given level of submaximal exercise and that the NO pathway 
contributes to the differential blood flow response found within and among the different 
locomotor muscles of the rat during exercise [200, 201]. 
Interestingly studies by Shen et al. in conscious exercising dogs, have shown that the 
vascular beds which normally experience decreased blood flow during exercise, such as the 
splanchnic an renal circulations, experience even greater vasoconstriction and vascular resistance 
following NO blockade [199].  These findings prompted them to hypothesize that the primary 
stimulus to overcome central command is metabolic, whereas NO promotes the fall in vascular 
resistance but is not responsible for the increase in blood flow.  NO therefore acts as an amplifier 
[188, 199, 202]. 
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“In this schema, metabolic dilation causes an increase in blood flow and shear stress and then the 
increased shear stress stimulates NO production by the endothelium and adds to the fall in 
vascular resistance.” [188] 
 
 This is consistent with the observation that vascular dilation appears to be initiated in the 
smallest microvessels [203] with the dilatory signal progressing upstream to include feed 
arteries.  Therefore, the distribution of flow is regulated by the microvessels and the larger 
vessels adjust the magnitude of flow [51, 204].  In fact, Doppler observation of the brachial 
artery has shown progressive dilation for handgrip exercise beyond 60 seconds, independent of 
arm position [190].  Although, the distinction if dilation during exercise is caused by ascending 
vasodilation, by flow mediated mechanisms, or by both is currently unclear. 
   A.4.4.4. Other Factors 
Experiments using hyperoxia or hypoxia suggest a closely coupled inverse relationship 
between arterial O2 or PaO2 content and blood flow at sub-maximal exercise intensities [148, 
205].  Interestingly hemoglobin concentration has a similar relationship [206].  This suggests 
these factors may play a role in the regulation of muscle blood flow [207]. 
 The possible effects of PaO2 could be mediated via an increase in adenosine production 
and by the opening of ATP-sensitive K+ channels (see earlier) [208].  Unfortunately, during sub-
maximal exercise arterial O2 content is usually relatively high and maneuvers which increase the 
PaO2 during contractions appear to have minimal impact on the overall level of dilation [148]. 
 A role for hemoglobin was suggested by Ellsworth et al. (1995), involving the release of 
ATP by erythrocytes depending upon the number of O2 binding sites occupied [209].  Although 
there is little direct evidence for this theory it is known that a variety of vasoactive substances 
including nitric oxide can bind to hemoglobin [210].  This binding appears to be more substantial 
when hemoglobin is in the oxygenated state so offloading occurs as O2 is stripped [116, 210].  
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Conversely, it is proposed that the hemoglobin molecule acts as a scavenger of nitric oxide in the 
vascular bed, whereby low hemoglobin concentrations would allow greater availability of NO to 
induce vasodilation [211, 212]. 
  A.4.5. Section Summary 
 The rapid increase in blood flow accompanying the onset of exercise involves multiple 
and redundant mechanisms to create a cascade of events to optimize peripheral blood flow and 
delivery to working tissues.  This involves both central cardiovascular upregulation and 
peripheral adaptations.  It appears, at the periphery, that the muscle pump is responsible for the 
initial increase in blood flow seen at the onset of contractions.  Soon afterwards, metabolic 
dilating substances are released and contribute to the model.  Further amplification of this system 
could be due to flow or ascending metabolic influences on larger proximal arteries.  
Additionally, any substances transported by the blood may help to coordinate oxygen and blood 
delivery at a local or systemic level.  The influence of dilating substances released by autonomic 
nerves is currently unclear. 
 
 A.5. Circulatory Adjustments to Exercise Training 
Having examined the changes brought about by a single bout of acute exercise we must 
now examine the chronic adaptations the body makes to exercise training.  Repeatedly 
challenging the cardiovascular system to increase the delivery of oxygen and metabolic 
substrates to, as well as removal of metabolic bi-products and heat from active skeletal muscle 
results in an increase in maximal oxygen consumption [213].  This increase in VO2peak is 
accompanied by classic adaptations to training in central and peripheral mechanisms including 
exercise tolerance, skeletal muscle oxidative capacity, cardiac output, cardiac hypertrophy, 
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bradycardia, and arterial capacitance [39].  More recently other adaptations such as vascular 
endothelial adaptations to training have emerged.  The increased ability of the heart to pump 
more blood will be outlined in this section, but the focus of the chapter will be the changes in 
peripheral perfusion to working skeletal muscles. 
To provide a solid foundation for considering the training adaptation we must compare 
changes at maximal and sub-maximal (relative and absolute) VO2 levels.  Although adaptations 
may be different for short duration, high-intensity activities the focus of this work will be mainly 
on endurance type activity.  Once again the Fick equation provides a scientific base from which 
to investigate many aspects of cardiovascular adaptations to training.  Presented below is a 
comparison of maximal values for each of the Fick equation components for endurance athletes 
and sedentary individuals.  It can be seen that each maximal oxygen uptake is the product of the 
three variables to the right.  Therefore VO2peak is limited by whichever variable cannot increase.  
Usually, in healthy individuals the stroke volume determines the range over which the heart rate, 
cardiac output and O2uptake can increase [3]. 
 Longitudinal studies supporting the increase in VO2peak are also available.  The size of the 
changes depend upon several factors including, the age of the participants, their fitness prior to 
training, and also the type and length of training undertaken [214].  Generally, for average fitness 
individuals, VO2peak increases by approximately 15-20% following 2 to 3 months of aerobic 
conditioning [Astrand, 1977 #392].  With continued training greater increases are possible [215]. 
  A.5.1. Central Adaptations 
(i) Cardiac Output 
When we consider cardiac output is the product of heart rate and stroke volume, it is 
normal at rest for these variables to act in a reciprocal manner.  For example, approximately 5 
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liters of blood is needed to supply the body at rest.  Sedentary individuals have a resting stroke 
volume of approximately 70ml and therefore the heart must beat 70 times per minute to meet this 
need.  In athletes stroke volume can be as high as 130ml and therefore the heart rate is much 
lower (40 beats per minute). 
Normal values for cardiac output at peak in sedentary individuals is approximately 25 
l/min whereas in endurance athletes it can be as high as 42 l/min [216]. 
(ii) Heart Rate 
Normal values for heart rate at peak is similar for both sedentary individuals and athletes 
at approximately 200 beats per minute.  The variation in the variable with training tends to be in 
the resting heart rate.  In sedentary individuals this tends to be approximately 70 beats per 
minute, whereas in athletes it can be as low as 30 beats per minute [3]. 
(iii) Stroke Volume 
As detailed in table A.1, the increase in peak cardiac output is almost entirely due to the 
increase in maximal stroke volume.  Additionally, at sub-maximal intensities increased stroke 
volume is the important factor in maintaining cardiac output [214].  The increased range of 
stroke volume available following conditioning allows heart rate to remain constant at relative 
intensities of VO2peak. 
The current literature is unclear on the exact mechanisms for increased stroke volume.  
Increases in preload, myocardial contractility, and decreases in afterload all have experimental 
support.  Cross-sectional [217] and longitudinal [218] research has shown increases in end 
diastolic volume, and wall thickness with training.  Although myocardial contractile state 
increases acutely during exercise it is difficult to match preload and afterload to allow 
comparisons following training.  Blomquist and Saltin suggest any improvements in  
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contractility, which occur, could be too small to measure [219].  Additionally they suggest that 
decreased β-adrenergic stimulation due to lower arterial concentrations of norepinephrine 
influence contractility and heart rate at sub-maximal intensities 
A crucial component in the increased stroke volume with training is the ability of an 
individual to reduce afterload via a reduction in systemic peripheral resistance.  Analysis of the 
performance characteristics of the normal heart suggest that any potential gain in stroke volume 
that could be achieved by a training-induced increase in heart size would largely be negated by 
the increased afterload unless training also induced a decrease in systemic resistance [219].  It 
must also be acknowledged that any improvements in the capacity of the heart to supply blood 
would be surpassed by the demand of the active tissue when only a fraction of it is utilized.  
These changes will be address in subsequent sections.  For a more detailed review of central 
adaptations to training see [3, 219]. 
  A.5.2. Peripheral Adaptations 
(i) Arteriovenous Oxygen Difference 
Estimates attribute half of the increase in VO2peak to the increase in total oxygen 
extraction or systemic arteriovenous difference [3].  The effects of increased arterial capacitance 
and improved delivery of blood flow are responsible for the majority of these changes (this will 
be addressed in more detail below).  The body increases its ability to pump more blood and 
directs most of this increase to the working tissues.  Actual increases in arteriovenous difference 
per-se are not large.  During maximal exercise the oxygen content of arterial blood is 
approximately 20ml per 100ml of blood and venous content can be as low as 3-4ml per 100ml of 
blood.  This indicates that there is very little oxygen left to be extracted as a result of training 
[220].  In a longitudinal study Ekblom et al. found 16 weeks of training resulted in a 17% 
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increase in VO2peak.  Arteriovenous difference only increased by 3.6% while cardiac output 
showed an 8% improvement [221].  Work by Hornig et al. identified low muscle cell partial 
pressure of oxygen relative to the arterial content is needed to maintain a driving force for 
diffusion [222].  Since myoglobin facilitated oxygen diffusion mediates a large percentage of 
total oxygen flux through the sarcoplasm it is interesting that there is no increase in myoglobin 
concentration with exercise training in humans [223], indicating it is probably not a limiting 
factor in oxygen flux. 
An increase in the efficiency and volume of oxidative muscle cell organelles and 
enzymes occur with training and help to increase the diffusion gradient for oxygen from the 
blood.  The mitochondria are the sites in the muscle cell where oxygen is consumed.  
Unfortunately, there is only a modest increase in VO2peak when mitochondrial enzymes are 
increased more than 2-fold [224].  The nature of these adaptations are beyond the scope of this 
review but include, an increase in the number and size of mitochondria (and constituent enzymes 
such as cytochrome c) [225], an increase in lactate dehydrogenase [226], along with a relative 
decrease in glycolytic flux [227].  The main effect of increasing mitochondrial enzymes is to 
improve endurance performance by greater utilization of fats as fuels and less production of 
lactate [228].  For a more detailed review of this area please refer to references [225, 229]. 
The strongest relationship between training-induced adaptations and increases in whole 
body maximal aerobic power is the increase in the ratio of capillaries per muscle fiber [225].  
These adaptations are once more related to delivery and allow greater transit time of oxygen 
through the capillaries and in turn greater diffusion to myofibrillar mitochondria through the 
sarcoplasm [230]. 
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  A.5.3. General Redistribution of Blood Flow 
   A.5.3.1. Rest and Pre-exercise 
Exercise training doesn’t appear to have any effect on blood flow during resting 
conditions [129].  However, an anticipatory response is evident and research suggests that blood 
flow is increased proportion to the work about to be performed.  Suggestion of higher intensity 
work leads to higher cardiac outputs, arterial pressures, and limb blood flows, than for the 
suggestion of lower intensity work [134].  It also appears that the intensity of training can 
influence the distribution of blood flow among muscles during pre-exercise, with low intensity 
long duration training elevating flow to Type IIa fibers and high intensity training elevating flow 
to both Type IIa and IIb fibers [129, 231].  Even at this anticipatory stage of exercise, specificity 
of training is evident.  The elevation of blood flow depends upon if that muscle was recruited 
during the proceeding training sessions [156].  It is unclear what factors contribute to this 
response.  In some animal models sympathetic cholinergic vasodilation may occur [134].  In 
humans, evidence of this is negligible, but a decrease in arteriole sensitivity to sympathetic 
nervous activity or an increase in endothelial-mediated dilation may be responsible [232, 233]. 
   A.5.3.2. Sub-Maximal Exercise 
During sub-maximal exercise there is no difference in whole body VO2 or cardiac output 
with training [111, 213].  Following exercise training, any relative VO2peak intensity will be 
reached at a higher absolute workload.  Therefore, comparisons between pre and post training are 
more appropriate when based on absolute exercise intensity. 
The previous chapter detailed the magnitude of reductions in blood flow to renal and 
splanchnic regions and showed they are directly related to the relative exercise intensity.  In 
1964, Rowell et al. found at exercise at an absolute work level equivalent to 60% VO2peak there 
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was a 40% fall in hepatic blood flow.  Following endurance training the same workload (now 
equal to 50% VO2peak) caused only a 30% fall in hepatic blood flow.  In highly trained endurance 
athletes this work load (45% VO2peak) elicited a 25% fall in hepatic blood flow [234].  Clausen et 
al. confirmed this adaptation but showed it was specific to only the muscles which had 
undergone training.  Their subjects underwent arm or leg training.  Hepatic blood flow was 
higher only when the same absolute exercise was performed in the trained limb and was no 
different when untrained limbs were used [235].  These changes appear to be caused primarily by 
lower plasma norepinephrine concentrations and possibly by reduced sensitivity of the tissues to 
norepinephrine [236]. 
In humans, studies suggest working muscle blood flow is unchanged [237, 238] or even 
slightly reduced [239, 240].  However, as in pre-exercise anticipation, the distribution of this 
flow is different.  Endurance training leads to increased perfusion of primarily high oxidative 
fibers [129], and diminished perfusion of low oxidative fibers [231].  Factors responsible for 
muscle blood flow redistribution are many-fold including, an increase in motor unit recruitment, 
an increase in the amount or type of metabolic vasodilator/s released, decreases in the amount of 
sympathetic stimulation to specific fibers or a decrease in sensitivity to norepinephrine, and/or 
enhanced endothelial dependent dilation of the microvessels [213]. 
   A.5.3.3. Maximal Exercise 
Since approximately 85% of cardiac output is directed to the working skeletal muscle 
during exercise at VO2peak [155, 241] and cardiac output is increased with training, then 
accordingly the working muscles should receive a relative increase in flow [242].  Crucial to this 
supply is the ability of the heart to maintain arterial pressure during the dramatic increase in 
vascular capacitance in the working tissues.  Therefore, a dynamic balance is created whereby 
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when the working tissue is small, cardiac output can meet the increased blood flow requirements 
and maintain arterial pressure.  However, when a critical mass of exercising muscle is reached 
the defense of arterial pressure takes precedence.  For example peak blood flow of oxidative 
muscle can often approach 300-400ml/min per 100g.  Therefore if a normal 75kg human has 
approximately 30kg of muscle and exercises only 50% of that mass, cardiac output would have 
to be in the range of 45-60L/min (15000g muscle * 300-400ml blood) [243].  This principle is 
confirmed in classic studies by Davis and Sargeant (1975), and Klausen et al. (1982).  Both 
groups trained both legs of subjects, one leg at a time.  Davis and Sargeant observed peak 
oxygen uptake during “maximal” one-legged exercise was approximately 0.35l/min in each leg, 
whereas the increase in VO2peak in two-legged exercise was only 0.14l/min [244].  Klausen’s 
group explained this with their finding that blood flow was similarly reduced in each leg when 
they were exercised together compared with alone [245]. 
    A.5.3.3.1. Cardiac Output vs. Vascular Capacitance 
This balance between muscle capacitance and cardiac output forms the crux of the debate 
about the limitations to aerobic exercise performance.  Fortunately, in theory, we have some 
absolute parameters with which to work.  Cardiac output falls within a known parameter, 
approximately 25l/min for most individuals, of which possibly 21l (85%) is available to supply 
muscle.  These figures set the upper limit for total muscle blood flow.  Therefore, if all of the 
30kg of muscle were employed peak blood flow would be approximately 70ml/min per 100g of 
tissue.  Even in an endurance trained athlete with a maximal cardiac output of 42l/min peak 
blood flow would be approximately 109ml/min per 100g of tissue.  Clearly this is well below the 
300-400ml/min per 100g previously observed.  Along these lines to achieve a muscle blood flow 
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of 300ml/min per 100g only 7kg of muscle mass, or 25% of total skeletal muscle mass could be 
perfused. 
It therefore becomes apparent that the greater the muscle mass we activate, the less blood 
flow can be supplied per 100g of tissue.  Additionally, to reach an upper limit for muscle blood 
flow we must maximally activate a relatively small muscle mass so not to outstrip the pumping 
capacity of the heart [243]. 
Unfortunately, maximal muscle blood flow can never be obtained in an intact setting.  In 
fact it could only be measured on a small muscle mass at a specific arterial pressure and vascular 
conductance.  Given that… 
Q ∝ MAP * TPR-1 
 …any change in cardiac output is countered by adjustments in total peripheral 
resistance (or capacitance in exercise).  Additionally, add to the complexity of this model, any 
decreases in working skeletal muscle vascular resistance is often counteracted by increases in 
non-working skeletal muscle vascular resistance to help maintain arterial pressure.  This is even 
more evident in maximal exercise when cardiac output is approaching its capacity.  The 
coordination of vascular resistances to optimize blood flow to working tissue and maintain 
arterial pressure occurs primarily due to the ability of local influences to attenuate the 
vasoconstrictive influence of the sympathetic nervous system. 
    A.5.3.3.1. Capillary Density Changes 
Increases in muscular perfusion at VO2peak appear to be as a result of increased capillary 
density, dilation of more arterioles associated with the recruitment of more motor units, dilation 
of newly formed arterioles, greater dilation of existing arterioles, and vascular remodeling 
(increased length, cross-sectional area and/or diameter of existing arteries and veins) [213].  
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These changes are specific to the muscle tissue recruited during training [246, 247].  But, unlike 
animal studies, human training-induced increases in capillarity appear to be more uniform in 
terms of fiber type [248, 249]. 
The significance of greater capillarization on active muscle blood flow is the idea that the 
number of resistance arterioles may also be increased [247, 250].  Secondly, the muscle pump 
may exert a greater effect because it could expel and in turn draw a greater volume of blood 
from/through [213].  Alterations in the vasodilatory properties of individual arteries and 
arterioles could also allow for greater vessel radius.  Mechanisms for this are speculative, but 
could include changes in vessel responsiveness to neurohumoral stimuli, modification of 
myogenic responsiveness, and changes in metabolite release/sensitivity. 
    A.5.3.3.3. Neurohumoral Changes 
 Plasma norepinephrine levels following training may actually be higher at VO2peak than in 
sedentary individuals [251], but these gross measures do not appear to reflect specific muscle 
sympathetic nerve activity examined using microneurography [252]. 
Several studies have indicated decreases in sympathetic outflow to trained muscle and/or 
attenuated muscle responsiveness [253-255].  Somers et al. (1992), reported that the increases in 
muscle sympathetic nervous activity during 2 minutes of 33% MVC isometric handgrip exercise 
decreased from 111% prior to training to 38% following training in the conditioned arm, as 
opposed to no change in the untrained arm.  This decrease was attributed to decreased activation 
of the muscle metaboreflex [255].  Sinoway found training specific reductions in muscle 
sympathetic nerve activity were specific to the limb trained and attributed this to a change in the 
muscle mechanoreflex [254].  Finally, Sheldahl et al, (1994), found no modification of 
sympathetic response during isometric forearm exercise in subjects that underwent 12 weeks of 
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leg training [256].  These studies show exercise-induced increases in muscle sympathetic nerve 
activity are attenuated following training.  These changes are specific to the trained muscles and 
may play an important role in blood flow adaptations to training [252]. 
Other changes to the neurohumoral control following training include a change in the 
number of adrenergic receptors [257].  Interestingly, evidence suggests that the vasculature of 
muscles comprised of primarily type I fibers are much less influenced by sympathetic adrenergic 
stimulation than muscles comprised of primarily type IIb fibers [258].  Therefore any conversion 
of ‘fast’ fibers to ‘slow’ fibers by exercise training may influence the blood flow responsiveness 
to an acute exercise bout. 
    A.5.3.3.4. Endothelial Control Changes 
The endothelial contribution to increased arterial capacitance with exercise training 
appears to be threefold; to contribute to the reduction in vasoconstrictor reactivity, to increase 
vasodilator reactivity, and to contribute to vascular remodeling [177]. 
Endothelial cells have been shown to exhibit α2–adrenergic receptors which mediate the 
release of nitric oxide in the presence of norepinephrine [259].  This was demonstrated by Delp 
et al. in endurance trained normal [232] and hyperthyroid rat [260] aortic vessel rings.  The study 
was conducted in a medium bath containing propranolol to negate a β2-receptor effect.  
However, the removal of the endothelial cell layer abolished the reduced sensitivity to 
norepinephrine in the vessel rings from the trained rats [232], and the phenylephrine response (an 
α1–adrenergic agonist) was not altered by training.  Additionally, the endothelium may reduce 
vasoconstrictor responsiveness by attenuating the release of norepinephrine from adrenergic 
nerves [261]. 
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The first work showing increased vasodilator reactivity was performed by Miller and 
colleagues [262, 263].  They demonstrated that canine femoral arteries exposed to chronic 
increases in blood flow, via opening an arteriovenus anastamosis, exhibited enhanced 
endothelium-dependent relaxation in vitro.  In 1992, Lash and Bohlen, investigated functional 
adaptations of arterioles within the skeletal muscle of rats aerobically trained for 8-10 weeks 
with treadmill exercise.  They found large and intermediate sized arterioles of the spinotrapezius 
dilated proportionally more in the trained group to 1-8Hz stimulation [264].  Similar responses to 
exercise training have been found in various tissues such as coronary arteries [265-268], thoracic 
and pulmonary arteries and arterioles [269], the abdominal aorta [53, 232, 260] and skeletal 
muscle tissues [233, 264, 270-272].  The issues surrounding this research concern the length of 
time needed to cause endothelial modifications to the vasculature, the caliber of vessels involved 
and the nature of the etiology of the modifications. 
Most aerobic training studies in the literature were designed to last between 8-10 weeks 
[177, 232, 260, 264, 269, 273], although Delp and associates designed a protocol to examine the 
time-course of enhanced endothelium-mediated dilation in the aorta of trained rats [53].  They 
treadmill ran groups of rats for 1, 2, 4, and 10 weeks periods at 30m/min on a 15% incline for 
1hr/day, for 5days/week.  The rats were tested with 24hrs of their last exercise bout.  Citrate 
synthase activity was significantly elevated, in comparison to controls, after 2 weeks (15%), and 
continued to increase to after 4 weeks (26%) and 10 weeks (33%) training, demonstrating a 
training stimulus sufficient to enhance skeletal muscle oxidative capacity.  To measure 
vasodilation, the aortic segments were first treated with norepinephrine, which induced a similar 
tension in all groups.  A single dose of acetylcholine was then used to induce endothelial-
mediated vasodilation.  The percent dilation in sedentary rats (61%) was similar to that in ring 
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segments from animals in the 1 day, 1 week and 2 week training groups.  However, the percent 
relaxation of the vessel rings was greater in the 4 week (72%) and 10 week (79%) trained rats.  
Acetylcholine did not change norepinephrine-induced tension in vessels denuded of the 
endothelial cell layer.  Interestingly, blockade of cyclooxygenase, and therefore prostaglandin 
production, with idomethacin in intact vessels, did not alter the acetylcholine response.  
However, treatment with the nitric oxide synthase blocker, L-NAME abolished the vasodilatory 
response.  Additionally, the amounts of endothelial cell nitric oxide synthase protein were greater 
after 4 weeks training.  These findings lead to the conclusions that responses to the endothelium-
dependent dilator ACh are enhanced by 4 weeks of endurance exercise training, and this 
enhancement is preceded by increases in skeletal muscle oxidative capacity.  In addition, the 
elevation appears to be mediated exclusively through the nitric oxide synthase-EDNO pathway 
in the rat aorta and is associated with increases in the expression of ecNOS protein [53]. 
Delp’s findings are in agreement with those of Muller et al. (1994), in coronary resistance 
vessels responses to bradykinin, idomethacin and L-NAME after 16-20 weeks of training [265] 
and those of Sun et al, (1994), in the arterioles of the rat gracillis muscle following 2-4 weeks 
treadmill training [233].  A plethora of studies also support nitric oxide mediated dilation 
following training [53, 177, 232, 266, 268, 270, 272, 274-276].  Taken together these finding 
indicate an up-regulation of endothelial cell nitric oxide production with training.  This process 
involves increases in mRNA [266, 276-278] and associated endothelial derived relaxing factor 
proteins [266, 274, 276].   
Interestingly, some studies have also shown that endothelium-dependent flow-mediated 
dilation in rat gracillis arterioles is regulated by the corelease of nitric oxide and prostaglandins 
and that they act in an additive manner [275, 279].  Furthermore, in a subsequent experiment 
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exercise training enhanced this response by 83.5% at maximum flow.  This enhanced sensitivity 
maintained a lower shear stress in the exercised rat’s arterioles.  Finally, inhibition of each of the 
dilator pathways reduced flow-dependent dilation to a similar degree (approximately 40-45%), 
and their combined inhibition nearly completely eliminated the dilation of arterioles of both 
sedentary and exercise trained rats [272].  Although interesting, it should be noted these findings 
all originate from the same laboratory.  Additionally, this study utilized shear stress as the in 
vitro stimulus rather than a pharmocological stimulus to initiate dilation.  This could possibly 
indicate different receptor/mechanisms are activated with different stimuli.  Currently, the 
literature has not provided a sufficient data to address these issues. 
This upregulation of vascular endothelial responsiveness may be a temporary adaptation 
which acts as a stimulus for vascular remodeling [39].  Laughlin investigated the role of 
endothelium derived relaxing factors in the control of coronary vascular resistance in subjects 
who have been exposed to exercise training for a period of time sufficient to complete the 
adaptation process.  He found in conduit coronary arteries endothelium-mediated vasodilator 
mechanisms are enhanced during the initial phases of exercise training but return to normal by 
the time the animals have completed the adaptation to exercise training [39].  The coronary 
microcirculation, however, appears to maintain enhanced responsiveness.  He concludes that 
structural adaptations may occur as part of the exercise adaptation which produce a relative 
decrease in coronary shear during exercise [39].  Again these results are interesting but must be 
viewed in context.  There are currently no studies supporting this hypothesis in human coronary 
vessels or in fact in the peripheral vascularture.  Additionally, non-cardiac vessel time course 
investigations currently do not support this idea [53]. 
 143
A third function of increased endothelial function in peripheral arteries is its influence on 
vascular remodeling.  Because both growth-promoting and growth-inhibitory factors are made 
and secreted by endothelial cells, they are pivotal in the control of vascular responsiveness, 
particularly in the case of abnormal growth of smooth muscle during disease [24].  Accordingly, 
this topic will be addressed in more detail in chapter 5.  Nevertheless, it is noteworthy here that, 
modifications to vessel caliber have been noted following exercise training.  Laughlin and co-
workers noted structural remodeling of canine coronary arteries to become larger in diameter 
which occurred as exercise training continued beyond 1 week [38].  He hypothesized that this 
may occur to reduce shear stress on the vessel walls. 
In humans studies involving small muscle groups have shown training induced 
improvements in peripheral vasodilation occur in the absence of central hemodynamic and 
sympathetic modulations [280-282].  Research identifying endothelial derived relaxing factors as 
responsible for these increase in flow have been conflicting.  Green et al, found increases in 
forearm hyperemic blood flow and decreases in vascular resistance following 4 weeks of 
handgrip training but failed to find any augmentation of the dilatory response to methacholine 
chloride or sodium nitroprusside [281].  In contrast Kingwell et al. reported enhanced dilation to 
acetylcholine in the forearm of endurance trained athletes compared to sedentary controls, with 
no difference in the response to sodium nitroprusside [283].  In 1993, Katz et al. showed that 8 
weeks of lower extremity aerobic training was associated with a specific increase in 
acetylecholine-mediated dilation in the trained lower extremity but not in the untrained upper 
extremity in normal subjects [284].  The differences in these studies could be related to the 
intensity of the exercise stimulus.  Green et al. had subjects train for 30 min, 4 times per week 
(for 4 weeks) at an intensity of approximately 70% of a resistance that could be maintained for 3 
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min [281].  Most recently, Clarkson et al. examined the effects of a 10 week aerobic and 
anaerobic (Army basic training) exercise program on flow-mediated and nitroglycerine-induced 
vasodilation in 25 healthy male military recruits.  Flow mediated dilation increased from 2.2% to 
3.9% following training (p=0.01) with no difference in nitroglycerine mediated dilation [285].  
Interestingly, these findings are supported by localized training protocols implemented in heart 
failure patients [286, 287].   
It is interesting that when examining the endothelial response to exercise training 
pharmocological approaches have provided conflicting results, whereas flow mediated dilation 
has consistently reported increases in vasoresponsiveness.  This could be due to varying 
methodological approaches, and in fact Joyner et al. suggest that infusions given via the brachial 
artery in humans may in fact reflect events at the resistance arteries rather than the conduit 
vessels [179].  When this is considered in conjunction with Laughlin’s schema of nonuniform 
vasomotor responsiveness of the arterial tree, albeit in the coronary vascularture [38, 39], it is 
possible that different locations or receptors/pathways are measured.  This could be a significant 
distinction because the in ascending theory of vasodilation attributes the microvessels for 
initiating the increase in blood flow and the conduit vessels adjust the magnitude of flow [51, 
204]. 
 
 A.6. Effects of Disease on Peripheral Circulation and Adaptation to Exercise 
 Viewing exercise physiology from a clinical perspective demands an examination of the 
impact of cardiovascular risk factors and disease states on vascular control mechanisms.  
Traditionally, there appear to be two major schools of thought within the literature.  The larger of 
these involves endothelial function and its involvement in cardiovascular disease pathogenesis.  
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The second school of thought involves autonomic dysfunction and its impact on disease.  
Unfortunately, most of the findings from either ideology take on a univariate approach and 
therefore attribute vascular dysfunction to the action of the particular variable of consideration 
whilst, failing to provide a combined model for disease initiation, progression, and possible 
interventions.  A third emerging school of thought is apoptosis and involves a form of actively 
regulated cell death.  The focus of this section is to describe the changes in the peripheral 
vasculature accompanying and/or promoting the disease process.  This review will focus on 
peripheral arteries and only reference systemic changes briefly as they impact the vasculature. 
Cardiovascular disease is the major cause of disease globally and accounts for 
approximately 20% of all mortality [288].  In the United States in 1995, approximately 54% 
(960,000) died of cardiovascular disease and stroke [289].  The current thinking in the 
pathogenesis of atherosclerosis proposes that “injury” to the intima or endothelium is the 
initiating event [290].  The progression of the disease process and its effects on vessel structure 
is relatively well established but is worthy of brief review. 
  A.6.1. The Pathogenesis of Atherosclerosis 
Atherosclerosis is defined by the World Health Organization as… 
“a variable combination of changes of the intima of arteries consisting of the focal 




The earliest lesion of atherosclerosis is known as a fatty streak and contains lipids-laden 
macrophages and underneath these are lipid-laden smooth muscle cells [291].  Macrophage cells 
play an important role in the development of the atheroma.  They promote an inflammatory 
response to injury and in combination with lipids create an active “foam cell” environment prone 
to rupture and further inflammatory debris accumulation.  These sites progress to fibro-muscular 
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lesions, which possess a dense hardened, fibrous cap of smooth muscle and connective tissue.  
The fibrous cap of theses lesions contain multiple layers of a special form of smooth muscle cell, 
each of which lies in a lacunae-like arrangement in which the lacunae consist of alternating 
layers of basement membrane and proteoglycan.  Beneath this cap, the lesions are highly cellular 
and contain smooth muscle and macrophages, which may contain lipid droplets surrounded by 
connective tissue.  Other leukocytes may also be present in these lesions.  Beneath this there may 
be an area of necrotic debris, cholesterol crystals, and calcification [290].  The increased 
proliferation of smooth muscle cells pushes the “plaque” into the lumen of the vessel creating a 
rigid narrowing of the artery. 
The key questions for this review involve the development of the circumstances that 
contribute to the initial intimal damage and the progression of the vessel athroma.  
Epidemiological studies have produced a multitude of risk factors for cardiovascular disease 
development [292-296] and although the exact mechanism of lesion progression may never be 
totally clear we have a good scientific understanding of how these risk factors influence vascular 
health.  Physical and chemical stresses have been shown to induce intimal damage and vascular 
dysfunction.  Although, currently it is not clear which comes first.  Does the vessel become less 
responsive which, predisposes the lining damage or, does damage occur first and cause the vessel 
to be less responsive? 
  A.6.2. Apoptosis 
 Apoptosis is a form of actively regulated cell death.  Various stimuli, using a variety of 
receptors and signal transduction pathways, activate a cascade of proteases that execute a 
program of cellular self-destruction by cleaving cellular structures at specific sites in a strictly 
controlled manner [297].  This occurs without cell content spillage and inflammatory responses.  
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(For a full review of the apoptotic process please refer to [298, 299]).  This process has recently 
been linked with several cardiovascular risk factors and with vascular disease progression itself.  
The influence of apoptosis on vascular atherogenesis centers on three major concepts; apoptotic 
influences cause endothelial damage/dysregulation, upregulate smooth muscle turnover and 
growth, and increase macrophage proliferation at the site of intimal lesions.  Although a majority 
of studies in this area are correlational, and cause and effect is yet to be established, the weight of 
numbers of studies warrants a brief synopsis. 
 Endothelial cell apoptosis has been shown in atherosclerosis [300], hypertension [301], 
and congestive heart failure [302]. Yet, apoptotic endothelial cells are rarely found in the intima 
of vessels that show no evidence of vascular disease [303].  Although there is evidence that 
endothelial apoptosis is present in vessel areas with low shear stress prior to disease 
manifestation [304], it is currently unclear if apoptosis is responsible for the initiation of disease 
or if the disease process causes cells to become apoptotic. 
Changes associated with endothelial apoptosis are embedded in a complex array of 
interdependent events [297].  Apoptotic endothelial cells have been shown to release the 
vasoconstrictor interleukin-1 [305].  In turn, this enhances apoptosis, endocytosis of apoptotic 
bodies and can activate apoptosis in neighboring endothelial cells [305, 306].  Interleukin-1 is 
also associated with the expression of adhesion molecules for inflammatory cells, leading to 
leukocyte adhesion and increased presence of oxidized-LDL’s [307], which happen to be 
extremely apoptotic bodies.  An increase in the apoptotic tumor necrosis factor is also involved 
in this cascade. 
Normal anti-coagulant endothelial properties are lost during apoptosis [308].  For 
example PGI2 production is decreased [309].  This particular area of apoptosis and inflammatory 
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responses is a little confusing at the moment with reports of pro and anti-apoptotic effects.  This 
confusion maybe related to attempts of to limit the inflammatory process to a particular area of 
damage.  For example, monocytes can release the pro-apoptotic TNF but, when monocytes are 
indirect contact with endothelial cells they prevent apoptosis in a pro-apoptotic environment 
[310]. 
 Unlike the endothelial destruction, vascular smooth muscle proliferation and hypertrophy 
are associated with atherosclerotic and hypertensive disease states [290].  In vascular tissue the 
balance between cell proliferation and apoptosis determine the extent of smooth muscle growth 
[311].  In atherogenesis apoptosis is decreased and the homeostasis is interrupted in favor of 
growth.  For example PDGF, angiotensin II, and thrombin promote H2O2 production in the 
smooth muscle [312] which, in turn, activates p38 MAPK which is implicated in hypertrophy 
[313].  Again, this research area is confusing because it is also apparent that some radical oxygen 
species are essential for the apoptosis of vascular smooth muscle [314]. 
 In dynamic plaques of pre-existing lesions formed in atherosclerosis apoptosis is 
promoted by NO and promotes plaque reductions and macrophage destruction [315].  In fact, 
Wang and colleagues fed male New Zealand white rabbits a high cholesterol diet for 12 weeks 
and added 2.5% L-arginine in the drinking water for the final two weeks.  They found L-arginine 
treatment increased the number of apoptotic cells (largely macrophages) in the atherosclerotic 
lesions by 3-fold [316].  In subsequent in vitro experiments, sodium nitroprusside or L-arginine 
caused a similar effect.  These results were linked to an increase in the nitrogen oxides released 
into the medium. 
 The current difficulty with this field of research is its modernity and the heterogeneity of 
the current findings.  Most of the research in this area is post 1997 and consistent patterns of 
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findings although apparent appear to vary between tissues, types, vessel locations, species and, 
duration and type of exposures used [297].  Therefore, although it cannot be considered proven 
at this time, the available data points toward involvement of endothelial, vascular smooth muscle 
and, lesion apoptosis in the progression and regression of vascular disease.  To strengthen this 
argument, known pro- and anti-apoptotic agents need to be evaluated, under various conditions, 
as treatment strategies for vascular diseases. 
  A.6.3. Autonomic Dysfunction 
 The autonomic nervous system has a major influence over cardiac and vascular function 
and alterations in autonomic function have important physiological, pathophysiological and 
clinical implications [317].  A good model for the demonstration of the influence of the 
autonomic nervous system on cardiovascular disease is essential hypertension.  Essential 
hypertension is defined as high blood pressure for which no specific cause can be found [318], 
and accounts for 95% of all hypertension cases [319].  Hypertension is also the most pervasive 
form of physical stress on the vessel intima and could contribute to endothelial damage.  In 
young, borderline hypertensives vascular resistance appears to be normal but pressure is elevated 
by an increased cardiac output [320].  This condition is characterized by both increased 
sympathetic drive and decreased parasympathetic restraint because both propranolol and atropine 
combined are needed to abolish the difference between borderline hypertensive and normal 
subjects [321].  These findings point towards a central modification of blood pressure regulation 
rather than a change in receptor sensitivity [320].  In this review our interest is mainly in the 
autonomic control of vascular resistance, which appears to be similar between normotensive and 
borderline hypertensives in many cases.  In fact, in normotensive individuals any increase in 
cardiac output is compensated for by a decrease in vascular resistance, which allows 
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normalization of blood pressure.  Borderline hyperkinetic hypertensives do not make this 
adjustment and tend to demonstrate widespread plasma catecholamine spillover [322].  It appears 
they have a relatively normal response to stress including, isometric and dynamic exercise [323], 
blood volume expansion [324], and cold pressor tests [325].  This leads to the conclusion that 
blood pressure regulation around the set point is normal but that set point has been raised. 
 Borderline hypertension is a progressive disease and often develops in to essential 
hypertension.  This disease state is characterized by increased sympathetic outflow in young 
subjects.  These observations have been made using microneurography recordings of nerves 
supplying skeletal muscle [326, 327], noradrenaline spillover in cardiac and renal beds [328].  
Additionally, heart rate variability techniques show the low-frequency component is depressed 
and the high-frequency component is elevated compared with normotensive individuals [329], 
suggesting enhanced sympathetic and reduced vagal activity.  Differences between normotensive 
and essential hypertensive subjects are less evident with increasing age [330].  In fact, in older 
primary hypertensives plasma norepinephrine levels may in fact be lower than normotensives 
[331].  Interestingly, spectral analysis of heart rate variability data has revealed vagal tone may 
still remain depressed [332].  It is not clear what controls this transformation from a high output 
to a high resistance state but it is believed changes in vessel caliber due to injury and possibly 
endothelial dysfunction may elevate blood pressure and reduce the reliance upon cardiac output 
to meet an elevated baroreceptor set point [320].  Additionally, the effect of increased resistance 
is to alter the perfusion of the kidneys and initiate an upregulation of the renin, angiotensin and 
aldosterone cascades with the resultant increase in plasma volume and a further reduction in 
vascular conductance.  Eventually, as this condition continues constant vascular afterload causes 
a left ventricular overload and depression of cardiac output. 
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 This section is not designed to provide a complete overview of hypertension or of 
autonomic arterial pressure regulation, but to recognize it’s role in disease etiology.  To this end, 
research has linked autonomic dysfunction with established risk factors for cardiovascular 
disease [333, 334], markers of cardiovascular disease itself [335-337], diabetes mellitus [338, 
339] and, aging [334, 335, 340].  Therefore, the importance of autonomic function on the 
peripheral vasculature and in health and disease is acknowledged and thus allows the proceeding 
work to be considered within a wider context of vascular control. 
  A.6.4. Endothelial Dysfunction 
In 1980, Furchgott and Zawadzki discovered the importance of the endothelial cell in the 
process of vascular relaxation/dilation in rabbit aorta [25].  Since that study research in this area 
has progressed rapidly.  Animal and human studies have consistently demonstrated endothelium-
dependent relaxation of the vasculature is impaired in disease models.  Our current 
understanding of this area implicates the endothelium in the progression or initiation of certain 
diseases and their clinical complications [37, 189]. 
The role of the endothelium is not limited to the ability to regulate vascular tone and 
vasodilate vessels, but also includes providing a physical barrier to protect medial smooth 
muscle, maintaining hemodynamic homeostasis, and the inhibition of smooth muscle cell 
proliferation and migration.  These functions are mediated by the synthesis and release of a 
variety of substances including vasodilators such as nitric oxide and prostacyclin, 
vasoconstrictors such as endothelin and thromboxaine, anticoagulants such as tissue plasmin 
activator and antithrombin III and procoagulants such as von Willebrand factor and plasminogin-
activator inhibitor.  During endothelial cell inhibition or damage the normal homeostatic balance 
becomes disrupted in favor of an atherogenic environment. 
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This section will attempt to outline the roles and mechanisms of endothelial function in 
vascular health and disease, along with factors known to damage or disrupt endothelial function 
and the implications for vascular health.  The subheadings adopted try to sectionalize the roles 
but considerable overlap occurs. 
   A.6.4.1. The Roles of the Endothelium 
    A.6.4.1.1. Provide a Physical Barrier 
This is the most obvious contribution of the luminal layer of the vasculature.  A normal 
endothelium is a layer of cells with tight intercellular junctions.  Despite only being one cell 
thick, this layer is able to “sense” changes in hemodynamic forces, or blood-borne signals, and 
respond to physical and chemical stimuli [26].  Given that shear stress on the arterial 
endothelium can range between 10 and 70 dyne/cm2, the endothelium acts to reduce these forces 
on the medial layer [40].  Under “normal” conditions shear appears to be approximately 15 to 20 
dyne/cm2 [41, 341].  In fact, chronic increases in shear stress in models such as the radial artery 
of dialysis patients proximal to arteriovenus fistula lead to an expansion of the luminal radius 
such that mean shear stress is returned to its baseline level [341], in an endothelium dependent 
process [41]. 
Two theories of shear stress and plaque localization exist.  Initially, it was believed high 
stress (400 dyne/cm2) directly damaged the endothelial layer and provided access to the vessel 
medial layer [342].  More recently, low shear (+ 4 dyne/cm2) has been implicated in the 
atherosclerotic process [343, 344].  This is supported by the formation of plaques at the outer 
walls of bifurcation’s and areas of blood flow recirculation and stasis [40].  Low shear has been 
implicated with a decrease in endothelial cell proliferation and consequent cell loss, 
desquamation, altered morphology with decreased elongation, decrease in actin stress fibers, 
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greater monocyte attachment and migration across the endothelial layer and increased expression 
of vascular cell adhesion molecule-1 (VCAM-1) [345].  Apoptosis may also play a role in 
endothelial cell loss [346]. 
 The second to second variations in shear stress appears to have a beneficial effect on the 
endothelial barrier, with increased secretion of nitric oxide and prostacyclin and the subsequent 
decrease in platelet activation, smooth muscle proliferation and neointima formation [347].  
Turbulent flow fails to induce alterations in endothelial cell calcium concentrations and activate 
protein kinases [348].  It also allows the upregulation of endothelin-1 mRNA [349] and increases 
the presence of superoxide anion [350], which are both atherogenic.  It is established that chronic 
hypertension injures the endothelium but it is unclear as to whether this is related to the constant 
pressure or to an increase in vessel turbulence.  Regardless, the physical stress associated with 
chronic high flow damages the endothelial barrier, exposing the medial layer, triggering an 
inflammatory response and contributing to a pro-thrombic environment. 
    A.6.4.1.2. Regulate Vascular Tone and Vasodilate Vessels 
Regulation of vascular tone is important for not only maintenance of optimal shear stress.  
It is also implicated in the control of blood flow to working tissues [188, 199-202].  Under 
clinical conditions this becomes increasingly significant in maintenance of normal tissue 
perfusion. 
The endothelium can release various factors to dilate or constrict vascular smooth 
muscle.  Nitric Oxide is the most documented vasodilator and its release can be triggered by 
platelet derived factors such as serotonin, histamine, fatty acids; or hormones such as 
acetylcholine, norepinephrine, bradykinin, vasopressin and thrombin; or by some metabolites 
such as adenosine diphosphate [189].  Other vasodilators released by the endothelium include 
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prostaglandin and endothelial-derived hyperpolarizing factor (see section 4 for details of 
chemical release pathways). 
The endothelium also releases vasoconstrictor substances such as endothelin, platelet 
derived growth factor (PDGF), thromboxaineA2, active oxygen species.  Endothelin-1 has 
received the most focus of the endothelial-vasoconstrictors.  An enzyme known as endothelin 
converting enzyme (ECE) is involved in endothelin production.  Interestingly, mRNA for ECE is 
stimulated by thrombin, transforming growth factor-β, interleukins, epinephrine, angiotensin II 
and vasopressin [351].  Endothelin-1 is a complex molecule which at lower concentrations 
evokes vasodilation and at higher concentrations evokes sustained and intense vasoconstriction 
[352].  This property is an interesting example of endothelial control.  Endothelin-1 production is 
inhibited by a cGMP dependent mechanism [353], by a cAMP mechanism, and by an 
unidentified product produce by vascular smooth muscle [354].  Blocking the L-arginine 
pathway, whereby thrombin- or angiotensin-induced endothelin production increases, can alter 
the balance of this mechanism in favor of vasoconstriction.  Interestingly, endothelin-1 causes 
the release of NO and PGI2 from endothelial cells in a negative feedback mechanism to limit the 
production of Endothelin-1 and vasoconstriction.  Therefore, at low levels endothelin-1 induces 
dilation via NO and PGI2 whereas, at higher concentrations it has a dominant effect. 
Control and counter-control mechanisms are a feature of many physiologic homeostatic 
systems.  In these systems, as with the endothelium, damage or prolonged perturbations often 
result in dysfunction and an unhealthy environment prevails.  When the endothelium becomes 
dysfunctional it loses its vasodilating mechanisms and the underlying smooth muscle become 
sensitive to vasoconstricting substances.  In fact, a loss of coronary artery vasodilatory capacity 
to Ach has been shown prior to overt atherosclerotic lesions in humans [355].  Additionally, 
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vasoconstriction may occur under conditions in which vasodilation would normally be present 
[189].  For example, the normal vasodilatory response of isolated artery to acetylcholine is 
replaced by paradoxical vasoconstriction [Ludmer, 1986 #507]. 
Additionally, tonic NO production may be inhibited by damage.  Given that basal 
circulation is in a constant state vasodilation and tonic NO secretion it is no surprise that in 
isolated arteries, L-NAME or other NO inhibitors induce endothelium-dependent contractions 
[356].  Additionally, infusing NO inhibitors into the human forearm also results in decreased 
forearm circulation [44].  In fact endothelial dysfunction has been implicated in essential 
hypertension [357, 358] and nitric oxide deficient animals have a markedly reduced survival 
rates due to target-organ damage suggests NO exerts an important protective role in the 
circulation [351]. 
    A.6.4.1.2. Maintaining Hemodynamic Homeostasis 
An intact endothelium presents an anticoagulant surface due to the action release of NO, 
PGI2, antithrombin III, thrombomodulin, herprin-like substances, tPA, and superoxide dismutase.  
Additionally NO and PGI2 inhibit platelet aggregation and the secretion of platelet contents [359, 
360].  Thrombin, a focal part of the thrombosis cascade, is cleared by endothelial released 
antithrombin III and thrombomodulin [361].  In fact, key signals to stimulate the endothelial-
dependent production of NO and PGI2 are thrombin [362, 363], and platelet released ADP and 
ATP [364].  Therefore, at sites where platelets and the coagulation cascade are activated, intact 
endothelial cells release NO and PGI2, which, in turn, initiates vasodilation and platelet 
inhibition, thereby preventing vasoconstriction and thrombus formation [351]. 
When the endothelial cell becomes dysfunctional there is a local accumulation of excess 
active oxygen species, inflammatory cytokines and abnormal recruitment of monocytes and 
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lymphocytes into the vessel wall.  These substances may shift the normal anticoagulant milieu to 
one of thrombosis.  A dysfunctional endothelium also releases platelet-activating factor and 
platelet derived growth factor which enhance the pro-coagulant environment [189], and 
thromboxane A2, a potent vasoconstrictor, causing vasospasm, thrombus formation and vascular 
occlusion [31]. 
    A.6.4.1.4. Inhibit Smooth Muscle Cell Proliferation and Migration 
The normal endothelial cell is thought to prevent vascular smooth muscle cell 
proliferation via production of NO, PGI2, and heparin-like substances.  The increase in smooth 
muscle cGMP levels accompanying NO stimulation has been found to be growth inhibitory, 
although the mechanism is unclear [365].  Additionally, the PGI2 induced increase in cAMP 
concentration appears to have an inhibitory effect on smooth muscle growth.  Endothelial cells 
may be involved in the action of other growth factors such as platelet-derived growth factor 
(PDGF), fibroblast growth factor, angiotensin II and endothelin-1.  For example, endothelial 
released transforming growth factor-β (TGF-β) is activated by smooth muscle and inhibits 
growth directly at the site and indirectly by inhibits PDGF secretion and extracellular mix 
composition. 
  A.6.5. The Relationship Between the Endothelium and Risk Factors for 
Cardiovascular Disease 
 
Endothelial dysfunction may result from several forms of injury, such as oxidative stress, 
advanced glycosylation end products, hemodynamic stresses, inflammation, and oxidized lipids 
[189].  There is an extensive body of recent research in this area linking these mechanisms with a 
variety of cardiovascular risk factors and/or conditions ranging from hypercholesterolemia [366, 
367], and hypertension [368, 369], to diabetes [370-372] and heart failure [373] models.  All 
these processes involve disruption or destruction of the normal endothelial homeostatic balance 
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and often degradation of the NO system and a consequent inability to vasodilate.  In animal 
models, relatively short-term in vivo exposure to cardiovascular risk factors such as lipids [374, 
375], glucose [376] or hypertension [377] results in endothelial vasomotor dysfunction, 
alteration in endothelial adhesion and infiltration of circulating inflammatory cells, and 
neointimal growth which are similar to changes observed in long-standing human vascular 
disease [37]. 
 The most available model for study of endothelial dysfunction is hypercholesterolemia.  
In clinical studies hypercholesterolemic subjects demonstrate a decreased response to 
endothelium-dependent dilators in the coronary and peripheral vascular beds [36, 366, 367, 378-
381].  Furthermore, an inverse relationship between cholesterol levels and endothelium-
dependent vasodilation has also been reported in asymptomatic individuals with cholesterol 
levels in the high normal range [379, 382].  Probably the best demonstration of the effects of 
cholesterol on the brachial artery was by Tamai et al. who studied hypercholesterolemics before 
and following plasma LDL apheresis [383].  They found a marked increase in blood flow 
response to ACH following treatment whereby, LDL cholesterol levels were lowered to 30-40 
mg/dL. 
 A good demonstration of the development of disease and its effects on artery function 
was performed by Zeiher and colleagues in the coronary vasculature [355].  They found 
hyperlipidemic patients, without atherosclerotic lesions, had already lost the endothelial 
dependent response to ACH, although their dilator response to increased blood flow was 
preserved.  By the time mild atherosclerotic lesions (< 30% narrowing) appeared, response to 
ACH and flow were significantly diminished or abolished.  This study raises two issues, are 
there separate mechanisms, with different time courses of inhibition between physical and 
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pharmacological stimuli, and does the extent of the neointimal lesion relate to the degree of 
inhibition of endothelial-dependent relaxation?  Currently, the answer to the first question 
remains to be elucidated, but it would appear that artery vasomotion is related to the stage of 
atherogenesis [355, 384].  Again, it is not clear if this is related to a decreased ability for of 
relaxing factors to be released [385], or travel to the smooth muscle [37], or a reduction of 
sensitivity of the smooth muscle itself [385-387].  It is probably a combination of all of these 
mechanisms.  Additionally, production of [388], and/or smooth muscle sensitivity to [389] 
vasoconstrictors may be increased. 
 A common factor between the pathogenesis of hypercholesterolemia and other risk 
factors is the production of oxygen free radicals.  Endothelial cells are particularly vulnerable to 
oxidative stress due to their low antioxidant activity, high feritin iron, polyunsaturated fatty acid 
content, and exposure to the high oxygen tension of arterial blood [189].  This mechanism helps 
to explain the effectiveness of antioxidant treatment on restoring endothelial function in many 
risk factor models [74, 390, 391]. 
In hypercholesterolemia, the atherosclerotic process is believed to be initiated by oxygen-
derived free radical-induced oxidation of lipoproteins [392].  Oxidized LDL acts via several 
different pathways to induce dysfunction.  NO availability is reduced by oxidative stress [393], 
because it acts as a free radical scavenger and reacts with superoxide anions (O2-) to produce less 
active nitrate metabolites.  This is advantageous in a healthy environment, as it protects the 
endothelial cells from the cytotoxic effects of O2-.  In disease conditions however the balance 
between NO and O2- may be altered [394].   
 Oxidized LDL has also been shown to increase the expression of endothelin [395], 
stimulate endothelial cell monocyte adhesion [396], activate cell protein kinases, and inhibit G-
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protein functions [31].  Additionally, oxidized LDL is cytotoxic to a variety of vascular cells 
including endothelium, smooth muscle, and fibroblasts.  It increases the presence of cytokines, 
such as tumor necrosis factor, vascular cell adhesion molecule (VCAM1) expression, and 
upregulation of monocyte-directed athero-endothelial leukocyte adhesion molecule (athero-
ELDM) [397], and monocyte chemoatractant protein-1 (MCP-1) which promotes monocyte 
migration into the sub-endothelial space in response [398].  The overall effects of theses 
mechanisms are stimulation of foam cell formation and a pro-coagulant environment [189]. 
 Clinical studies linking other major risk factors linked with vascular dysfunction are 
numerous (Figure A.12).  The major mechanisms of pathogenesis in these all involve damage to, 
or inhibition of, the endothelium via either increased oxidative stress, decreased vasodilator 
synthesis, increased vasoconstrictor synthesis, increased cell adhesion molecules, and eventually 
smooth muscle abnormalities. 
 Although the associations between individual risk factors for cardiovascular disease and 
abnormal endothelium-dependent dilation are relatively well documented.  In 1994, Celermajer 
and colleagues, attempted to investigate the relative importance of smoking, family history of 
disease, blood pressure, total cholesterol, gender and age, on flow-mediated dilation of the 
brachial and femoral arteries [379].  Univariate analysis confirmed the findings for individual 
risk factors and for the composite risk score (r=-0.30, p<0.0001).  Stepwise multiple regression 
analysis of all variables, including the risk score, revealed an interaction effect with 40% of the 
variability of flow-mediated dilation accounted for by the risk factors measured. 
In the absence of longitudinal or serial studies linking endothelial dysfunction with 
disease outcome measures, Allen et al. attempted to further determine the predictive validity of 
























Figure A.12. Cardiovascular Risk Factors Linked with Vascular Dysfunction 
[7, 70, 184, 221, 272, 335, 338, 348, 349, 366-369] 
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They extended Celermajers vasoreactivity-risk factor findings by linking flow-mediated dilation 
to an established epidemiological coronary heart disease (CHD) risk factor composite score 
algorithm.  This model integrated the categorical approaches recommended by the JNC-V and 
NCEP programs and was developed and validated from the Framingham study population [404].  
They found the univariate analyses on the association between individual CHD risk factors and 
FMD confirmed previous reports.  In addition there was a significant relation between flow-
mediated dilation and the composite risk score (r=-0.461, p=0.002) and for the 10 year CHD 
predicted risk (r=-0.500, p=0.001). 
 Taken together these findings indicate loss of vasoreactivity in the systemic arteries 
occurs in the pre-clinical phase of vascular disease and is associated with the interaction of risk 
factors known to promote the development of atherosclerosis. 
   A.6.5.1. Local vs. Global Dysfunction 
Research evidence shows that risk factors for cardiovascular disease are associated with 
loss of coronary artery [380] and peripheral artery  [379, 403] endothelium-dependent 
vasodilation in non-atherosclerotic vessels.  Additionally, clinically overt atherosclerosis is 
associated with paradoxical vasoconstriction in the coronary beds [36] and vascular dysfunction 
in the brachial and femoral arteries [389, 405].  Therefore, it is logical that endothelial 
dysfunction maybe a generalized process across the entire vasculature.  In this case non-invasive 
assessment of brachial artery endothelial function could serve as a useful surrogate measure for 
the coronary arteries.  In 1995, Anderson and colleagues tested this hypothesis [406].  They 
assigned subjects into two groups on the basis of their coronary epicardial vasomotor response to 
ACH.  In the normal group the coronary arteries dilated by 9+11% and the brachial artery by 
10.8+7.6%.  In the dysfunctional group coronary constriction of 17+14% occurred and brachial 
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dilation was significantly reduced 4.8+5.5% (p<0.01).  Additionally, in a multivariate model, the 
presence of coronary endothelial dysfunction was the strongest predictor of an abnormal brachial 
artery vasodilator response after accounting for baseline brachial artery diameters.  There were 
no differences in response to nitroglycerin administration between the groups, indicating the 
differences do not appear to be related to smooth muscle structural alterations.  Takase et al. 
modified this study protocol in a small (n=15) heterogeneous population of those with mild to 
moderate coronary artery disease and normal subjects [407].  They used serial infusions of ATP 
to increase flow in the coronary arteries to match the hyperemic responses in the brachial tests.  
Their results showed a stronger relationship between flow-mediated dilation in coronary and 
brachial arteries (r = 0.78, p<0.001) when the same stimulus was used. 
   A.6.5.2. Treatment Strategies 
 Due to the complex nature of endothelial dysfunction and the existence of several 
different pathways for pathogenesis, it is difficult to pinpoint exactly what strategy provides the 
most effective treatment for a particular disease-state and stage of disease development.  This 
section will focus on studies performed, which provide efficacy and therefore an insight into 
possible therapeutic mechanisms. 
 Two approaches to disease management include the indirect approach, by reducing the 
risk factors implicated in the initiation and progression of the disease process, and the direct 
approach, by modifying the endothelium itself.  The attenuation of nitric oxide production is a 
key step in many of the endothelial disablement processes.  Accordingly, many of the treatment 
processes are aimed at redressing the delicate balance of constriction/dilation, hemodynamic 
homeostasis, and therefore reestablishing the endothelial barrier to protect the vessel intima and 
further prevent long term vascular remodeling.  The pathogenic processes have been outlined 
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previously in this section and figure A.13 illustrates the current literature involving various 
methods of approach.  It repeats the established risk factor model from figure A.12 and provides 
additional information pertaining to the method of intervention resulting in an increase in 
endothelial-mediated dilation.  Additionally, the authors of these studies are presented to provide 
some idea of the respective weight of papers in this area. 
 The efficacy of these treatments may depend upon the initial degree of perturbation, for 
example, Kugiyama and colleagues, treated subjects with high and low levels of remnant 
lipoprotein with the antioxidant alpha-tocopherol for a 4-week period.  Subjects with high 
remnant lipoprotein levels significantly improved brachial artery flow mediated dilation from 
4.1+0.3% at baseline to 7.5+0.4% following alpha-tocopherol versus 4.2+0.4% following 
placebo.  The treatment was ineffective in the low remnant group but this group had significantly 
higher dilations (6.0+0.5%) original [410].  Additionally, the literature in this area is further 
complicated by often-conflicting reports of vascular disablement.  For example, several studies 
report impaired vasoreactivity in patients with Type I diabetes mellitus [371, 372, 411, 414, 
415], while others do not [416-418].  These discrepancies appear to be linked to differences in 
the selection of patients with or without the presence of other risk factors known to influence 
vascular reactivity and to differences in vascular assessment [416].  Another issue to consider in 
assessment of the efficacy of interventions may be the duration of the disease process.  If 
endothelial damage is long-term vascular structural modifications could have occurred with 
associated alterations in the vessel smooth muscle and maybe therefore less responsive to 
treatment. 
 In order to expand upon the role of exercise training in endothelial function from section 
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Figure A.13. The Indirect Method of Treatment 
[272, 273, 375-380]
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linked with direct adaptations to endothelial function such as, reduced sensitivity to NE [232, 
260] and attenuated NE release [261], and an increase in eNOS [53], mRNA [266, 276-278], and 
associated endothelial derived relaxing factor proteins [266, 274, 276].  Vascular remodeling has 
also been shown following exercise training [38].  These changes contribute to increased arterial 
vasodilatory response to various stimuli [53, 232, 233, 260, 262-268, 270-272]. 
Indirect mechanisms by which exercise training can reduce endothelial dysfunction are 
shown in figure A.14.  This illustrates the potential influence of exercise training on established 
risk factors.  Central cardiovascular changes to training are also outlined in Section 5. 
 Due to the relatively recent discovery of the roles of the endothelium there is a dearth of 
longitudinal studies examining the effects of exercise training on vascular function.  Several 
studies were outlined in Section 5 [280, 281, 284, 285, 373, 420].  Of particular importance here 
are studies involving changes in endothelial function in clinical models. 
For the purpose of this review aging will be considered as a disease state.  Additionally, 
endothelial function traditionally decreases with age [369, 379, 421, 422].  However this could in 
part, be related to changes in lipoprotein profile, insulin sensitivity, and blood pressure.  Several 
studies have been performed during the last 2 years demonstrating enhanced or preserved 
endothelial vasoreactivity in healthy endurance-trained older men [412, 413, 423, 424]. 
Cross-sectional studies unanimously demonstrate significantly greater endothelium-
dependent dilation in elderly physically trained subjects compared to healthy, sedentary, age-
matched controls [412, 413, 423, 424].  The average age of subjects combined across studies was 
approximately 76yr. (n=29).  Interestingly, in studies where multivariate regression analyses 
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Figure A.14. Possible Indirect Mechanisms by which Exercise Training May Improve 
Endothelial Function  
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  There were also no differences between training groups for endothelium-independent 
dilator responsiveness [412, 413, 423, 424]. 
The current literature shows only two longitudinal studies involving flow-mediated 
improvement in vascular function training in the elderly.  In 1990 Martin et al. trained 9 men and 
10 women aged 64+3yr. by walking/jogging at 70-90% VO2peak for 45 minutes on 3-5 days per 
week for approximately 6 months.  They used plethysmography to examine calf blood flow pre- 
and post-training.  Vasodilatory capacity to occlusion combined with heel-raise exercise, 
increased by 25% in males and by 21% in females following training [425].  In 2000, DeSouza 
and colleagues, walk-trained 13, previously sedentary, middle aged and older healthy men for 3 
months.  Following training ACH-mediated vasodilation increased by 30% versus baseline.  In 
fact, when the authors compared these results to previous cross-sectional results between young 
and older subjects they found no difference in endothelium-mediated dilation between the post-
training group and the young subjects.  They concluded regular aerobic exercise can prevent the 
age associated loss in endothelium-dependent vasodilation and restore levels in previously 
sedentary middle aged and older healthy males [423]. 
Heart failure is another population in which increases in endothelial function following 
exercise training have been documented [286, 287].  Hornig et al, performed a cross-sectional 
study demonstrating reduced flow-mediated dilation in the forearm radial artery of 12 congestive 
heart failure subjects (NYHA class III) compared with 7 age-matched controls (41+8yr.) 
(8.6+0.9% vs. 13.5+0.7% respectively p<0.05) [286].  The heart failure subjects’ non-dominant 
arms were then trained for 4 week using handgrip exercise at a rate of 30 contractions per minute 
for 30 minutes daily for 4 weeks at an intensity of 70% of a previously tested 3 minute 
maximum.  Following training, flow-mediated vasoactivity increased by 58% (13.6+0.9%) 
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compared to baseline.  These values were similar to the untrained healthy population.  
Interestingly, this improvement could be abolished by L-NMMA administration.  Finally, a 6-
week no-training period was designed following the training.  Vasoactivity in the heart failure 
subjects returned to near pre-training values (8.6+0.9%).  No differences were observed with 
administration of NTG or for the untrained dominant arms across the study time-period.  These 
findings were supported Katz et al, who performed an identical training program for 8 weeks in 
12 similar heart failure subjects [287].  Blood flows increased from baseline to ACH infusions 
only in the trained limb (8.6+1.3 to 16.6+2.0ml/min/100ml/tissue), assessed by strain-gauge 
plethysmography. 
Similar results have been shown in several other heart failure studies [426-428] and in 
one study involving walk training in mildly hypertensive subjects [429].  It is therefore 
reasonable to suggest exercise training can improve endothelial-dependent vasoactivity in these 
populations.  Given previous studies this process is most likely mediated by a shear-induced up 
regulation of the nitric oxide synthase pathway and is specific to the tissues undergoing training.  
Additionally, this process is reversible when training ceases. 
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APPENDIX B. CONSENT FORM 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
Title of Study: 
 
The time course of vascular adaptations following localized short-term exercise training 
 
What you should know about a research study 
  
• We give you this consent form so that you may read about the purpose, risks and 
benefits of this research study. 
• The main goal of research studies is to gain knowledge that may help future 
patients. 
• You have the right to refuse to take part, or agree to take part now and change your 
mind later on. 
• Please review this consent form carefully and ask any questions before you make a 
decision. 
• Your participation is voluntary. 
• By signing this consent form, you agree to participate in the study as it is described. 
 
1- Who is doing the study? 
     Investigator Information: 
 
      Principal Investigator: Michael A. Welsch, Ph.D. 
    Phone No: 225/578-9143 
 
      Medical Investigator: Frank Greenway, M.D. 
    Day Phone: 225/763-2576 
    24-hr. Emergency Phone Nos.: 
    225/763-2576 (Weekdays 8:00a.m.-5:00 p.m.) 
    225/765-4644 (After 5:00 p.m. and Weekends) 
 
      Co-Investigators: Jason Allen, M.Ed. 
 
Dr. Michael Welsch directs this study, which is under the medical supervision of Dr. 
Frank Greenway.  We expect about 15 people will be in this study.  The study will take 
place over a period of 12 weeks.  Your expected time in this study will be 6 weeks.  This 
study is developed at the PBRC and is not part of a national study.
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2- Where is the study being conducted  
This study is being conducted at the Pennington Biomedical Research Center 
Outpatient Clinic, 6400 Perkins Road, Baton Rouge, LA 70808 and the Department of 
Kinesiology at Louisiana State University, 112 Huey P. Long Field House, Baton Rouge, 
LA 70803. 
 
3- What is the purpose of this study? 
You have been invited to participate in a research study to investigate how quickly your 
forearm blood vessel changes during a 4-week exercise program. 
 
4- Who is eligible to participate in the study?  Who is ineligible?  
You are eligible to participate in this study if you are: 
 Female (not nursing or pregnant), or male, 18 years of age or older 
 Apparently healthy 
 
You are ineligible to participate in this study if you have any of the following conditions: 
 Current smoker 
 Kidney disease 
 Liver disease 
 Gout 
 Anemia 
 High cholesterol 
 High blood pressure 
 Diabetes 
 Acute medical/congestive conditions 
 Active infection 
 Poor circulation or previous arm surgery 
 Currently on medications with known blood vessel effects (e.g. anti-inflammatory or 
cardiovascular medications) 
 
5- What will happen to you if you take part in the study? 
If you are selected to participate in this study it will involve 25 visits (11 visits to the 
Pennington Biomedical Research Center Clinic (PBRC) and 14 additional visits to the 
Department of Kinesiology at Louisiana State University (LSU)), over a period of 6-
weeks.  The total number of tests performed over the entire study includes… 
 10 forearm dilation ultrasound scans on each arm 
 6 MVC (handgrip strength tests) and forearm circumference assessments 
 3 venous blood draws (approx. 2 tablespoons of blood) 
 2 VO2peak arm ergometry protocols (handcrank tests) 
 2 anthropometric assessments (height, weight) 
 20 forearm resistance-training sessions (20 min handgrip training) 
 
During the first week of the study you will be required to attend 3 visits at PBRC and 1 
visit at LSU. 
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 On your first visit you will attend the PBRC clinic, where you will be interviewed and 
undergo a standard PBRC clinic screening this includes height, weight, blood 
pressure and body fat measures.  Additionally, you will be given health and activity 
questionnaires to complete. Finally, you will be asked to provide 2 tablespoons of 
blood for the determination of variables known to affect your blood vessels. The total 
time for this visit will be approximately 60 minutes. 
 On your second visit you will again attend the PBRC clinic and will be examined by a 
physician. The total time for this visit is approximately 30 minutes. 
 On your third visit to PBRC you will be escorted to a quiet room and asked to lie 
down on an examination bed. Subsequently, a laboratory technician will place 4 
electrodes and 2 blood pressure cuffs on your chest and both arms, respectively. 
The electrodes are used to examine your heartbeat. The cuffs are used to measure 
blood pressure in one arm and change blood flow to the hand in the other arm to 
allow us to test how your blood vessels react. After all the equipment is in place you 
will be given a 15-minute rest period. During this time an ultrasound technician will 
be taking pictures of a blood vessel (Brachial artery) in your arm. After a clear 
picture has been obtained the width of your blood vessel will be measured before 
and after 5-minutes of forearm occlusion. Forearm occlusion will be established with 
the blood pressure cuff on the arm being scanned. Throughout the procedure, heart 
rate, and blood pressure will also be recorded. Following this, we will swap the cuffs 
and repeat the procedure on your other arm.  This procedure is called the forearm 
dilation measure. Finally, you will be asked to provide 2 tablespoons of blood for the 
determination of variables known to affect your blood vessels. The total time for this 
visit will be approximately 60 minutes. 
 On your fourth visit you will attend LSU. This time you will be escorted to a quiet 
room where your weight and height are measured. Additionally, the circumference of 
both your forearms will be measured and you will be asked to perform a handgrip 
strength test. This will involve squeezing a hand gripper as tightly as you can. Each 
hand will be tested 3 times. These tests will be done once per week for the 6 weeks 
of the study duration, to check if you are getting stronger and if the muscle is getting 
bigger. Finally, you will perform an arm ergometer test. This involves sitting and 
performing an action similar to pedaling a bicycle but you will be using your arms 
rather than your legs. The test involves you arm cranking at a set speed (50 rpm) 
and resistance (0.5kp) for 2 minutes. After the initial 2 minutes the resistance will be 
increased by 0.25kp every subsequent 2 minutes until you reach a point that you 
want to or have to stop. This arm ergometer test will be repeated at the end of the 6-
week trial. This visit is expected to last approximately 40 minutes. 
 
The next 4 weeks of the study (weeks 2-5) are all very similar in terms of what you will 
be asked to do. 
 On Mondays and Fridays you will attend PBRC and Tuesday through Thursday you 
will attend LSU. 
 On Mondays and Fridays, at PBRC, you will undergo the forearm dilation measure. 
During the third week of the study, on one of these days, you will also be asked to 
provide 2 tablespoons of blood. 
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 Every day, Monday through Friday, you will be asked to perform handgrip training for 
a period of 20 minutes. This involves gripping and releasing the handgripper at a 
rate of 15 times per minute at a resistance set at 60 percent of your last measured 
maximum (performed the previous week).  
 Additionally, on Wednesdays you will perform the handgrip strength test to check if 
you are getting stronger. 
 These visits are expected to last approximately 70 minutes on Mondays and Fridays, 
20 minutes on Tuesdays and Thursdays, and 30 minutes on Wednesdays. 
 
During the final week of the study (week 6) you will be required to make 1 visit to PBRC 
and 1 visit to LSU. 
 The PBRC visit will involve a forearm dilation study and a blood draw (2 
tablespoons). This visit will take approximately 60 minutes. 
 The LSU visit will involve a handgripper strength test, measurements of forearm 
circumferences, and the handcrank test. This visit will take approximately 60 
minutes. 
 
6- What are the possible risks and discomforts? 
The possible risks and discomforts of participation in this study include… 
 
 Inflation of the blood pressure cuff on the forearm may cause some temporary 
discomfort in the forearm and hand. If the discomfort is too severe you may 
terminate the procedure immediately by asking the technician to stop the test. 
Temporary numbness and tingling in the hand similar to the sensation of 
having your hand “fall asleep” may occur. There is no known risk to the use of 
ultrasound to measure the size of the brachial artery blood vessel. There is 
also no known risk to blocking blood flow in the artery through inflation of the 
blood pressure cuff for the 5-minute period of time. Not a single permanent 
adverse event has been associated with this procedure in over 30,000 
examinations reported in the medical literature. 
 
 The discomforts and risks of a blood test are the pain of a needle going into 
an arm vein, possible bruising and the remote risk of infection. 
 
 The risk of cardiovascular complications during arm ergometer exercise 
protocols is lower than treadmill exercise tests and is estimated as less than 
one per 100,000 tests.  
 
In addition to the risks listed above, the procedures may have unknown, unforeseen or 
unanticipated side effects.  There is always the possibility that you will have a reaction 
that is currently not known and not expected. 
 
7- What are the possible benefits? 
We cannot promise any benefits from your being in the study.  However, possible 
benefits include helping the investigators in gathering information leading to better 
treatments for cardiovascular disease. All clinic visits, physical examinations, laboratory 
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tests, electrocardiograms, and any other procedures associated with the conduct of this 
study are free if you participate. Information received from these tests, such as 
information about your blood pressure or cholesterol for example will be available to 
you. 
 
8- If you do not want to take part in the study, are there other choices?  
You have the choice at any time to not participate or to withdraw from this 
research study. A decision to not participate will not jeopardize in any way your medical 
treatment at your medical facility at this time or in the future.  
 
9- If you have any questions or problems, whom can you call? 
If you have any questions about your rights as a research volunteer, you should call the 
Institutional Review Board Office at 225/763-2693 or Dr. Claude Bouchard, Executive 
Director of PBRC at 225/763-2513.  If you have any questions about the research study, 
contact Dr. Michael Welsch (PI) at 225/578-9143.  If you think you have a research-
related injury or medical illness, you should call Dr. Frank Greenway at 225/763-2576 
(phone number) during regular working hours.  After working hours and on weekends 
you should call the answering service at 225/765-4644.  The on-call physician will 
respond to your call. 
 
10- What information will be kept private? 
Every effort will be made to maintain the confidentiality of your study records.  However, 
someone from the Food and Drug Administration, the Pennington Biomedical Research 
Center, and Louisiana State University Department of Kinesiology (the sponsor) may 
inspect and/or copy the medical records related to the study.  Results of the study may 
be published; however, we will keep your name and other identifying information 
private.  Other than as set forth above, your identity will remain confidential unless 
disclosure is required by law. 
 
11- Can your taking part in the study end early? 
Dr. Greenway or the study sponsor can withdraw you from the study for any reason or 
for no reason.  You may withdraw from the study at any time without penalty. 
Possible reasons for withdrawal include an adverse event, injury or medical condition 
which may place you at risk of further complications if you continue to participate, failure 
to keep your scheduled appointments, early termination or other administrative reasons.  
Your participation in this research study is voluntary.  You have the right to refuse to 
participate or to withdraw from participation at any time for any reason.  Your refusal to 
participate or your withdrawal from the study will involve no penalty or loss of entitled 
benefits, nor affect your ongoing medical care.  If you decide to withdraw from the study, 




12- What if information becomes available that might affect your decision to stay 
in the study? 
During the course of this study there may be new findings from this or other research, 
which may affect your willingness to continue participation.  Information concerning any 
such new findings will be provided to you. 
 
13- What charges will you have to pay? 
None 
 
14- What payment will you receive? 
None 
 
15- Will you be compensated for a study-related injury or medical illness? 
No form of compensation for medical treatment is available from the Pennington 
Biomedical Research Center. In the event of injury or medical illness resulting from the 
research procedures in which you participate, you will be referred to a treatment facility.  
Medical treatment may be provided at your expense or at the expense of your health 
care insurer (e.g., Medicare, Medicaid, Blue Cross-Blue Shield, Dental Insurer, etc.) 
which may or may not provide coverage.  The Pennington Biomedical Research Center 
is a research facility and provides medical treatment only as part of research protocols.  
Should you require ongoing medical treatments, they must be provided by community 
physicians and hospitals.  
 
16- Signatures 
The study has been discussed with me and all my questions have been answered.  I 
understand that additional questions regarding the study should be directed to the study 
investigators.  I agree with the terms above and acknowledge that I have been given a 
copy of the consent form. 
 
__________________________________                              _____________ 
Signature of Volunteer          Date 
                                                               
__________________________________ 
Social Security No. of Volunteer 
 
__________________________________________             _____________ 
Signature of Person Administering Informed Consent             Date                                                   
 
__________________________________                             _____________ 
Investigator (Dr. Michael Welsch)                                         Date 
 
__________________________________                             _____________ 








Subject Visit Arm diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 peak prev/relv abs chg 60abs chg 90abs ch pk
1 1 1 3.896827 3.854639 3.973369 3.970523 63.83668 52.37234 103.1036 85.1739 77.67443 1.964216 1.891171 1.964216 96.86658 0.076542 0.073696 0.076542
1 3 1 3.776527 3.814683 4.146876 4.091078 91.38093 63.62305 125.3524 110.691 101.3866 9.806616 8.329098 9.806616 97.0236 0.37035 0.314551 0.37035
1 4 1 3.871922 3.806655 4.073416 3.946046 70.00085 52.76798 126.63 111.7439 99.65974 5.203978 1.914397 5.203978 139.9751 0.201494 0.074124 0.201494
1 5 1 3.971584 4.00247 4.134223 4.085166 78.97309 54.65734 116.5522 98.11097 93.45377 4.095048 2.859869 4.095048 113.2417 0.162638 0.113582 0.162638
1 6 1 3.965458 3.832573 4.083283 4.08443 73.80319 65.52178 127.0804 109.8298 108.4511 2.971282 3.000218 3.000218 93.95131 0.117825 0.118972 0.118972
1 7 1 3.808329 3.803759 4.005309 3.875275 71.38757 51.37989 134.666 101.3823 91.21733 5.172335 1.757877 5.172335 162.0987 0.19698 0.066946 0.19698
1 8 1 4.245427 4.022643 4.49088 4.50688 80.70144 51.21438 129.4968 101.5566 90.01333 5.781572 6.158443 6.158443 152.8525 0.245452 0.261452 0.261452
1 9 1 3.521167 3.35207 3.857285 3.661576 81.22193 46.3877 139.324 109.8506 95.35481 9.545631 3.987561 9.545631 200.3469 0.336118 0.140409 0.336118
1 10 1 3.950757 3.758081 4.191875 4.089249 62.77799 51.56627 160.706 92.59454 81.04194 6.103106 3.505455 6.103106 211.6494 0.241119 0.138492 0.241119
1 1 2 3.856076 3.83547 3.829676 3.828601 69.56944 61.55172 116.5275 92.71634 93.15219 -0.68463 -0.7125 -0.68463 89.31635 -0.0264 -0.02747 -0.0264
1 3 2 3.661142 3.502653 3.828582 3.828559 76.03448 65.1783 119.1466 103.9753 96.0351 4.573443 4.572802 4.573443 82.80096 0.16744 0.167417 0.16744
1 4 2 3.858227 3.911534 4.025537 3.918526 53.10628 66.72806 130.5184 105.6922 97.5902 4.336447 1.562856 4.336447 95.59744 0.16731 0.060299 0.16731
1 5 2 3.842586 3.78005 4.044015 4.049078 92.93901 62.41864 133.7931 105.3485 99.48576 5.242037 5.373796 5.373796 114.348 0.20143 0.206493 0.206493
1 6 2 3.814399 3.744966 4.074577 4.017152 89.48342 35.17316 102.7659 89.48542 79.48351 6.820959 5.315469 6.820959 192.1714 0.260179 0.202753 0.260179
1 7 2 3.8239 3.828826 3.903525 3.87343 72.59033 45.6929 139.4915 91.56113 91.38972 2.082303 1.295265 2.082303 205.2806 0.079625 0.04953 0.079625
1 8 2 3.918723 3.87426 3.925786 3.89226 46.04761 45.52 92.07696 72.94108 71.38774 0.18022 -0.6753 0.18022 102.278 0.007062 -0.02646 0.007062
1 9 2 3.61376 3.509437 3.726989 3.605215 60.87179 50.89765 126.3937 90.53368 84.34255 3.133291 -0.23645 3.133291 148.3291 0.11323 -0.00854 0.11323
1 10 2 3.824053 3.802194 4.011448 3.856563 64.49184 59.66166 145.5406 96.9026 89.48592 4.900432 0.850157 4.900432 143.9433 0.187395 0.03251 0.187395
2 1 1 3.50829 3.445598 3.757224 3.725302 88.96699 66.29516 139.0587 114.3167 108.707 7.0956 6.185709 7.0956 109.757 0.248934 0.217013 0.248934
2 3 1 3.500777 3.360025 3.885462 3.901589 123.9703 89.83918 156.7312 136.8987 128.1155 10.98855 11.44924 11.44924 74.45753 0.384685 0.400812 0.400812
2 4 1 3.851703 3.37484 3.842809 3.864577 123.7933 57.07564 155.0055 136.0354 122.414 -0.23091 0.334237 0.334237 171.5791 -0.00889 0.012874 0.012874
2 5 1 3.589527 3.253209 3.698831 3.644086 107.2425 78.2774 169.8479 148.4503 138.4491 3.0451 1.51997 3.0451 116.982 0.109305 0.05456 0.109305
2 6 1 3.548176 3.43399 3.861725 3.937216 98.96612 61.72664 141.5528 121.0456 103.4489 8.83692 10.96452 10.96452 129.322 0.313549 0.389041 0.389041
2 7 1 3.574281 3.511843 3.701765 3.57514 75.35465 60.36507 153.1225 123.806 128.122 3.566705 0.024036 3.566705 153.6607 0.127484 0.000859 0.127484
2 8 1 3.734416 3.644399 3.962427 3.645155 112.9418 58.28866 157.9408 146.3809 153.4583 6.105663 -2.39023 6.105663 170.9631 0.228011 -0.08926 0.228011
2 9 1 3.549366 3.59477 3.906676 3.603853 101.7292 66.90011 162.0814 115.1775 132.9351 10.06688 1.535122 10.06688 142.2737 0.35731 0.054487 0.35731
2 10 1 3.383267 3.537368 3.56515 3.463268 111.3971 74.49003 170.352 130.3566 139.8388 5.375941 2.364604 5.375941 128.6909 0.181882 0.080001 0.181882
2 1 2 3.192426 3.245511 3.235104 3.112955 93.10622 85.00176 121.5548 130.692 131.5522 1.336849 -2.48936 1.336849 43.00273 0.042678 -0.07947 0.042678
2 3 2 2.941282 2.744868 3.088905 3.074582 132.246 75.00079 178.1112 150.5203 140.8642 5.019015 4.532051 5.019015 137.4791 0.147623 0.1333 0.147623
2 4 2 3.301651 2.942831 3.415825 3.404445 141.3804 85.51794 178.4486 141.8982 128.6212 3.458077 3.113408 3.458077 108.668 0.114174 0.102794 0.114174
2 5 2 3.097847 3.008084 3.333976 3.278281 130.3505 97.93103 173.1089 142.7588 147.5913 7.62236 5.824505 7.62236 76.76618 0.236129 0.180434 0.236129
2 6 2 3.200964 2.996159 3.339572 3.326707 97.43738 73.96709 185.1737 145.8801 148.1099 4.330173 3.928279 4.330173 150.3461 0.138607 0.125743 0.138607
2 7 2 2.985588 2.934577 3.093306 3.042368 77.77153 57.76284 131.7437 113.293 107.2469 3.607945 1.901823 3.607945 128.0769 0.107718 0.056781 0.107718
2 8 2 3.098572 3.059383 3.289293 3.21587 97.59866 61.03693 115.1809 117.5966 111.2123 6.155102 3.785538 6.155102 88.70691 0.19072 0.117298 0.19072
2 9 2 2.989115 2.920563 3.07484 3.01645 87.77011 68.97112 170.3509 123.1066 123.803 2.867907 0.914512 2.867907 146.9887 0.085725 0.027336 0.085725
2 10 2 2.83954 2.838262 3.007106 2.953206 78.45782 68.62611 134.494 104.8359 109.8346 5.901155 4.002949 5.901155 95.98078 0.167566 0.113665 0.167566
Subject Visit Arm diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 peak prev/relv abs chg 60abs chg 90abs ch pk
3 1 1 3.535771 3.460977 3.787529 3.729624 100.8648 94.74427 162.2468 129.1481 120.6059 7.120291 5.482599 7.120291 71.4755 0.251757 0.193852 0.251757
3 3 1 3.577063 3.608322 3.826921 3.765874 83.96552 73.62392 145.6957 131.9079 138.1116 6.985003 5.278381 6.985003 97.89181 0.249858 0.188811 0.249858
3 4 1 3.627345 3.551562 3.737255 3.626881 86.89689 77.24176 150.8797 131.2145 129.8297 3.030035 -0.01278 3.030035 95.33436 0.10991 -0.00046 0.10991
3 5 1 3.574459 3.579804 3.65764 3.639789 96.7318 71.38616 173.4702 141.7258 135.1787 2.327087 1.827691 2.327087 143.0026 0.083181 0.06533 0.083181
3 6 1 3.823356 3.511362 4.047114 3.904683 85.17943 57.41483 144.3278 113.4587 106.7355 5.852396 2.127101 5.852396 151.3772 0.223758 0.081327 0.223758
3 7 1 3.626511 3.534809 3.656324 3.587947 83.63207 63.45202 139.1467 114.662 105.8649 0.82208 -1.06339 0.82208 119.2943 0.029813 -0.03856 0.029813
3 8 1 3.563353 3.429211 3.802014 3.661834 112.419 77.07554 176.0401 155.0162 150.5293 6.697658 2.763725 6.697658 128.3994 0.238661 0.098481 0.238661
3 9 1 3.627607 3.507269 3.81335 3.601312 83.80018 64.14021 154.8404 117.9415 108.2773 5.12027 -0.72485 5.12027 141.4093 0.185743 -0.02629 0.185743
3 10 1 3.609609 3.585061 3.800349 3.797193 94.83658 67.93694 146.4 130.706 125.8765 5.284243 5.19681 5.284243 115.494 0.190741 0.187585 0.190741
3 1 2 3.681131 3.598072 3.911148 3.868847 104.1421 107.1672 177.6786 142.2428 135.0912 6.248528 5.099421 6.248528 66.98802 0.230017 0.187716 0.230017
3 3 2 3.732563 3.594974 3.986896 3.904095 88.62136 88.10772 153.4493 133.4611 135.0035 6.813888 4.595541 6.813888 74.16096 0.254333 0.171531 0.254333
3 4 2 3.645962 3.524997 3.681373 3.607045 95.86328 77.07041 155.5248 118.1047 113.7976 0.97123 -1.06741 0.97123 101.7957 0.035411 -0.03892 0.035411
3 5 2 3.643301 3.492343 3.713357 3.608055 96.20937 108.4483 175.3697 140.6948 132.9347 1.922868 -0.96744 1.922868 61.7081 0.070056 -0.03525 0.070056
3 6 2 3.91844 3.673479 3.96594 3.933994 93.28001 82.58804 153.6277 130.6936 123.4531 1.212225 0.396945 1.212225 86.01691 0.0475 0.015554 0.0475
3 7 2 3.618795 3.488536 3.607234 3.569016 79.82909 84.82933 147.0761 120.0062 127.0751 -0.31946 -1.37557 -0.31946 73.37879 -0.01156 -0.04978 -0.01156
3 8 2 3.722325 3.70765 3.758303 3.714383 88.28664 87.94489 165.1782 117.427 114.8379 0.966546 -0.21336 0.966546 87.82009 0.035978 -0.00794 0.035978
3 9 2 3.670674 3.598855 3.734233 3.681956 93.10881 79.48465 170.3452 128.9858 120.8684 1.731534 0.307357 1.731534 114.3121 0.063559 0.011282 0.063559
3 10 2 3.684557 3.493534 3.706253 3.569115 108.4497 110.694 160.1787 118.6287 117.2427 0.588842 -3.13313 0.588842 44.70404 0.021696 -0.11544 0.021696
4 1 1 3.341451 3.333396 3.639214 3.663916 92.33283 59.4842 155.0959 134.5693 120.7806 8.91118 9.650454 9.650454 164.1901 0.297763 0.322465 0.322465
4 3 1 3.402562 3.393251 3.760402 3.649714 91.38475 51.04897 147.2481 122.2513 142.6045 10.51679 7.263714 10.51679 188.4449 0.35784 0.247152 0.35784
4 4 1 3.227571 3.162649 3.448946 3.250036 107.0701 64.8285 156.5565 126.9058 121.2119 6.858901 0.696035 6.858901 141.4933 0.221376 0.022465 0.221376
4 5 1 3.445823 3.487752 3.748678 3.425744 104.1471 70.52277 150.8702 131.9006 140.0087 8.78904 -0.5827 8.78904 113.9312 0.302855 -0.02008 0.302855
4 6 1 3.460548 3.498822 3.786103 3.703449 107.0815 89.1406 198.1074 133.8095 140.7025 9.407611 7.019167 9.407611 122.2415 0.325555 0.242902 0.325555
4 7 1 2.949729 3.035165 3.420228 3.297182 77.42136 51.21735 121.3912 112.9331 104.1429 15.95057 11.77915 15.95057 137.0118 0.470499 0.347453 0.470499
4 8 1 2.949729 3.035165 3.420228 3.297182 77.42136 51.21735 121.3912 112.9331 104.1429 15.95057 11.77915 15.95057 137.0118 0.470499 0.347453 0.470499
4 9 1 3.207487 3.440861 3.712531 3.499303 116.9009 74.82798 150.6899 135.1742 135.6919 15.74579 9.097962 15.74579 101.3817 0.505044 0.291816 0.505044
4 10 1 3.117928 3.123629 3.611818 3.531946 96.55727 70.6913 197.6078 156.899 128.801 15.84034 13.27863 15.84034 179.5362 0.49389 0.414018 0.49389
4 1 2 3.297557 3.179943 3.701997 3.52097 106.9872 54.31448 170.3109 139.8295 121.8188 12.26484 6.775116 12.26484 213.4837 0.40444 0.223413 0.40444
4 3 2 3.158691 2.998196 3.527304 3.276441 82.93465 57.76546 155.8692 120.1794 106.5655 11.6698 3.727793 11.6698 169.8312 0.368613 0.117749 0.368613
4 4 2 3.024515 2.956873 3.419847 3.213102 85.53147 62.76047 168.6338 134.4992 130.1818 13.07095 6.235285 13.07095 168.6943 0.395333 0.188587 0.395333
4 5 2 3.124275 2.973794 3.500259 3.45799 76.3851 66.55579 154.8466 141.735 122.9349 12.0343 10.68138 12.0343 132.6569 0.375985 0.333716 0.375985
4 6 2 3.193808 3.031733 3.576828 3.352392 93.28122 76.91243 167.0864 134.4915 127.072 11.9926 4.965383 11.9926 117.2424 0.383021 0.158585 0.383021
4 7 2 3.050884 2.982176 3.439763 3.27602 83.11057 66.7277 175.8771 142.5864 137.2574 12.74646 7.37937 12.74646 163.5744 0.38888 0.225136 0.38888
4 8 2 3.115932 3.018189 3.463243 3.304216 85.69542 66.03825 170.7904 145.0871 130.0141 11.17901 6.069962 11.17901 158.5713 0.347311 0.188284 0.347311
4 9 2 3.180981 3.054203 3.486723 3.332413 88.28027 65.34881 165.7038 147.5878 122.7708 9.611561 4.760554 9.611561 153.5681 0.305742 0.151432 0.305742
4 10 2 3.143917 2.992685 3.526904 3.452072 74.31355 45.69029 147.9439 139.6573 140.1781 12.18183 9.801647 12.18183 223.7971 0.382987 0.308156 0.382987
209
Subject Visit Arm diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 peak prev/relv abs chg 60abs chg 90abs ch pk
5 1 1 4.20731 4.069474 4.308717 4.211103 92.50277 69.14196 154.9224 134.4044 114.9174 2.410257 0.090175 2.410257 130.993 0.101407 0.003794 0.101407
5 3 1 4.322536 4.287863 4.580487 4.469033 71.72961 77.41527 145.6979 112.5951 105.867 5.967569 3.389151 5.967569 88.203 0.25795 0.146497 0.25795
5 4 1 4.293341 4.260544 4.36703 4.34335 74.48319 46.21204 126.7359 114.6639 91.56145 1.71635 1.164816 1.71635 174.2486 0.073689 0.050009 0.073689
5 5 1 4.527506 4.415838 4.586912 4.668966 133.985 106.554 214.1485 168.9769 155.1741 1.312112 3.124455 3.124455 100.9765 0.059406 0.14146 0.059406
5 6 1 4.238683 4.246194 4.674033 4.50459 87.24751 97.4144 179.6569 133.9719 131.3913 10.27089 6.273346 10.27089 84.42537 0.43535 0.265907 0.43535
5 7 1 4.111188 4.131065 4.347292 4.146197 94.83903 74.15476 174.1572 148.6342 146.3885 5.742962 0.851554 5.742962 134.8565 0.236104 0.035009 0.236104
5 8 1 4.296872 4.173358 4.41341 4.243926 72.41911 82.07549 150.7126 118.8017 110.3459 2.712156 -1.23219 2.712156 83.62679 0.116538 -0.05295 0.116538
5 9 1 4.325588 4.322964 4.465412 4.412132 86.5562 77.759 129.8468 117.0855 104.6625 3.232492 2.000745 3.232492 66.98624 0.139824 0.086544 0.139824
5 10 1 4.325588 4.322964 4.465412 4.412132 86.5562 77.759 129.8468 117.0855 104.6625 3.232492 2.000745 3.232492 66.98624 0.139824 0.086544 0.139824
5 1 2 4.134644 4.236783 4.44807 4.32218 90.69793 74.57336 168.1168 136.8991 130.8642 7.580491 4.535712 7.580491 127.2186 0.313426 0.187536 0.313426
5 3 2 4.249483 4.204651 4.420872 4.441478 61.73281 141.5629 123.6216 118.1135 4.033157 4.518079 4.518079 129.3155 0.171388 0.191995 0.171388
5 4 2 4.19498 4.230068 4.330485 4.304823 80.70144 54.83192 134.8294 114.1426 110.5239 3.230153 2.618423 3.230153 145.8957 0.135504 0.109842 0.135504
5 5 2 4.546194 4.499655 4.665738 4.597313 96.72567 76.56164 152.7642 124.4875 122.4157 2.629538 1.124437 2.629538 99.53098 0.119544 0.051119 0.119544
5 6 2 4.288957 4.257687 4.393124 4.325177 85.17959 62.7605 164.6714 132.7631 134.3192 2.428729 0.844508 2.428729 162.3807 0.104167 0.036221 0.104167
5 7 2 4.170812 3.909838 4.28396 4.046099 89.83818 70.52843 143.1053 133.1226 130.0225 2.712853 -2.99012 2.712853 102.9044 0.113148 -0.12471 0.113148
5 8 2 4.242529 4.159226 4.363665 4.198016 73.11147 71.39118 146.2279 127.2509 115.5214 2.855267 -1.04922 2.855267 104.8262 0.121136 -0.04451 0.121136
5 9 2 4.468926 4.138349 4.362304 4.207931 76.38243 60.52947 207.2427 137.7659 125.1821 -2.38586 -5.84022 -2.38586 242.3831 -0.10662 -0.261 -0.10662
5 10 2 -2.38586 -0.10662 -0.261 -0.10662
6 1 1 3.911647 3.873014 3.969286 3.897997 86.21165 51.64178 128.8063 111.7267 106.3829 1.473539 -0.34896 1.473539 154.1517 0.05764 -0.01365 0.05764
6 3 1 3.882448 3.866942 4.117833 4.089259 92.24458 71.03999 133.6318 107.9553 112.4234 6.0628 5.326813 6.0628 88.10789 0.235385 0.206811 0.235385
6 4 1 3.999859 3.953525 4.228885 4.246274 100.3498 50.00295 146.9115 144.8442 142.2485 5.725871 6.160597 6.160597 193.8057 0.229027 0.246415 0.229027
6 5 1 3.947975 4.014937 4.378111 4.338627 99.66264 90.51858 148.1206 150.5198 143.2793 10.89511 9.895004 10.89511 63.63553 0.430136 0.390652 0.430136
6 6 1 3.895528 3.925906 4.273863 4.187875 110.3486 94.82946 159.8405 148.9685 144.5733 9.695891 7.472048 9.695891 68.34178 0.378335 0.292347 0.378335
6 7 1 3.843082 3.836875 4.169616 4.037122 121.0345 99.14033 171.5604 147.4172 145.8673 8.496667 5.049091 8.496667 73.04803 0.326534 0.194041 0.326534
6 8 1 3.977567 3.981505 4.209278 4.212919 116.3839 70.17326 184.8384 159.3111 154.4878 5.825444 5.916998 5.916998 163.4029 0.231711 0.235353 0.235353
6 9 1 3.977567 3.981505 4.209278 4.212919 116.3839 70.17326 184.8384 159.3111 154.4878 5.825444 5.916998 5.916998 163.4029 0.231711 0.235353 0.235353
6 10 1 3.876567 3.88888 3.972033 3.941047 91.03779 69.14137 128.9715 113.2834 117.2424 2.462645 1.341452 2.462645 86.53308 0.095466 0.06448 0.095466
6 1 2 3.889867 3.940931 4.006512 4.010473 70.26365 66.98664 132.9413 113.3804 103.8836 2.998704 3.100534 3.100534 108.6964 0.116646 0.120607 0.120607
6 3 2 4.046457 4.02074 4.193139 4.157922 75.52232 77.59578 138.4665 121.2178 112.5929 3.624956 2.754634 2.754634 78.44591 0.146682 0.111465 0.146682
6 4 2 4.237899 87.76194 1.642344
6 5 2 4.267207 4.225258 4.2853 4.289825 88.9672 68.96595 168.9662 133.452 129.3106 0.424 0.530054 0.530054 144.9995 0.018093 0.022619 0.022619
6 6 2 4.235565 4.155232 4.293444 4.253759 102.6749 84.1389 167.3401 139.3209 133.0179 1.373615 0.428814 1.426642 105.9308 0.05788 0.018195 0.05788
6 7 2 4.203922 4.085205 4.301589 4.217693 116.3826 99.31186 165.7139 145.1898 136.7252 2.32323 0.327573 2.32323 66.86218 0.097667 0.013771 0.097667
6 8 2 4.315466 4.126976 4.378998 4.316897 103.2876 69.82972 163.6236 118.2855 112.9352 1.472188 0.033166 1.472188 134.3179 0.063532 0.001431 0.063532
6 9 2 4.11403 3.942728 4.136973 4.142944 90.69706 64.48634 146.7294 109.6615 102.5024 0.510582 0.737289 1.4568 126.9229 0.022943 0.028914 0.028914
6 10 2 3.912595 3.758481 3.894948 3.968992 78.10652 59.14295 129.8353 101.0375 92.06961 -0.45102 1.441412 1.441412 119.5279 -0.01765 0.056397 0.056397
Subject Visit Arm diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 peak prev/relv abs chg 60abs chg 90abs ch pk
7 1 1 3.069464 2.957245 3.326579 3.370671 104.6575 56.29956 162.8503 139.1511 137.2449 8.376547 9.813041 9.813041 189.6983 0.257115 0.301208 0.301208
7 3 1 3.311537 3.021293 3.659464 3.596864 124.1476 94.82789 159.4942 131.2128 122.5872 10.50651 11.25413 10.50651 68.19328 0.347927 0.285327 0.347927
7 4 1 3.159553 3.202581 3.508307 3.545323 99.49271 90.0135 169.3191 138.4487 131.7325 11.03807 12.20962 12.20962 88.10409 0.348754 0.38577 0.38577
7 5 1 3.639685 3.51345 3.962283 3.928784 108.6232 87.2458 167.0821 155.8742 139.836 8.863355 7.942977 8.863355 91.50733 0.322598 0.289099 0.322598
7 6 1 3.13436 2.970193 3.350588 3.392999 141.7243 71.72783 174.1384 154.1471 150.3656 6.898629 8.251737 8.251737 142.7766 0.216228 0.258639 0.258639
7 7 1 3.482447 3.291375 3.686851 3.789995 128.4487 79.83132 167.2431 146.3811 133.4538 5.869534 8.831374 8.831374 109.4957 0.204403 0.307548 0.307548
7 8 1 3.297694 3.082633 3.552644 3.65903 121.2133 78.45473 153.4521 136.5546 135 7.731179 10.95724 10.95724 95.59323 0.254951 0.361336 0.361336
7 9 1 3.133731 3.046871 3.503904 3.452701 102.7601 48.27903 162.0725 131.387 102.9321 11.81252 10.1786 11.81252 235.6996 0.370173 0.31897 0.370173
7 10 1 3.076828 3.085342 3.482081 3.429398 132.933 97.93346 153.6348 141.3898 141.7293 13.17113 11.45888 13.17113 56.87669 0.405253 0.35257 0.405253
7 1 2 3.072604 2.92794 3.403001 3.318238 89.40549 71.29405 157.8549 123.373 116.1295 10.75298 7.994302 10.75298 153.9018 0.330396 0.245633 0.330396
7 3 2 3.194749 2.994939 3.518343 3.501801 122.9515 87.24313 153.4624 143.969 125.1854 10.12895 9.611143 10.12895 75.90196 0.323594 0.307052 0.323594
7 4 2 3.293038 3.200628 3.548814 3.668797 81.89692 83.10379 145.8673 122.0739 125.6927 7.767171 11.4107 11.4107 75.52421 0.255776 0.375759 0.375759
7 5 2 3.661041 3.632121 3.942047 3.870629 111.3859 97.93578 159.3195 145.3567 139.3146 7.675575 5.72482 7.675575 62.67757 0.281006 0.209588 0.281006
7 6 2 3.145393 3.35239 3.393508 131.2098 68.27799 167.2458 147.5945 153.6449 6.580974 7.888209 7.888209 144.9484 0.206998 0.248115 0.248115
7 7 2 3.384329 3.060953 3.488122 3.512108 112.7663 66.21139 169.6724 146.5568 140.3509 3.066872 3.775612 3.775612 156.2586 0.103793 0.127779 0.127779
7 8 2 3.358729 3.142503 3.510364 3.51141 102.7645 75.95087 166.3889 143.8829 136.2118 4.525781 4.551715 4.880151 123.3007 0.151635 0.152681 0.152681
7 9 2 3.333129 3.224052 3.532607 3.510712 92.7628 85.69035 163.1054 141.209 132.0726 5.984689 5.327818 5.984689 90.34281 0.199477 0.177583 0.199477
7 10 2 3.283876 3.127172 3.504567 3.478666 103.7959 47.2445 148.9681 133.2875 135.6905 6.720441 5.931706 6.720441 215.3132 0.220691 0.19479 0.220691
8 1 1 3.385247 3.292256 3.607909 3.550398 95.52304 72.50411 169.1532 135.0892 129.0599 6.577411 4.878542 6.577411 134.6359 0.222662 0.165151 0.222662
8 3 1 3.620999 3.623525 3.981872 3.910346 82.24176 70.17785 160.0137 121.2157 114.321 9.96612 7.990805 9.96612 128.0117 0.360873 0.289347 0.360873
8 4 1 3.495374 3.550078 3.936402 3.951058 108.6221 87.9324 186.8998 143.4491 143.4503 12.61749 13.03677 13.03677 112.5494 0.441028 0.455684 0.455684
8 5 1 3.710963 3.595451 4.081777 4.014479 114.3155 96.90052 249.3299 146.5558 130.1803 9.99241 8.17891 9.99241 157.305 0.370815 0.303516 0.370815
8 6 1 3.487846 3.386334 3.973145 4.010913 112.5896 96.38083 200.5217 142.9352 125.7003 13.914 14.99683 14.99683 108.0514 0.485299 0.523067 0.523067
8 7 1 3.513394 3.52541 3.940532 3.846434 100.1801 82.42279 181.56 138.2814 118.4503 12.15743 9.479176 12.15743 120.2789 0.427138 0.333041 0.427138
8 8 1 3.482073 3.434201 3.91336 3.879164 92.2417 99.1394 195.179 127.4233 126.7363 12.38594 11.40388 12.38594 96.87326 0.431287 0.397092 0.431287
8 9 1 3.615469 3.519952 4.109317 4.072468 108.9735 99.3142 198.9734 159.8393 155.6953 13.65932 12.64011 13.65932 100.3473 0.493848 0.456999 0.493848
8 10 1 3.53732 3.558059 3.90934 3.887497 91.72575 56.73106 154.6648 131.3815 115.6922 10.517 9.899503 10.517 172.628 0.37202 0.350177 0.37202
8 1 2 3.432048 3.37561 3.773639 3.663864 79.49271 79.74824 180.4524 114.0551 110.4429 9.95298 6.754435 9.95298 126.2212 0.341591 0.231815 0.341591
8 3 2 3.701039 3.719096 4.085902 4.038411 96.5557 65.86967 182.0886 127.2456 117.7612 10.39878 9.115615 10.39878 176.4377 0.384863 0.337372 0.384863
8 4 2 3.609599 3.757446 3.976753 3.916216 111.386 99.65786 203.9746 150.5347 142.7621 10.17161 8.494501 10.17161 104.6749 0.367154 0.306617 0.367154
8 5 2 3.735607 3.695472 4.017773 3.910331 104.6577 88.97155 153.1044 114.3116 120.6928 7.553418 4.677247 7.553418 72.08246 0.282166 0.174724 0.282166
8 6 2 3.727332 3.593258 3.918397 3.798634 103.7989 89.48828 171.0413 135.1747 116.3798 5.126055 1.912941 5.126055 91.13266 0.191065 0.071302 0.191065
8 7 2 3.518567 3.496206 3.805038 3.761399 106.2174 84.31495 195.3558 134.6574 125.0059 8.141679 7.910306 8.141679 131.6977 0.28647 0.242832 0.28647
8 8 2 3.561181 3.445695 3.669418 3.714605 93.28903 81.03448 160.1766 118.2853 107.7642 3.039381 4.30825 4.30825 97.66472 0.108238 0.153425 0.153425
8 9 2 3.757856 3.637072 4.074824 3.977231 112.0779 85.6959 205.6986 146.2162 149.1454 8.434825 5.837768 8.434825 140.0331 0.316969 0.219375 0.316969
8 10 2 3.787033 3.543846 3.903591 3.889249 72.07692 72.93469 175.1869 119.3215 109.1434 3.07782 2.699117 3.07782 140.1969 0.116558 0.102216 0.116558
210
Subject Visit Arm diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 peak prev/relv abs chg 60abs chg 90abs ch pk
10 1 1 2.706295 2.692113 2.924518 2.895363 59.66449 36.38187 141.8131 91.98958 92.67705 8.063517 6.986208 8.063517 289.8967 0.218223 0.189067 0.218223
10 3 1 2.94831 2.768477 3.17769 3.047828 50.86497 38.79701 147.9379 98.10869 92.06929 7.780046 3.375418 7.780046 281.3125 0.22938 0.099518 0.22938
10 4 1 2.848709 3.157949 3.15372 72.41461 135.6952 105.8716 94.6558 10.85541 10.70698 10.85541 0.309239 0.305011 0.309239
10 5 1 2.975431 2.890033 3.306803 3.256169 78.44864 47.24138 146.3862 109.8325 106.3843 11.13695 9.435197 11.13695 209.8687 0.331372 0.280738 0.331372
10 6 1 2.907725 2.852902 3.150099 3.067344 67.24183 57.07001 144.8303 118.9735 111.2104 8.335501 5.489449 8.335501 153.7765 0.242373 0.159618 0.242373
10 7 1 3.084546 2.811311 3.395872 3.367025 77.76246 48.10583 163.4565 126.9083 121.9035 10.09312 9.157894 10.09312 239.7852 0.311327 0.282479 0.311327
10 8 1 3.064814 2.92295 3.439188 3.380243 68.625 44.13928 155.8672 113.1982 105.7823 12.22899 10.29932 12.22899 222.3749 0.374374 0.31543 0.374374
10 9 1 3.045082 3.03459 3.482504 3.393462 66.731 48.62133 148.2778 99.48814 89.66114 14.36487 11.44074 14.36487 204.9646 0.437422 0.34838 0.437422
10 10 1 2.877541 2.831573 3.27702 3.221991 62.93198 35.00087 136.208 109.139 91.041 13.88266 11.97029 13.88266 289.156 0.399479 0.34445 0.399479
10 1 2 2.725785 2.621996 2.892266 2.874354 73.02307 63.88118 159.3995 111.3843 103.3629 6.107613 5.450474 6.107613 149.3533 0.16648 0.148568 0.16648
10 3 2 3.021749 2.670737 3.024038 2.94831 65.17606 90.8637 145.1856 101.73 101.5638 0.075728 -2.43035 0.075728 59.78395 0.002288 -0.07344 0.002288
10 4 2 2.927802 2.785048 2.958632 2.850353 72.58703 88.97388 180.364 136.559 127.42 1.052997 -2.64529 1.052997 102.7157 0.03083 -0.07745 0.03083
10 5 2 2.972198 2.8232 3.142076 3.106005 85.00589 75.00994 154.3325 134.6608 120.6909 5.715587 4.501955 5.715587 105.7494 0.169879 0.133807 0.169879
10 6 2 3.019549 2.755506 3.061464 3.055076 82.93566 77.58697 149.6578 113.7957 107.9321 1.388109 1.17655 1.388109 92.89035 0.041915 0.035527 0.041915
10 7 2 2.933355 2.684607 3.163154 3.053322 78.62438 88.28123 158.4537 117.2541 113.626 7.834033 4.089768 7.834033 79.48742 0.2298 0.119967 0.2298
10 8 2 2.782737 2.75823 3.042297 2.924247 80.1791 92.5894 170.1837 121.7285 106.035 9.327501 5.08528 9.327501 83.80472 0.25956 0.14151 0.25956
10 9 2 2.998745 2.921402 3.322557 3.288595 66.03896 72.76681 139.1422 109.663 103.7979 10.79826 9.66571 10.79826 91.21656 0.323812 0.28985 0.323812
10 10 2 2.851355 2.748407 3.126714 2.982996 64.14217 64.48747 166.5521 113.9744 103.6221 9.657137 4.616789 9.657137 158.2704 0.275359 0.131641 0.275359
12 1 1 2.81709 2.92902 3.007223 2.982072 89.1406 67.67427 140.356 107.5048 103.3631 6.749277 5.856487 6.749277 112.17 0.190133 0.164982 0.190133
12 3 1 2.836097 2.932417 2.958313 2.957754 82.93695 73.97563 147.939 119.8278 115.1751 4.309307 4.289601 4.309307 99.98339 0.122216 0.121657 0.122216
12 4 1 2.96444 2.987062 3.140477 3.217699 105.5228 95.69493 152.2634 124.6583 126.8996 5.938268 8.54323 8.54323 59.11336 0.176036 0.253259 0.253259
12 5 1 2.931274 2.919054 3.113595 3.169108 83.79381 91.03776 150.6971 113.11 105.6911 6.219878 8.113685 8.113685 65.53249 0.182322 0.237834 0.237834
12 6 1 2.777629 2.646755 3.009417 2.936034 73.45348 58.97031 133.6298 100.1739 106.7255 8.344846 5.702919 8.344846 126.6052 0.231789 0.158406 0.231789
12 7 1 2.864291 2.887275 3.192505 3.131366 93.454 57.75914 137.0852 112.5896 110.357 11.45882 9.324295 11.45882 137.3395 0.328214 0.267075 0.328214
12 8 1 2.828477 2.956099 2.973401 2.949536 82.06969 58.62069 148.1044 109.4833 107.0833 5.12376 4.280029 9.976668 152.6488 0.144924 0.12106 0.144924
12 9 1 2.855849 2.890186 3.035273 3.098439 87.93947 60.00192 144.4894 116.8988 113.2843 6.282696 8.494512 8.494512 140.8079 0.179424 0.24259 0.24259
12 10 1 3.079586 3.094036 3.346801 3.296024 78.28348 68.45389 134.8333 107.4149 103.9692 8.677003 7.028161 8.677003 96.96944 0.267216 0.216438 0.267216
12 1 2 3.366765 3.291544 3.373661 3.265295 62.41646 78.53746 110.9502 85.26184 79.65647 0.204808 -3.01387 0.204808 45.87753 0.006895 -0.10147 0.006895
12 3 2 3.3905 3.343968 3.459771 3.482314 75.34859 76.38129 154.3246 112.2466 99.31156 2.043083 2.707962 2.043083 102.045 0.069271 0.091813 0.069271
12 4 2 3.496358 3.402628 3.605809 3.468149 91.72544 65.86252 136.558 117.9442 112.7613 3.13042 -0.80681 3.13042 107.338 0.109451 -0.02821 0.109451
12 5 2 3.501323 3.425333 3.449633 3.426886 73.79511 85.0007 140.0004 95.51882 86.20759 -1.47629 -2.12596 -1.47629 64.70503 -0.05169 -0.07444 -0.05169
12 6 2 3.269614 3.258558 3.332955 3.387607 69.13879 94.3136 150.0148 108.6261 94.49057 1.937261 3.608778 3.608778 59.05952 0.063341 0.117993 0.117993
12 7 2 3.530054 3.527716 3.454641 3.446677 68.10911 62.93575 116.3798 103.1058 91.21504 -2.1363 -2.3619 -2.1363 84.91847 -0.07541 -0.08338 -0.07541
12 8 2 3.283144 3.255705 3.478335 3.34327 68.79525 53.27586 109.8303 85.17828 76.55484 5.945238 1.831355 1.831355 106.154 0.195191 0.060126 0.195191
12 9 2 3.557771 3.343933 3.487613 3.419469 70.86934 69.65731 139.6167 106.217 99.66054 -1.97196 -3.88732 -1.97196 100.4337 -0.07016 -0.1383 -0.07016
12 10 2 3.613128 3.406517 3.592931 3.524854 78.62218 62.58669 145.6974 96.90057 99.14548 -0.55898 -2.44316 -0.55898 132.793 -0.0202 -0.08827 -0.0202
Subject Visit Arm diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 peak prev/relv abs chg 60abs chg 90abs ch pk
13 1 1 3.097054 3.026505 3.268402 3.262778 129.5773 83.27958 184.6699 144.0554 131.0408 5.532611 5.35103 5.532611 124.7875 0.171348 0.165724 0.171348
13 3 1 3.489266 3.423479 3.670604 3.592872 98.10647 75.52433 164.6813 132.7624 121.3805 5.197041 2.969288 5.197041 118.0506 0.181339 0.103606 0.181339
13 4 1 3.335179 3.232851 3.508515 3.428759 137.4159 65.51922 140.6917 127.5902 126.5536 5.197215 2.805852 5.197215 114.7335 0.173336 0.09358 0.173336
13 5 1 3.260905 3.122055 3.47626 3.418623 145.3478 90.00309 180.3515 151.3884 148.7962 6.636956 4.883988 6.636956 103.4525 0.215355 0.157719 0.215355
13 6 1 3.186631 3.01126 3.444005 3.408488 153.2797 114.487 220.0114 175.1865 171.0388 8.076697 6.962124 8.076697 92.17153 0.257375 0.221857 0.257375
13 7 1 3.311586 3.094667 3.564038 3.479545 107.9324 80.52645 192.419 144.8303 151.566 7.623313 5.071862 7.623313 138.9513 0.252453 0.167959 0.252453
13 8 1 3.257061 3.111355 3.454243 3.515649 108.7942 85.0028 179.4862 136.5545 131.2071 6.054004 7.939311 7.939311 111.1533 0.197183 0.258588 0.258588
13 9 1 3.37453 3.220792 3.537989 3.478365 107.5951 72.06979 176.8998 146.0347 141.2107 4.8439 3.077023 4.8439 145.4562 0.163459 0.103835 0.163459
13 10 1 3.187492 3.095528 3.348299 3.28113 106.2075 85.00305 194.4861 155.0025 153.7996 5.044926 2.937659 5.044926 128.799 0.160807 0.093638 0.160807
13 1 2 3.227684 3.183051 3.469416 3.443047 111.8173 74.13811 180.2638 130.35 128.7154 7.489326 6.672366 7.489326 143.5864 0.241732 0.215363 0.241732
13 3 2 3.298185 3.331967 3.4225 3.376426 86.38 79.31222 155.7113 117.2545 110.8687 3.769185 2.372241 3.769185 96.32698 0.124315 0.078241 0.124315
13 4 2 3.477418 3.521838 3.672068 3.602443 101.9051 75.34676 165.5415 136.7252 131.0483 5.597537 4.394821 5.597537 119.7062 0.19465 0.125024 0.19465
13 5 2 3.439258 3.421029 3.601356 3.548301 120.0961 82.59284 182.9474 143.8809 143.0258 4.703261 3.565531 4.703261 121.36 0.162099 0.109043 0.162099
13 6 2 3.401098 3.32022 3.530645 3.49416 138.2871 89.83893 200.3532 151.0365 155.0033 3.808985 2.73624 3.808985 123.0138 0.129547 0.093062 0.129547
13 7 2 3.303802 3.260848 3.537102 3.531142 119.6562 91.55469 171.0537 141.7252 133.6216 7.061566 6.881161 7.061566 86.83222 0.2333 0.22734 0.2333
13 8 2 3.48426 3.409317 3.663963 3.630879 102.2496 100.692 160.3624 137.7641 138.9711 5.157567 4.208034 5.157567 59.26026 0.179703 0.146619 0.179703
13 9 2 3.380558 3.43956 3.572255 3.528833 97.58932 64.48878 146.3911 120.5234 112.2414 5.670561 4.386107 5.670561 127.0025 0.191697 0.148275 0.191697
13 10 2 3.250404 3.135396 3.333903 3.285006 89.14369 63.62303 153.1114 137.414 117.5912 2.568883 1.064553 2.568883 140.6541 0.083499 0.034602 0.083499
14 1 1 2.824926 2.832721 2.889721 2.891255 68.37811 77.24472 122.8532 98.10576 83.7999 2.293712 2.347989 2.347989 59.31676 0.064796 0.066329 0.064796
14 3 1 2.843804 2.920327 3.040122 2.923699 56.2074 70.51724 133.2826 106.0356 97.58651 6.90336 2.809464 6.90336 89.00705 0.196318 0.079896 0.196318
14 4 1 2.761133 2.869934 3.126056 3.12748 72.94304 65.86996 148.2955 114.3209 109.6598 13.21642 13.268 13.268 125.1337 0.364923 0.366347 0.366347
14 5 1 2.73368 2.774755 3.047159 2.991806 58.45478 65.00445 150.0099 101.7299 73.10877 11.46731 9.442461 11.46731 130.7687 0.313479 0.258127 0.313479
14 6 1 2.667493 2.580111 2.97188 2.987 71.21105 79.48351 136.041 102.946 84.83113 11.41099 11.97779 11.41099 71.15628 0.304387 0.319507 0.319507
14 7 1 2.888899 2.885308 2.991424 3.04452 68.62156 61.8985 123.8042 101.3805 95.52636 3.548947 5.386851 5.386851 100.0117 0.102526 0.155621 0.155621
14 8 1 2.910296 2.90283 3.110488 3.000729 55.17349 43.9662 117.0723 92.59258 105.0023 6.878759 3.107339 6.878759 166.2779 0.200192 0.090433 0.200192
14 9 1 2.874886 2.80233 3.080855 2.988265 7.167976 0.205969 0.113378 0.205969
14 10 1 2.839477 2.701831 3.051222 2.975801 82.76588 88.62411 130.0167 113.2793 100.5246 7.457192 4.801033 7.457192 46.70582 0.211745 0.136324 0.211745
14 1 2 3.027006 2.997838 3.048469 3.04826 60.77781 67.33194 115.0899 89.40622 83.54223 0.709026 0.702124 0.709026 70.36288 0.021462 0.021253 0.021462
14 3 2 3.138298 3.029446 3.082954 3.163858 64.48463 82.76326 141.5545 109.3224 103.4555 -1.7635 0.814457 0.814457 71.03539 -0.05534 0.02556 0.02556
14 4 2 3.022985 2.957016 3.050201 2.99794 73.45232 77.24519 123.2941 106.8966 97.41688 0.900295 -0.82848 0.900295 59.61392 0.027216 -0.02504 0.027216
14 5 2 3.041835 2.960595 3.158454 3.099954 65.00092 93.97066 143.2761 104.4877 94.65928 3.833842 1.910667 3.833842 52.46894 0.116619 0.058119 0.116619
14 6 2 3.10395 3.126536 3.329665 3.263111 62.58668 73.11077 119.4898 94.66439 77.9318 7.271853 5.127703 7.271853 63.43661 0.225715 0.159161 0.225715
14 7 2 3.023035 2.858985 2.951285 2.840408 72.58823 75.86556 145.0059 107.5868 87.07345 -2.37344 -6.04121 -2.37344 91.13531 -0.07175 -0.18263 -0.07175
14 8 2 3.187911 3.151396 3.369355 3.339021 56.20953 60.00203 102.5876 88.28193 81.37967 5.691633 4.740093 5.691633 70.97357 0.181444 0.15111 0.181444
14 9 2 3.179729 3.13322 3.363716 3.328924 5.78649 0.183987 0.149195 0.183987
14 10 2 3.171547 3.115045 3.358077 3.318828 66.55976 66.72592 118.627 92.59421 89.14131 5.881348 4.643806 5.881348 77.78253 0.18653 0.147281 0.18653
211
Subject Visit Arm diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 peak prev/relv abs chg 60abs chg 90abs ch pk
15 1 1 3.635358 3.751176 3.909914 3.810726 90.94908 59.22869 153.6315 113.3645 103.7982 7.552374 4.823962 7.552374 158.4289 0.274556 0.175368 0.274556
15 3 1 4.035264 4.018634 4.381597 4.373604 67.93834 36.72414 157.4371 115.1757 100.8644 8.582654 8.384574 8.582654 328.7021 0.346333 0.33834 0.346333
15 4 1 3.84181 4.413302 4.09257 97.76136 45.6903 193.9934 116.3865 107.2425 14.87562 6.527139 14.87562 324.5834 0.571493 0.25076 0.571493
15 5 1 3.990551 3.96464 4.382157 4.149548 9.995216 0.391605 0.158996 0.391605
15 6 1 4.139293 3.96464 4.351011 4.206526 90.34807 38.79386 155.0004 115.5224 118.7973 5.114814 1.624246 5.114814 299.5488 0.211717 0.067232 0.211717
15 7 1 3.838151 3.676389 4.046472 3.967943 80.34779 54.48489 135.8657 104.4902 92.25454 5.427629 3.381621 5.427629 149.3641 0.208321 0.129792 0.208321
15 8 1 3.927995 3.948686 4.193444 4.191848 83.79913 27.24357 151.215 114.8367 107.5906 6.757877 6.717248 6.757877 455.0484 0.265449 0.263853 0.265449
15 9 1 3.958974 4.048415 4.517087 4.176301 91.38741 61.72414 156.3903 116.8968 101.7256 14.09741 5.489492 14.09741 153.3698 0.558113 0.217328 0.558113
15 10 1 3.644906 3.439266 3.91149 3.761365 66.37976 35.86294 176.0407 114.3149 102.5891 7.31389 3.195121 7.31389 390.8709 0.266584 0.116459 0.266584
15 1 2 3.794989 3.707679 3.845827 3.783032 77.94055 83.79381 164.147 120.5175 102.0742 1.339621 -0.31505 1.339621 95.89392 0.050838 -0.01196 0.050838
15 3 2 3.665825 3.353971 3.753846 3.549544 97.58923 47.936 157.4259 106.0418 101.5618 2.401142 -3.17203 2.401142 228.4086 0.088022 -0.11628 0.088022
15 4 2 3.962651 3.680661 3.965715 3.762247 94.31346 62.42237 154.4835 101.036 113.7944 0.077324 -5.05731 0.077324 147.481 0.003064 -0.2004 0.003064
15 5 2 2.874886 2.80233 3.080855 2.988265 -0.73181 0.205969 0.113378 0.205969
15 6 2 4.121513 3.843866 4.058003 4.026973 89.65584 61.89855 174.4858 115.8646 97.59014 -1.54095 -2.29381 -1.54095 181.89 -0.06351 -0.09454 -0.06351
15 7 2 3.840727 3.753099 4.082676 4.011258 92.07221 51.89952 144.3145 95.52001 98.80317 6.299584 4.440089 6.299584 178.0651 0.24195 0.170532 0.24195
15 8 2 3.937819 3.767049 4.108304 4.049118 65.52313 35.52145 154.8317 112.2427 106.3818 4.329427 2.826418 4.329427 335.8823 0.170485 0.111299 0.170485
15 9 2 3.624283 3.379698 4.047222 3.984644 87.24206 54.31269 176.3815 120.8671 104.1451 11.66958 9.942947 11.66958 224.7519 0.422939 0.360361 0.422939
15 10 2 3.68913 3.566296 3.903993 3.787244 71.38096 50.0051 139.8315 109.8289 91.38737 5.824194 2.659544 5.824194 179.6344 0.214862 0.098114 0.214862
16 1 1 3.397871 3.404298 3.751215 3.584855 117.0765 119.4015 183.3001 143.2847 134.4865 10.39896 5.502978 10.39896 53.49166 0.353343 0.186984 0.353343
16 3 1 3.452559 3.419624 3.849518 3.632355 119.6564 101.0375 164.8512 128.4541 127.4168 11.49751 5.207591 11.49751 63.1584 0.396958 0.179795 0.396958
16 4 1 3.395123 3.560535 4.097768 4.044787 123.9778 103.9669 156.3909 131.3811 121.3906 20.69573 19.13522 20.69573 50.42369 0.702645 0.649664 0.702645
16 5 1 3.426304 4.027005 3.739914 124.489 130.5209 194.3312 158.7978 139.4896 17.53204 9.153021 20.09786 48.88898 0.600701 0.31361 0.600701
16 6 1 3.547751 3.467939 4.016295 3.631957 126.897 109.8471 175.3668 141.56 132.7622 13.20678 2.373484 13.20678 59.64629 0.468544 0.084205 0.468544
16 7 1 3.460382 3.405741 4.165597 4.014922 126.8987 89.49965 205.7467 166.3896 145.8655 20.37971 16.02543 20.37971 129.8855 0.705216 0.554541 0.705216
16 8 1 3.538087 3.310165 4.07286 4.129832 115.3474 64.65749 154.1404 146.3812 129.1473 15.11475 16.725 16.725 138.3953 0.534773 0.591745 0.591745
16 9 1 2.874886 2.80233 3.080855 2.988265 15.72969 0.205969 0.113378 0.205969
16 10 1 3.408108 3.386308 3.765655 3.729818 115.0003 111.2079 173.4487 133.1037 121.2074 10.49105 9.439537 10.49105 55.96791 0.357546 0.32171 0.357546
16 1 2 3.533973 3.320106 3.572366 3.379838 82.68011 87.07377 158.2868 121.4697 113.4528 1.086395 -4.36152 1.086395 81.73805 0.038393 -0.15413 0.038393
16 3 2 3.648982 3.503958 95.87108 108.4505 -3.97438 -3.97438 -3.64898 -0.14502 -0.14502
16 4 2 3.751394 3.677658 3.776772 3.53186 92.41921 92.76439 154.8311 109.6731 111.3865 0.676499 -5.85207 -3.5099 66.90785 0.025378 -0.21953 0.025378
16 5 2 3.752567 3.612544 3.731299 3.769604 116.2102 106.3804 145.8741 116.3826 114.4848 -0.56675 0.454017 0.454017 37.12497 -0.02127 0.017037 0.017037
16 6 2 3.628568 3.381354 3.909257 3.690542 100.6911 112.9336 157.0932 137.2512 151.0488 7.73552 1.707947 7.73552 39.10226 0.280689 0.061974 0.280689
16 7 2 3.736951 3.512594 3.92534 3.703065 97.41531 83.10805 150.8732 125.5196 109.8321 5.04124 -0.90677 5.04124 81.53857 0.188389 -0.03389 0.188389
16 8 2 3.756639 3.621449 4.097973 4.044779 92.42409 97.58771 174.8345 136.7294 125.6897 9.086144 7.670158 9.086144 79.15632 0.341334 0.28814 0.341334
16 9 2 2.874886 2.80233 3.080855 2.988265 10.06989 0.205969 0.113378 0.205969
16 10 2 3.778034 3.61631 4.195644 3.875926 84.14146 85.86276 173.97 118.9688 116.3875 11.05364 2.591098 11.05364 102.614 0.41761 0.097893 0.41761
212
Subject 01 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.984479 3.891321 4.013361 4.076812 64.22414 60.08621 103.4484 87.7587 82.41389 0.724868 2.317317 72.16655 62 64
b2 3.809175 3.817958 3.933377 3.864234 63.44922 44.65848 102.7589 82.5891 72.93497 3.260601 1.445413 130.0995 58 61
w2 3.776527 3.814683 4.146876 4.091078 91.38093 63.62305 125.3524 110.691 101.3866 9.806616 8.329098 97.0236 67 66
w3a 3.871922 3.806655 4.073416 3.946046 70.00085 52.76798 126.63 111.7439 99.65974 5.203978 1.914397 139.9751 58 63
w3b 3.971584 4.00247 4.134223 4.085166 78.97309 54.65734 116.5522 98.11097 93.45377 4.095048 2.859869 113.2417 62 60
w4a 3.965458 3.832573 4.083283 4.08443 73.80319 65.52178 127.0804 109.8298 108.4511 2.971282 3.000218 93.95131 61 60
w4b 3.808329 3.803759 4.005309 3.875275 71.38757 51.37989 134.666 101.3823 91.21733 5.172335 1.757877 162.0987 67 65
w5a 4.052609 4.022643 4.253746 4.206041 80.70144 51.21438 129.4968 101.5566 90.01333 4.963143 3.786012 152.8525 62 62
w5b 3.396324 3.35207 3.808711 3.548575 81.22193 46.3877 139.324 109.8506 95.35481 12.14214 4.48281 200.3469 66 67
end 3.814014 3.758081 3.988157 3.933183 62.77799 51.56627 160.706 92.59454 81.04194 4.565877 3.124521 211.6494 58 59
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 64 64 62 62 104 100 100 102 72 66 68 72
b2 59 59 62 57 114 116 114 116 70 72 70 76 26 52.3
w2 68 67 65 67 105 102 102 100 70 70 70 72 53.3
w3a 60 61 58 61 105 107 107 102 75 75 75 75 26.7 49
w3b 60 61 58 58 116 114 116 114 70 70 72 72 26.25 53
w4a 60 61 58 60 104 102 102 100 70 70 70 70 25.95 53.67
w4b 64 62 63 63 114 114 114 114 74 76 76 78 26.75 52.3
w5a 64 65 64 59 110 110 110 108 70 72 74 72
w5b 64 65 68 64 110 116 118 118 74 74 74 74
end 61 59 60 60 106 108 108 108 70 76 76 74
Subject 01 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.846285 3.806119 3.829043 3.824752 68.6208 64.65517 112.02 90.43144 88.27654 -0.44829 -0.55984 73.25756 62 65
b2 3.865867 3.864821 3.83031 3.832451 70.51808 58.44828 121.035 95.00124 98.02785 -0.91977 -0.86438 107.0805 58 56
w2 3.661142 3.502653 3.828582 3.828559 76.03448 65.1783 119.1466 103.9753 96.0351 4.573443 4.572802 82.80096 66 67
w3a 3.858227 3.911534 4.025537 3.918526 53.10628 66.72806 130.5184 105.6922 97.5902 4.336447 1.562856 95.59744 59 59
w3b 3.842586 3.78005 4.044015 4.049078 92.93901 62.41864 133.7931 105.3485 99.48576 5.242037 5.373796 114.348 59 61
w4a 3.814399 3.744966 4.074577 4.017152 89.48342 35.17316 102.7659 89.48542 79.48351 6.820959 5.315469 192.1714 57 58
w4b 3.8239 3.828826 3.903525 3.87343 72.59033 45.6929 139.4915 91.56113 91.38972 2.082303 1.295265 205.2806 68 60
w5a 3.918723 3.87426 3.925786 3.89226 46.04761 45.52 92.07696 72.94108 71.38774 0.18022 -0.6753 102.278 66 62
w5b 3.61376 3.509437 3.726989 3.605215 60.87179 50.89765 126.3937 90.53368 84.34255 3.133291 -0.23645 148.3291 65 65
end 3.824053 3.802194 4.011448 3.856563 64.49184 59.66166 145.5406 96.9026 89.48592 4.900432 0.850157 143.9433 58 58
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 61 64 62 61 102 98 98 96 68 70 66 70
b2 57 57 60 58 112 112 112 110 72 72 70 70 25.6 50
w2 64 62 64 77 95 102 102 102 70 70 70 75 51.7
w3a 59 59 60 59 102 102 102 102 75 75 75 75 26.4 52.67
w3b 59 62 59 58 116 116 114 114 70 70 70 68 25.95 51
w4a 58 60 61 59 104 102 102 102 70 70 70 70 26.15 55.9
w4b 63 63 63 64 110 112 112 112 68 70 72 72 26.6 54.67
w5a 61 61 60 61 100 108 104 104 72 72 72 70
w5b 65 64 64 64 110 110 114 116 74 74 74 76 26 53
end 57 58 57 57 108 108 108 108 74 76 76 74
213
Subject 02 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.482977 3.488997 3.829327 3.783581 100.865 75.51877 154.8294 112.762 126.8968 9.944085 8.630653 105.021 55 55
b2 3.533602 3.402199 3.68512 3.667024 77.06897 57.07155 123.2881 115.8714 90.51724 4.287924 3.775794 116.0237 64 58
w2 3.500777 3.360025 3.885462 3.901589 123.9703 89.83918 156.7312 136.8987 128.1155 10.98855 11.44924 74.45753 69 64
w3a 3.851703 3.37484 3.842809 3.864577 123.7933 57.07564 155.0055 136.0354 122.414 -0.23091 0.334237 171.5791 75 72
w3b 3.589527 3.253209 3.698831 3.644086 107.2425 78.2774 169.8479 148.4503 138.4491 3.0451 1.51997 116.982 68 65
w4a 3.548176 3.43399 3.861725 3.937216 98.96612 61.72664 141.5528 121.0456 103.4489 8.83692 10.96452 129.322 58 55
w4b 3.574281 3.511843 3.701765 3.57514 75.35465 60.36507 153.1225 123.806 128.122 3.566705 0.024036 153.6607 52 55
w5a 3.734416 3.644399 3.962427 3.645155 112.9418 58.28866 157.9408 146.3809 153.4583 6.105663 -2.39023 170.9631 64 56
w5b 3.549366 3.59477 3.906676 3.603853 101.7292 66.90011 162.0814 115.1775 132.9351 10.06688 1.535122 142.2737 58 51
end 3.383267 3.537368 3.56515 3.463268 111.3971 74.49003 170.352 130.3566 139.8388 5.375941 2.364604 128.6909 52 56
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 54 55 55 57 98 100 100 98 70 62 62 68
b2 66 60 58 58 118 124 120 118 74 78 78 78 24.55 39
w2 70 70 68 65 115 115 115 115 70 72 72 72 24.4 32.7
w3a 69 70 68 68 115 115 115 115 66 66 65 65 38.3
w3b 65 66 65 68 116 116 116 114 62 70 70 72 25.35 38.3
w4a 60 58 60 63 100 104 98 100 64 70 68 66
w4b 57 61 56 52 108 108 104 102 70 68 68 70 24.8 42
w5a 59 57 58 60 104 100 102 100 70 70 72 70 24.4 43.3
w5b 48 52 48 50 110 108 108 100 70 70 70 72 24.9 43.5
end 58 58 63 60 100 110 108 100 70 78 74 72 25 40.3
Subject 02 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.192426 3.245511 3.235104 3.112955 93.10622 85.00176 121.5548 130.692 131.5522 1.336849 -2.48936 43.00273 55 57
b2 3.238943 2.87117 3.107025 2.917525 107.4161 64.66118 105.6925 98.45103 97.06926 -4.07286 -9.92354 63.45588 64 63
w2 2.941282 2.744868 3.088905 3.074582 132.246 75.00079 178.1112 150.5203 140.8642 5.019015 4.532051 137.4791 61 59
w3a 3.301651 2.942831 3.415825 3.404445 141.3804 85.51794 178.4486 141.8982 128.6212 3.458077 3.113408 108.668 67 71
w3b 3.097847 3.008084 3.333976 3.278281 130.3505 97.93103 173.1089 142.7588 147.5913 7.62236 5.824505 76.76618 64 72
w4a 3.200964 2.996159 3.339572 3.326707 97.43738 73.96709 185.1737 145.8801 148.1099 4.330173 3.928279 150.3461 59 58
w4b 2.985588 2.934577 3.093306 3.042368 77.77153 57.76284 131.7437 113.293 107.2469 3.607945 1.901823 128.0769 68 67
w5a 3.098572 3.059383 3.289293 3.21587 97.59866 61.03693 115.1809 117.5966 111.2123 6.155102 3.785538 88.70691 62 61
w5b 2.989115 2.920563 3.07484 3.01645 87.77011 68.97112 170.3509 123.1066 123.803 2.867907 0.914512 146.9887 58 50
end 2.83954 2.838262 3.007106 2.953206 78.45782 68.62611 134.494 104.8359 109.8346 5.901155 4.002949 95.98078 65 55
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 57 55 58 61 108 102 109 108 68 68 68 68
b2 60 68 68 68 118 115 115 112 78 74 75 74 26.33 41
w2 60 60 62 60 112 115 115 115 70 70 70 70 26.2 41.7
w3a 68 69 70 75 117 120 117 117 66 65 65 65 46.3
w3b 64 68 64 68 118 120 118 116 70 64 62 62 26.25 47
w4a 59 60 58 55 102 104 100 104 70 70 72 70
w4b 63 67 62 62 104 102 108 110 72 72 70 74 26.4 52
w5a 60 56 60 64 102 100 104 104 70 68 70 70 26.25 53
w5b 45 50 47 50 108 100 100 100 70 72 70 70 26.7 53.5
end 60 61 54 60 100 110 100 110 78 74 80 78 26.65 48
214
Subject 03 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.413776 3.532603 3.805356 3.797566 105.3499 98.79823 164.1405 137.9483 127.9347 11.4706 11.2424 66.13705 107 105
b2 3.552075 3.38935 3.769701 3.661681 96.37962 90.69031 160.3531 120.348 113.2772 6.126725 3.085692 76.81395 70 64
w2 3.461796 3.608322 3.808833 3.765874 83.96552 73.62392 145.6957 131.9079 138.1116 10.02476 8.783821 97.89181 74 70
w3a 3.627345 3.551562 3.641691 3.626881 86.89689 77.24176 150.8797 131.2145 129.8297 0.3955 -0.01278 95.33436 61 61
w3b 3.574459 3.579804 3.65764 3.639789 96.7318 71.38616 173.4702 141.7258 135.1787 2.327087 1.827691 143.0026 70 65
w4a 3.687038 3.511362 3.856274 3.741588 85.17943 57.41483 144.3278 113.4587 106.7355 4.590007 1.479495 151.3772 68 64
w4b 3.626511 3.534809 3.656324 3.587947 83.63207 63.45202 139.1467 114.662 105.8649 0.82208 -1.06339 119.2943 65 72
w5a 3.425454 3.429211 3.61486 3.549917 112.419 77.07554 176.0401 155.0162 150.5293 5.529358 3.633475 128.3994 69 65
w5b 3.481338 3.507269 3.679396 3.560615 83.80018 64.14021 154.8404 117.9415 108.2773 5.689125 2.277194 141.4093 66 65
end 3.456144 3.585061 3.70081 3.682087 94.83658 67.93694 146.4 130.706 125.8765 7.079167 6.53742 115.494 64 64
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 102 95 92 92 158 156 152 152 60 70 72 68
b2 67 67 64 63 120 117 117 117 80 80 80 80 25.27 40
w2 69 70 70 71 120 122 122 118 68 68 68 70 25.3 41.3
w3a 58 58 56 61 122 120 120 118 66 66 68 68 25.3 39.7
w3b 67 69 71 68 122 120 120 122 60 60 60 64 25.55 41
w4a 65 68 63 65 122 118 118 120 78 72 72 74
w4b 78 82 70 71 118 120 120 128 68 66 68 70 25.2 43.67
w5a 65 63 62 70 118 120 118 120 76 72 74 74 25.35 45
w5b 62 63 58 61 120 120 116 122 80 78 76 78 25.7 42.3
end 61 64 63 67 112 114 120 116 68 70 80 70 25.45 43.33
Subject 03 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.525389 3.647262 3.914923 3.882169 116.7282 116.0427 177.0718 149.6572 135.1815 11.04941 10.12032 52.59193 98 91
b2 3.707897 3.548883 3.96858 3.855526 91.55597 98.29163 178.2854 134.8285 135.0009 7.030478 3.981462 81.38411 80 87
w2 3.502581 3.594974 3.776981 3.733185 88.62136 88.10772 153.4493 133.4611 135.0035 7.834214 6.583818 74.16096 70 73
w3a 3.645962 3.524997 3.681373 3.607045 95.86328 77.07041 155.5248 118.1047 113.7976 0.97123 -1.06741 101.7957 59 63
w3b 3.643301 3.492343 3.713357 3.608055 96.20937 108.4483 175.3697 140.6948 132.9347 1.922868 -0.96744 61.7081 70 64
w4a 3.91844 3.673479 3.96594 3.933994 93.28001 82.58804 153.6277 130.6936 123.4531 1.212225 0.396945 86.01691 69 68
w4b 3.618795 3.488536 3.607234 3.569016 79.82909 84.82933 147.0761 120.0062 127.0751 -0.31946 -1.37557 73.37879 79 71
w5a 3.722325 3.70765 3.758303 3.714383 88.28664 87.94489 165.1782 117.427 114.8379 0.966546 -0.21336 87.82009 77 69
w5b 3.670674 3.598855 3.734233 3.681956 93.10881 79.48465 170.3452 128.9858 120.8684 1.731534 0.307357 114.3121 61 60
end 3.684557 3.493534 3.706253 3.569115 108.4497 110.694 160.1787 118.6287 117.2427 0.588842 -3.13313 44.70404 67 66
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 91 82 82 84 148 148 152 148 62 68 62 60
b2 73 68 65 68 120 130 120 126 75 78 80 86 25.6 43
w2 65 69 68 65 118 120 120 118 68 70 68 68 25.65 41.5
w3a 60 59 61 62 118 118 116 118 68 68 70 70 25.5 41.67
w3b 62 65 68 62 120 120 120 118 64 68 70 70 26 43
w4a 67 68 72 67 118 118 118 116 72 72 72 72
w4b 71 72 74 73 130 120 120 120 70 70 70 70 25.7 25.2
w5a 67 65 67 72 122 122 118 116 72 72 72 72 25.75 43.3
w5b 62 61 62 63 112 108 108 112 78 76 76 74 26.1 41.67
end 68 67 65 68 118 114 116 118 72 76 78 74 26.15 42.67
215
Subject 04 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.118959 3.172761 3.409273 3.43806 78.967 50.00245 142.941 115.5178 112.0742 9.308044 10.23103 185.8681 85 87
b2 3.563943 3.494032 3.869155 3.889772 105.6987 68.96595 167.2508 153.6209 129.4869 8.563867 9.142368 142.5121 77 74
w2 3.140246 #DIV/0! 3.471983 3.42195 98.96942 71.03991 174.3796 131.9022 127.0699 10.56404 8.970738 145.4671 77 75
w3a 3.402562 3.393251 3.760402 3.649714 91.38475 51.04897 147.2481 122.2513 142.6045 10.51679 7.263714 188.4449 75 76
w3b 3.227571 3.162649 3.448946 3.250036 107.0701 64.8285 156.5565 126.9058 121.2119 6.858901 0.696035 141.4933 70 72
w4a 3.445823 3.487752 3.748678 3.425744 104.1471 70.52277 150.8702 131.9006 140.0087 8.78904 -0.5827 113.9312 75 73
w4b 3.460548 3.498822 3.786103 3.703449 107.0815 89.1406 198.1074 133.8095 140.7025 9.407611 7.019167 122.2415 72 73
w5a 2.949729 3.035165 3.420228 3.297182 77.42136 51.21735 121.3912 112.9331 104.1429 15.95057 11.77915 137.0118 74 70
w5b
end 3.207487 3.440861 3.712531 3.499303 116.9009 74.82798 150.6899 135.1742 135.6919 15.74579 9.097962 101.3817 77 68
3.117928 3.123629 3.611818 3.531946 96.55727 70.6913 197.6078 156.899 128.801 15.84034 13.27863 179.5362 72 71
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 77 74 83 81 13 142 138 138 70 76 76 78
b2 72 69 68 67 118 116 112 112 76 74 74 74 26 41
w2 81 74 74 73 130 120 120 118 72 68 68 70 26.1 38
w3a 70 69 68 67 116 114 112 112 80 80 76 78
w3b 74 70 77 69 118 116 120 122 74 76 80 82
w4a 68 73 73 75 116 112 112 112 80 82 82 82 26.35 38.3
w4b 77 75 74 77 118 114 116 120 80 80 80 78 26.3 39.6
w5a 76 77 118 116 116 78 80 82 26.6 37.6
w5b
end 68 68 70 70 116 108 108 106 80 78 78 78 26.45 39
72 72 64 64 110 110 112 112 78 78 78 80
Subject 04 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.12138 3.068585 3.523625 3.365213 98.28131 54.14071 156.0345 131.5553 121.5609 12.88679 7.811703 188.2018 79 75
b2 3.473733 3.2913 3.880368 3.676727 115.693 54.48824 184.5874 148.1036 122.0768 11.70597 5.843674 238.7656 73 74
w2 3.263338 3.106655 3.635952 3.366626 112.9316 59.65617 179.5732 139.8331 129.6563 11.41821 3.165103 201.0136 74 73
w3a 3.158691 2.998196 3.527304 3.276441 82.93465 57.76546 155.8692 120.1794 106.5655 11.6698 3.727793 169.8312 65 74
w3b 3.024515 2.956873 3.419847 3.213102 85.53147 62.76047 168.6338 134.4992 130.1818 13.07095 6.235285 168.6943 72 74
w4a 3.124275 2.973794 3.500259 3.45799 76.3851 66.55579 154.8466 141.735 122.9349 12.0343 10.68138 132.6569 74 75
w4b 3.193808 3.031733 3.576828 3.352392 93.28122 76.91243 167.0864 134.4915 127.072 11.9926 4.965383 117.2424 81 77
w5a 3.050884 2.982176 3.439763 3.27602 83.11057 66.7277 175.8771 142.5864 137.2574 12.74646 7.37937 163.5744 72 79
w5b
end 3.180981 3.054203 3.486723 3.332413 88.28027 65.34881 165.7038 147.5878 122.7708 9.611561 4.760554 153.5681 76 71
3.143917 2.992685 3.526904 3.452072 74.31355 45.69029 147.9439 139.6573 140.1781 12.18183 9.801647 223.7971 65 75
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 78 76 80 73 142 140 140 138 60 62 64 68
b2 71 68 67 67 110 108 108 108 70 72 72 72 26.5 42.7
w2 77 76 78 77 118 112 112 112 72 68 70 68 27 39.7
w3a 75 72 68 116 120 120 78 80 78
w3b 77 73 71 75 116 118 120 120 74 80 82 80
w4a 68 68 68 72 110 112 110 112 80 82 80 82 27 42.3
w4b 80 80 78 81 120 118 122 120 82 78 80 80 26.65 45.3
w5a 71 74 82 74 118 116 120 118 82 82 82 82 27.05 42
w5b 71 70 71 72 110 108 108 108 84 80 80 80 26.6 40
end 69 67 71 71 112 110 110 110 80 80 80 80
216
Subject 05 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 4.229489 4.00943 4.346631 4.212346 91.55472 80.69565 152.9412 135.3488 116.0389 2.769652 -0.4053 89.52845 52 57
b2 4.185131 4.129519 4.270802 4.209861 93.45082 57.58826 156.9035 133.46 113.7958 2.047053 0.590904 172.4575 51 51
w2 4.322536 4.287863 4.580487 4.469033 71.72961 77.41527 145.6979 112.5951 105.867 5.967569 3.389151 88.203 56 58
w3a 4.293341 4.260544 4.36703 4.34335 74.48319 46.21204 126.7359 114.6639 91.56145 1.71635 1.164816 174.2486 49 50
w3b 4.527506 4.415838 4.586912 4.668966 133.985 106.554 214.1485 168.9769 155.1741 1.312112 3.124455 100.9765 54 55
w4a 4.238683 4.246194 4.674033 4.50459 87.24751 97.4144 179.6569 133.9719 131.3913 10.27089 6.273346 84.42537 49 51
w4b 4.111188 4.131065 4.347292 4.146197 94.83903 74.15476 174.1572 148.6342 146.3885 5.742962 0.851554 134.8565 57 57
w5a 4.296872 4.173358 4.41341 4.243926 72.41911 82.07549 150.7126 118.8017 110.3459 2.712156 -1.23219 83.62679 49 57
w5b 4.325588 4.322964 4.465412 4.412132 86.5562 77.759 129.8468 117.0855 104.6625 3.232492 2.000745 66.98624 64 52
end
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 55 57 56 56 122 128 128 126 78 78 80 80
b2 51 52 52 51 122 120 122 122 66 66 66 70 28.7 53
w2 53 55 53 53 124 122 120 118 74 80 74 74 29.35 56
w3a 46 46 45 50 122 124 122 122 78 80 78 78 28.9 55
w3b 53 53 53 55 128 120 120 120 70 70 70 70 29 49.3
w4a 51 48 50 53 128 122 120 122 80 74 74 76 29 53.3
w4b 63 61 61 61 130 128 128 130 78 76 80 80 29.15 53
w5a 53 55 52 53 118 126 130 128 74 74 80 80
w5b 55 52 51 112 120 120 72 70 70 28.9 50.33
end
Subject 05 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.995222 4.165752 4.437243 4.35179 84.84102 69.65723 177.088 125.8669 125.866 11.06373 8.924843 154.2277 58 52
b2 4.274066 4.307813 4.458898 4.292569 96.55485 79.4895 159.1455 147.9312 135.8625 4.324506 0.43293 100.2095 52 47
w2 4.249483 4.204651 4.420872 4.441478 #DIV/0! 61.73281 141.5629 123.6216 118.1135 4.033157 4.518079 129.3155 54 51
w3a 4.19498 4.230068 4.330485 4.304823 80.70144 54.83192 134.8294 114.1426 110.5239 3.230153 2.618423 145.8957 49 46
w3b 4.546194 4.499655 4.665738 4.597313 96.72567 76.56164 152.7642 124.4875 122.4157 2.629538 1.124437 99.53098 53 53
w4a 4.288957 4.257687 4.393124 4.325177 85.17959 62.7605 164.6714 132.7631 134.3192 2.428729 0.844508 162.3807 52 52
w4b 4.170812 3.909838 4.28396 4.046099 89.83818 70.52843 143.1053 133.1226 130.0225 2.712853 -2.99012 102.9044 56 54
w5a 4.242529 4.159226 4.363665 4.198016 73.11147 71.39118 146.2279 127.2509 115.5214 2.855267 -1.04922 104.8262 56 56
w5b 4.468926 4.138349 4.362304 4.207931 76.38243 60.52947 207.2427 137.7659 125.1821 -2.38586 -5.84022 242.3831 57 54
end
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 53 54 55 54 124 122 124 122 78 72 72 72
b2 46 49 48 47 120 120 120 122 70 68 70 68 29.7 60
w2 52 52 51 56 122 122 120 120 76 74 78 74 29.8 61.3
w3a 47 46 47 47 118 120 118 118 78 80 78 80 29.9 55
w3b 53 54 54 52 118 120 118 118 68 70 68 70 29.7 54.3
w4a 51 50 51 51 124 118 122 120 72 80 72 72 30 56.3
w4b 56 55 58 56 130 128 132 132 80 78 78 80 29.75 58.3
w5a 53 52 54 57 130 130 130 128 80 80 78 82
w5b 54 56 55 56 122 126 124 122 74 76 76 74 29.65 52.67
end
217
Subject 06 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.898877 3.942552 3.97452 3.946404 88.28254 61.9028 142.594 122.5884 121.7254 1.94013 1.218995 130.3515 51 64
b2 3.924416 3.803475 3.964052 3.849589 84.14076 41.38075 115.0186 100.8651 91.04036 1.009985 -1.9067 177.952 58 53
w2 3.882448 3.866942 4.117833 4.089259 92.24458 71.03999 133.6318 107.9553 112.4234 6.0628 5.326813 88.10789 57 58
w3a 3.999859 3.953525 4.228885 4.246274 100.3498 50.00295 146.9115 144.8442 142.2485 5.725871 6.160597 193.8057 70 69
w3b 3.947975 4.014937 4.378111 4.338627 99.66264 90.51858 148.1206 150.5198 143.2793 10.89511 9.895004 63.63553 81 73
w4a #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!
w4b 3.733996 3.836875 4.010507 3.930702 121.0345 99.14033 171.5604 147.4172 145.8673 7.405225 5.267984 73.04803 79 81
w5a 3.977567 3.981505 4.209278 4.212919 116.3839 70.17326 184.8384 159.3111 154.4878 5.825444 5.916998 163.4029 64 60
w5b #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0!
end 3.942937 3.88888 3.972033 3.875267 91.03779 69.14137 128.9715 113.2834 117.2424 0.737942 -1.71622 86.53308 52 56
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 58 63 59 59 110 112 108 112 64 70 70 70
b2 57 58 57 54 100 98 100 100 74 68 72 74 28.2 59.3
w2 58 58 57 57 102 104 104 102 64 62 62 62 28.3 57.5
w3a 62 67 63 63 112 120 120 116 62 64 64 60 28.3 66
w3b 75 76 68 77 130 120 118 120 80 70 70 72 28.5 64
w4a
w4b 81 82 84 82 120 120 120 60 68 68 28.35 66.67
w5a 110 112 68 70
w5b
end 57 56 60 60 104 104 64 62 27.95
Subject 06 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.926731 3.940145 4.067812 4.061053 74.66298 82.24174 134.6664 119.8388 103.7943 3.592831 3.42069 63.74462 65 59
b2 3.853002 3.941716 3.945213 3.959894 65.86433 51.73154 131.2161 106.9221 103.9729 2.393208 2.774252 153.6481 61 62
w2 4.046457 4.02074 4.193139 4.157922 75.52232 77.59578 138.4665 121.2178 112.5929 3.624956 2.754634 78.44591 63 59
w3a 4.237899 87.76194 61 65
w3b 4.267207 4.225258 4.2853 4.289825 88.9672 68.96595 168.9662 133.452 129.3106 0.424 0.530054 144.9995 77 79
w4a
w4b 4.036017 4.085205 4.186993 4.147693 116.3826 99.31186 165.7139 145.1898 136.7252 3.740708 2.766984 66.86218 78 74
w5a 4.251244 4.126976 4.23764 4.191894 103.2876 69.82972 163.6236 118.2855 112.9352 -0.31999 -1.39605 134.3179 66 68
w5b
end 3.912595 3.758481 3.894948 3.968992 78.10652 59.14295 129.8353 101.0375 92.06961 -0.45102 1.441412 119.5279 60 64
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 59 58 55 57 118 110 112 112 72 72 70 70
b2 58 58 57 58 116 116 116 116 80 78 78 80 28.15 67
w2 59 58 59 58 108 110 110 110 62 62 68 64 27.95 61.3
w3a 64 64 62 118 116 118 62 64 62 28.5 67.3
w3b 75 71 72 74 124 118 120 120 74 74 70 70 28.45 68.3
w4a
w4b 76 74 74 116 116 66 66 28.5 70
w5a 120 118 80 66
w5b
end 61 62 61 60 104 108 106 106 66 66 64 64 28.3
218
Subject 07 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.017541 2.852451 3.171773 3.196905 96.38178 51.89939 153.2838 133.4598 128.1053 5.111179 5.944071 195.348 59 66
b2 3.121386 3.062039 3.481385 3.544437 112.9331 60.69974 172.4168 144.8425 146.3846 11.53328 13.55329 184.0486 73 75
w2 3.233016 3.021293 3.540715 3.596864 124.1476 94.82789 159.4942 131.2128 122.5872 9.517392 11.25413 68.19328 81 77
w3a 3.159553 3.202581 3.508307 3.545323 99.49271 90.0135 169.3191 138.4487 131.7325 11.03807 12.20962 88.10409 74 74
w3b 3.639685 3.51345 3.962283 3.928784 108.6232 87.2458 167.0821 155.8742 139.836 8.863355 7.942977 91.50733 82 80
w4a 3.13436 2.970193 3.350588 3.392999 141.7243 71.72783 174.1384 154.1471 150.3656 6.898629 8.251737 142.7766 74 76
w4b 3.482447 3.291375 3.686851 3.789995 128.4487 79.83132 167.2431 146.3811 133.4538 5.869534 8.831374 109.4957 86 87
w5a 3.297694 3.082633 3.552644 3.65903 121.2133 78.45473 153.4521 136.5546 135 7.731179 10.95724 95.59323 92 91
w5b 3.133731 3.046871 3.503904 3.452701 102.7601 48.27903 162.0725 131.387 102.9321 11.81252 10.1786 235.6996 79 75
end 3.076828 3.085342 3.482081 3.429398 132.933 97.93346 153.6348 141.3898 141.7293 13.17113 11.45888 56.87669 72 71
b1 HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b2 66 66 65 64 124 128 126 124 74 70 68 66
w2 74 75 72 70 124 120 120 120 70 70 70 70 25.3 42
w3a 78 75 76 77 116 122 120 120 64 60 64 62 26.05 42.33
w3b 70 68 68 67 128 126 126 124 80 72 72 70 25.7 46
w4a 80 77 73 74 124 128 128 128 74 78 76 70 25.55 45.6
w4b 74 72 68 72 122 124 128 120 64 70 70 64 25.5 45.3
w5a 85 85 85 83 118 122 118 118 74 74 76 68 25.4 47.6
w5b 87 88 83 88 118 124 124 126 78 76 72 70 25.6 49
end 82 84 78 79 120 122 122 124 70 78 80 78 25.45 50
69 70 66 70 116 116 118 118 70 74 70 70
Subject 07 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.031733 2.869353 3.320511 3.313513 88.10785 46.3806 160.8812 139.157 114.837 9.525196 9.294363 246.8718 64 67
b2 3.113476 2.986528 3.48549 3.322962 90.70313 96.20751 154.8285 107.5889 117.4219 11.94852 6.728374 60.93185 74 73
w2 3.023768 2.994939 3.405486 3.408182 122.9515 87.24313 153.4624 143.969 125.1854 12.6239 12.71307 75.90196 80 80
w3a 3.293038 3.200628 3.548814 3.668797 81.89692 83.10379 145.8673 122.0739 125.6927 7.767171 11.4107 75.52421 69 74
w3b 3.661041 3.632121 3.942047 3.870629 111.3859 97.93578 159.3195 145.3567 139.3146 7.675575 5.72482 62.67757 81 76
w4a 3.145393 3.35239 3.393508 131.2098 68.27799 167.2458 147.5945 153.6449 6.580974 7.888209 144.9484 74 71
w4b 3.384329 3.060953 3.488122 3.512108 112.7663 66.21139 169.6724 146.5568 140.3509 3.066872 3.775612 156.2586 84 85
w5a 87 89
w5b 3.333129 3.224052 3.532607 3.510712 92.7628 85.69035 163.1054 141.209 132.0726 5.984689 5.327818 90.34281 78 83
end 3.283876 3.127172 3.504567 3.478666 103.7959 47.2445 148.9681 133.2875 135.6905 6.720441 5.931706 215.3132 77 73
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 70 67 64 66 120 124 124 120 76 80 78 76
b2 77 87 81 75 120 124 124 130 70 74 74 80 27.3 43
w2 77 77 77 77 116 118 116 112 74 76 76 76 26.85 45.67
w3a 68 66 64 64 120 120 120 120 72 74 72 74 27.4 46.7
w3b 83 77 74 77 130 126 124 128 78 80 80 78 26.8 52
w4a 77 73 72 70 122 124 120 120 74 74 72 72 26.8 52.67
w4b 84 82 86 84 120 118 120 122 72 70 84 76 27.2 54
w5a 92 84 83 85 120 120 130 122 76 80 82 76 26.7 54.67
w5b 80 81 79 75 122 120 124 120 76 80 80 80
end 73 67 75 70 114 114 118 118 78 78 78 76
219
Subject 08 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.355653 3.349745 3.69954 3.606386 99.66259 81.3829 182.0858 133.2781 131.5639 10.24801 7.471974 123.7397 71 64
b2 3.414842 3.234767 3.516277 3.494409 91.3835 63.62531 156.2206 136.9003 126.556 2.970432 2.330061 145.5322 58 57
w2 3.620999 3.623525 3.981872 3.910346 82.24176 70.17785 160.0137 121.2157 114.321 9.96612 7.990805 128.0117 64 62
w3a 3.495374 3.550078 3.936402 3.951058 108.6221 87.9324 186.8998 143.4491 143.4503 12.61749 13.03677 112.5494 79 79
w3b 3.673492 3.595451 3.975741 3.959637 114.3155 96.90052 249.3299 146.5558 130.1803 8.227831 7.789445 157.305 78 77
w4a 3.441617 3.386334 3.973145 4.010913 112.5896 96.38083 200.5217 142.9352 125.7003 15.44415 16.54153 108.0514 80 86
w4b 3.513394 3.52541 3.940532 3.846434 100.1801 82.42279 181.56 138.2814 118.4503 12.15743 9.479176 120.2789 70 70
w5a 3.482073 3.434201 3.91336 3.879164 92.2417 99.1394 195.179 127.4233 126.7363 12.38594 11.40388 96.87326 68 69
w5b 3.491625 3.519952 4.068026 4.00106 108.9735 99.3142 198.9734 159.8393 155.6953 16.5081 14.59021 100.3473 65 69
end 3.53732 3.558059 3.90934 3.887497 91.72575 56.73106 154.6648 131.3815 115.6922 10.517 9.899503 172.628 58 59
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 62 63 57 62 122 128 122 124 74 72 70 76
b2 58 57 59 59 122 124 122 122 80 74 74 76 28.2 44.6
w2 64 60 63 64 130 134 134 136 80 82 80 80 28.3 37.7
w3a 80 82 99 90 132 138 140 144 84 80 84 82 28.2 44.3
w3b 81 73 79 82 146 140 138 138 84 82 82 82 28.05 41.3
w4a 78 75 75 76 148 146 138 140 86 84 78 78 28.3 46.3
w4b 68 68 74 73 122 128 124 130 76 76 68 76
w5a 73 74 76 72 130 126 130 130 68 76 78 78 28.15 47.3
w5b 64 61 62 67 132 130 130 128 74 72 70 70 28.6 45.67
end 60 59 58 60 124 124 126 126 74 78 72 72
Subject 08 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.422925 3.424337 3.767479 3.734184 84.3175 79.3122 171.2353 112.9313 105.1815 10.06607 9.093365 115.9003 65 63
b2 3.441171 3.326883 3.7798 3.593543 74.66792 80.18428 189.6695 115.1788 115.7044 9.840492 4.427908 136.542 60 68
w2 3.701039 3.719096 4.085902 4.038411 96.5557 65.86967 182.0886 127.2456 117.7612 10.39878 9.115615 176.4377 63 59
w3a 3.609599 3.757446 3.976753 3.916216 111.386 99.65786 203.9746 150.5347 142.7621 10.17161 8.494501 104.6749 85 79
w3b 3.652414 3.695472 3.945095 3.885619 104.6577 88.97155 153.1044 114.3116 120.6928 8.013349 6.384931 72.08246 78 67
w4a 3.727332 3.593258 3.918397 3.798634 103.7989 89.48828 171.0413 135.1747 116.3798 5.126055 1.912941 91.13266 78 69
w4b 3.485672 3.496206 3.805038 3.761399 106.2174 84.31495 195.3558 134.6574 125.0059 9.162238 7.910306 131.6977 74 66
w5a 3.561181 3.445695 3.669418 3.714605 93.28903 81.03448 160.1766 118.2853 107.7642 3.039381 4.30825 97.66472 79 74
w5b 3.703697 3.637072 4.035363 3.941524 112.0779 85.6959 205.6986 146.2162 149.1454 8.95498 6.421334 140.0331 61 66
end 3.787033 3.543846 3.903591 3.889249 72.07692 72.93469 175.1869 119.3215 109.1434 3.07782 2.699117 140.1969 65 60
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 67 64 58 61 122 124 126 124 80 78 80 78
b2 65 63 85 66 120 122 130 128 82 82 80 80 29.2 48
w2 60 59 60 58 133 140 138 140 82 86 84 88 28.85 49.7
w3a 73 73 74 72 144 140 140 130 82 80 80 80 29.1 53.67
w3b 70 67 71 72 142 132 130 130 84 82 80 78 29.3 53.3
w4a 77 65 74 75 140 134 130 130 82 80 82 80 29.05 52.67
w4b 69 67 68 71 128 124 120 120 80 76 78 76
w5a 67 72 68 73 130 134 126 126 84 78 74 68 29.15 52.67
w5b 60 62 61  124 130 124 124 70 74 70 72 29.05 52.33
end 70 64 65 67 126 122 122 122 76 74 78 78
220
Subject 10 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 2.659333 2.654125 2.873712 2.893593 58.46455 37.58699 145.3465 95.0052 93.28219 8.061381 8.808969 286.6935 64 68
b2 2.753258 2.730101 2.975324 2.897133 60.86444 35.17675 138.2797 88.97397 92.0719 8.065581 5.225627 293.0998 76 69
w2 2.871514 2.768477 3.05425 3.030065 50.86497 38.79701 147.9379 98.10869 92.06929 6.363751 5.521518 281.3125 76 74
w3a 2.848709 3.157949 3.15372 72.41461 135.6952 105.8716 94.6558 10.85541 10.70698 76 80
w3b 2.975431 2.890033 3.306803 3.256169 78.44864 47.24138 146.3862 109.8325 106.3843 11.13695 9.435197 209.8687 82 83
w4a 2.907725 2.852902 3.150099 3.067344 67.24183 57.07001 144.8303 118.9735 111.2104 8.335501 5.489449 153.7765 79 84
w4b 3.015176 2.811311 3.27976 3.217907 77.76246 48.10583 163.4565 126.9083 121.9035 8.775086 6.72369 239.7852 68 72
w5a 2.977874 68.625 44.13928 77 76
w5b 3.045082 3.03459 3.482504 3.393462 66.731 48.62133 148.2778 99.48814 89.66114 14.36487 11.44074 204.9646 73 79
end 2.877541 2.831573 3.27702 3.221991 62.93198 35.00087 136.208 109.139 91.041 13.88266 11.97029 289.156 72 70
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 73 73 70 72 110 108 108 106 80 78 72 72
b2 77 76 70 78 100 102 98 102 72 80 76 76 24.8 45.3
w2 76 71 73 72 110 112 112 108 70 68 68 64 25.1 44.6
w3a 76 77 75 77 102 108 106 108 76 78 80 74 25 40.6
w3b 82 85 82 82 102 98 100 98 72 76 74 70 24.9 44.67
w4a 78 82 80 82 102 100 100 100 72 70 70 70
w4b 74 71 76 78 98 100 98 102 68 74 70 74 25.75 42.7
w5a 75 73 72 74 98 98 98 96 72 72 70 72 25 46.3
w5b 77 76 77 75 96 96 96 96 68 68 70 70 25.05 46
end 70 71 72 74 100 96 94 98 76 72 70 70
Subject 10 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 2.679929 2.599597 2.836021 2.814544 73.44976 65.5191 167.7596 107.4174 100.0003 5.824464 5.023089 156.0469 76 78
b2 2.771642 2.644395 2.948511 2.934163 72.59638 62.24326 151.0394 115.3512 106.7255 6.381393 5.863716 142.6598 78 72
w2 2.943447 2.670737 2.847957 2.79592 65.17606 90.8637 145.1856 101.73 101.5638 -3.24417 -5.01206 59.78395 76 70
w3a 2.927802 2.785048 2.958632 2.850353 72.58703 88.97388 180.364 136.559 127.42 1.052997 -2.64529 102.7157 74 78
w3b 2.878187 2.8232 3.107461 3.030741 85.00589 75.00994 154.3325 134.6608 120.6909 7.965933 5.300368 105.7494 85 82
w4a 2.960863 2.755506 2.955514 2.912983 82.93566 77.58697 149.6578 113.7957 107.9321 -0.18065 -1.61707 92.89035 76 76
w4b 2.831545 2.684607 3.132344 3.075377 78.62438 88.28123 158.4537 117.2541 113.626 10.62312 8.611246 79.48742 75 74
w5a 2.782737 2.75823 3.042297 2.924247 80.1791 92.5894 170.1837 121.7285 106.035 9.327501 5.08528 83.80472 75 73
w5b 2.892958 2.921402 3.216584 3.261753 66.03896 72.76681 139.1422 109.663 103.7979 11.18667 12.74803 91.21656 71 75
end 2.851355 2.748407 3.126714 2.982996 64.14217 64.48747 166.5521 113.9744 103.6221 9.657137 4.616789 158.2704 70 71
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 69 73 74 73 104 108 108 104 70 76 78 74
b2 72 76 77 77 102 102 108 102 74 76 78 78 24.55 44
w2 78 70 70 76 110 110 112 110 72 76 70 70 24.7 47
w3a 79 77 78 76 110 112 106 110 78 78 76 78 24.55 48.33
w3b 78 82 82 79 98 98 102 98 78 76 76 74 24.5 48.33
w4a 77 80 78 77 102 104 100 102 72 74 70 72
w4b 73 73 71 74 100 98 100 98 72 70 72 72 24.65 47
w5a 75 69 73 72 110 96 98 100 78 72 72 72 24.9 45.67
w5b 78 72 75 74 100 98 98 98 72 70 74 74 24.55 46
end 70 70 71 72 102 100 94 102 72 72 72 74
221
Subject 12 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 2.865834 2.953333 3.048545 3.015281 73.79843 56.72414 137.0759 102.0696 104.6557 6.375464 5.214783 141.6536 70 73
b2 2.768345 2.904707 2.965901 2.948863 104.4828 78.62439 143.636 112.94 102.0704 7.136255 6.52079 82.68633 75 69
w2 2.836097 2.932417 2.958313 2.957754 82.93695 73.97563 147.939 119.8278 115.1751 4.309307 4.289601 99.98339 64 64
w3a 2.96444 2.987062 3.140477 3.217699 105.5228 95.69493 152.2634 124.6583 126.8996 5.938268 8.54323 59.11336 74 77
w3b 2.931274 2.919054 3.113595 3.169108 83.79381 91.03776 150.6971 113.11 105.6911 6.219878 8.113685 65.53249 62 73
w4a 2.777629 2.646755 3.009417 2.936034 73.45348 58.97031 133.6298 100.1739 106.7255 8.344846 5.702919 126.6052 61 65
w4b 2.864291 2.887275 3.192505 3.131366 93.454 57.75914 137.0852 112.5896 110.357 11.45882 9.324295 137.3395 62 66
w5a 2.828477 2.956099 2.973401 2.949536 82.06969 58.62069 148.1044 109.4833 107.0833 5.12376 4.280029 152.6488 65 65
w5b 2.855849 2.890186 3.035273 3.098439 87.93947 60.00192 144.4894 116.8988 113.2843 6.282696 8.494512 140.8079 72 68
end 3.079586 3.094036 3.346801 3.296024 78.28348 68.45389 134.8333 107.4149 103.9692 8.677003 7.028161 96.96944 70 69
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 71 75 76 73 114 120 120 122 88 90 88 90
b2 72 72 73 72 110 118 116 118 68 80 80 80 24.5 27
w2 65 64 64 67 110 112 108 108 72 70 72 74 24.9 26
w3a 78 76 75 76 120 112 116 118 74 72 72 74
w3b 63 61 61 64 120 118 118 116 84 84 84 84 24.7
w4a 64 60 63 65 104 104 118 116 84 88 84 84 24.4 25.3
w4b 62 64 62 65 112 116 110 110 78 82 82 82 24.55 24.3
w5a 68 65 65 66 110 108 112 110 82 82 84 84 24.75 27.6
w5b 64 68 68 71 116 108 112 110 78 76 80 80 24.55 28.3
end 67 68 70 73 114 118 110 108 72 80 82 78
Subject 12 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.299001 3.183216 3.298045 3.216848 63.10393 92.76277 111.7252 89.48445 80.17425 -0.02897 -2.49024 20.44188 75 82
b2 3.43453 3.399872 3.449276 3.313743 61.729 64.31215 110.1752 81.03922 79.13869 0.429359 -3.51685 71.31318 79 80
w2 3.3905 3.343968 3.459771 3.482314 75.34859 76.38129 154.3246 112.2466 99.31156 2.043083 2.707962 102.045 64 64
w3a 3.496358 3.402628 3.605809 3.468149 91.72544 65.86252 136.558 117.9442 112.7613 3.13042 -0.80681 107.338 77 77
w3b 3.501323 3.425333 3.449633 3.426886 73.79511 85.0007 140.0004 95.51882 86.20759 -1.47629 -2.12596 64.70503 60 60
w4a 3.269614 3.258558 3.332955 3.387607 69.13879 94.3136 150.0148 108.6261 94.49057 1.937261 3.608778 59.05952 62 63
w4b 3.530054 3.527716 3.454641 3.446677 68.10911 62.93575 116.3798 103.1058 91.21504 -2.1363 -2.3619 84.91847 63 65
w5a 3.283144 3.255705 3.478335 3.34327 68.79525 53.27586 109.8303 85.17828 76.55484 5.945238 1.831355 106.154 66 65
w5b 3.557771 3.343933 3.487613 3.419469 70.86934 69.65731 139.6167 106.217 99.66054 -1.97196 -3.88732 100.4337 67 67
end 3.613128 3.406517 3.592931 3.524854 78.62218 62.58669 145.6974 96.90057 99.14548 -0.55898 -2.44316 132.793 70 70
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 78 75 79 74 116 118 118 118 88 86 86 88
b2 71 76 69 75 118 116 116 116 80 80 80 80 25.2 29
w2 67 64 61 67 106 104 108 106 78 72 76 74 25.4 29.6
w3a 78 71 73 77 112 110 114 112 72 74 74 72
w3b 62 61 62 65 112 116 110 110 84 80 80 82 25.15
w4a 71 68 62 64 110 112 116 110 80 78 82 80 25.25 22
w4b 63 66 68 65 108 108 110 112 78 82 82 84 25.4 24.3
w5a 64 75 66 76 108 104 108 112 80 84 82 84 25.1 30
w5b 66 73 68 75 104 108 108 110 80 78 80 80 25.1 27
end 70 68 70 75 114 108 106 116 80 80 80 84
222
Subject 13 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.126419 3.033025 3.346116 3.343945 141.7277 98.27981 204.3304 154.4837 144.3229 7.027101 6.957669 107.9068 80 77
b2 3.067688 3.019984 3.190687 3.181611 117.4268 68.27935 165.0094 133.6271 117.7586 4.009509 3.713631 141.6682 71 71
w2 3.458904 3.423479 3.617909 3.542736 98.10647 75.52433 164.6813 132.7624 121.3805 4.596998 2.423665 118.0506 63 61
w3a 3.335179 3.232851 3.508515 3.428759 137.4159 65.51922 140.6917 127.5902 126.5536 5.197215 2.805852 114.7335 66 67
w3b
w4a 3.186631 3.01126 3.444005 3.408488 153.2797 114.487 220.0114 175.1865 171.0388 8.076697 6.962124 92.17153 73 77
w4b 3.222601 3.094667 3.453107 3.426341 107.9324 80.52645 192.419 144.8303 151.566 7.152798 6.322226 138.9513 80 76
w5a 3.257061 3.111355 3.454243 3.515649 108.7942 85.0028 179.4862 136.5545 131.2071 6.054004 7.939311 111.1533 82 77
w5b 3.37453 3.220792 3.537989 3.478365 107.5951 72.06979 176.8998 146.0347 141.2107 4.8439 3.077023 145.4562 67 77
end 3.187492 3.095528 3.348299 3.28113 106.2075 85.00305 194.4861 155.0025 153.7996 5.044926 2.937659 128.799 62 62
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 79 76 74 76 116 112 110 110 64 68 64 64 25.5 43
b2 78 71 72 70 110 110 114 108 68 68 70 68 25.6 47.6
w2 63 63 63 64 102 100 102 100 60 64 64 62 25.75 48
w3a 67 68 69 65 112 106 106 104 64 66 64 64 25.7 50.3
w3b
w4a 76 75 73 73 112 108 110 106 58 58 58 58 25.55 49
w4b 79 75 74 77 106 104 110 104 60 62 62 64 25.65 57.67
w5a 73 72 74 80 102 100 98 110 64 64 62 70 25.45 55
w5b 69 67 66 68 96 100 100 100 62 68 68 68 25.45 54.33
end 61 63 61 60 100 104 104 102 62 64 64 64
Subject 13 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.334545 3.243795 3.539803 3.56598 123.2868 82.75898 198.4542 129.8369 132.5993 6.155508 6.940527 139.7978 77 84
b2 3.120823 3.122308 3.399029 3.320114 100.3478 65.51724 162.0733 130.8632 124.8314 8.914488 6.385841 147.3751 72 79
w2 3.298185 3.331967 3.4225 3.376426 86.38 79.31222 155.7113 117.2545 110.8687 3.769185 2.372241 96.32698 68 60
w3a 3.450787 3.521838 3.672068 3.602443 101.9051 75.34676 165.5415 136.7252 131.0483 6.412491 4.394821 119.7062 69 65
w3b
w4a 3.308294 3.32022 3.578044 3.524777 138.2871 89.83893 200.3532 151.0365 155.0033 8.153721 6.543625 123.0138 72 77
w4b 3.23153 3.260848 3.549315 3.503297 119.6562 91.55469 171.0537 141.7252 133.6216 9.83388 8.409846 86.83222 70 75
w5a 3.48426 3.409317 3.663963 3.630879 102.2496 100.692 160.3624 137.7641 138.9711 5.157567 4.208034 59.26026 70 74
w5b 3.380558 3.43956 3.572255 3.528833 97.58932 64.48878 146.3911 120.5234 112.2414 5.670561 4.386107 127.0025 74 68
end 3.250404 3.135396 3.333903 3.285006 89.14369 63.62303 153.1114 137.414 117.5912 2.568883 1.064553 140.6541 64 61
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 78 76 75 77 110 112 110 110 68 70 68 68 26.3 47.67
b2 71 76 82 79 112 114 112 114 68 68 68 70 26.3 48.33
w2 62 60 59 57 108 106 108 104 72 72 70 70 26.5 52.33
w3a 66 64 64 63 108 106 108 108 68 70 68 68 26.7 52.33
w3b
w4a 74 75 73 76 102 112 108 108 60 60 60 62 26.3 53
w4b 76 76 73 71 106 100 102 104 62 60 64 64 26.1 62
w5a 69 69 68 65 106 104 102 100 66 66 68 62 26 60.67
w5b 66 66 67 64 100 96 96 92 68 66 68 68 26.2 58
end 59 58 60 58 102 102 106 104 70 78 68 68
223
Subject 14 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 2.786079 2.786639 2.932946 2.905556 67.76442 73.9659 122.5906 100.6902 88.11314 5.271447 4.288352 65.73932 62 65
b2 2.863772 2.878802 2.846497 2.876953 68.99181 80.52353 123.1158 95.52127 79.48667 -0.60324 0.460266 52.89419 48 49
w2 2.843804 2.920327 3.040122 2.923699 56.2074 70.51724 133.2826 106.0356 97.58651 6.90336 2.809464 89.00705 72 58
w3a 2.761133 2.869934 3.126056 3.12748 72.94304 65.86996 148.2955 114.3209 109.6598 13.21642 13.268 125.1337 63 63
w3b 2.73368 2.774755 3.047159 2.991806 58.45478 65.00445 150.0099 101.7299 73.10877 11.46731 9.442461 130.7687 65 60
w4a 2.667493 2.580111 2.97188 2.987 71.21105 79.48351 136.041 102.946 84.83113 11.41099 11.97779 71.15628 69 66
w4b 2.888899 2.885308 2.991424 3.04452 68.62156 61.8985 123.8042 101.3805 95.52636 3.548947 5.386851 100.0117 58 62
w5a 2.910296 2.90283 3.110488 3.000729 55.17349 43.9662 117.0723 92.59258 105.0023 6.878759 3.107339 166.2779 55 58
w5b
end 2.839477 2.701831 3.051222 2.975801 82.76588 88.62411 130.0167 113.2793 100.5246 7.457192 4.801033 46.70582 59 58
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 65 67 72 68 100 100 102 102 70 70 70 70
b2 51 50 51 52 100 104 104 100 64 70 64 64 22.7 36
w2 62 61 60 62 94 90 94 92 70 72 70 72 22.85 35.33
w3a 63 63 63 63 108 102 104 102 70 72 72 72
w3b 70 68 67 64 120 116 116 116 88 84 84 86 22.9 36.67
w4a 68 67 66 66 100 104 104 102 66 72 72 70 22.75 36.7
w4b 60 65 65 73 110 106 106 106 76 78 76 76
w5a 58 59 58 61 98 100 100 98 68 66 66 66 22.9 36.7
w5b
end 59 64 62 62 114 104 104 100 80 72 74 72
Subject 14 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.003932 2.985095 3.083056 3.065155 67.93493 75.17906 131.73 98.11899 96.73878 2.633994 2.038103 75.22172 67 77
b2 3.05008 3.01058 3.013882 3.031364 53.62069 59.48482 98.44978 80.69344 70.34567 -1.18682 -0.61364 65.50404 55 58
w2 3.138298 3.029446 3.082954 3.163858 64.48463 82.76326 141.5545 109.3224 103.4555 -1.7635 0.814457 71.03539 61 59
w3a 3.022985 2.957016 3.050201 2.99794 73.45232 77.24519 123.2941 106.8966 97.41688 0.900295 -0.82848 59.61392 63 60
w3b 3.041835 2.960595 3.158454 3.099954 65.00092 93.97066 143.2761 104.4877 94.65928 3.833842 1.910667 52.46894 65 62
w4a 3.10395 3.126536 3.329665 3.263111 62.58668 73.11077 119.4898 94.66439 77.9318 7.271853 5.127703 63.43661 65 62
w4b 3.023035 2.858985 2.951285 2.840408 72.58823 75.86556 145.0059 107.5868 87.07345 -2.37344 -6.04121 91.13531 67 66
w5a 3.077322 3.151396 3.357365 3.339021 56.20953 60.00203 102.5876 88.28193 81.37967 9.100201 8.504118 70.97357 64 60
w5b
end 3.171547 3.115045 3.358077 3.318828 66.55976 66.72592 118.627 92.59421 89.14131 5.881348 4.643806 77.78253 66 62
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 69 74 67 65 102 102 104 104 74 72 72 70
b2 53 56 52 56 104 104 104 104 70 70 68 70 23.55 36
w2 60 62 61 62 94 96 96 96 70 78 76 76 23 32.67
w3a 62 62 62 58 110 106 106 104 74 70 72 74
w3b 67 65 63 65 112 116 114 118 84 80 82 80 23.75 36.67
w4a 67 64 64 62 108 108 106 108 72 72 70 70 23.55 36.5
w4b 66 62 64 57 106 106 104 106 76 78 78 70
w5a 63 62 60 63 100 98 98 100 68 68 66 70 23.35 36
w5b
end 59 68 62 68 106 108 112 106 78 78 78 80
224
Subject 15 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.589853 3.60801 3.905656 3.895725 86.72448 61.21185 175.702 116.3806 103.803 8.797081 8.520461 187.0391 60 63
b2 3.680862 3.894343 3.914172 3.725727 95.17368 57.24553 131.561 110.3483 103.7934 6.338443 1.218859 129.8187 64 61
w2 4.035264 4.018634 4.381597 4.373604 67.93834 36.72414 157.4371 115.1757 100.8644 8.582654 8.384574 328.7021 60 67
w3a 3.84181 #DIV/0! 4.413302 4.09257 97.76136 45.6903 193.9934 116.3865 107.2425 14.87562 6.527139 324.5834 71 62
w3b 61 77
w4a 4.139293 3.96464 4.351011 4.206526 90.34807 38.79386 155.0004 115.5224 118.7973 5.114814 1.624246 299.5488 70 70
w4b 3.838151 3.676389 4.011766 3.967943 80.34779 54.48489 135.8657 104.4902 92.25454 4.523412 3.381621 149.3641 68 61
w5a 3.927995 3.948686 4.193444 4.191848 83.79913 27.24357 151.215 114.8367 107.5906 6.757877 6.717248 455.0484 66 63
w5b 3.958974 4.048415 4.517087 4.176301 91.38741 61.72414 156.3903 116.8968 101.7256 14.09741 5.489492 153.3698 69 67
end 3.675044 3.439266 3.876415 3.761365 66.37976 35.86294 176.0407 114.3149 102.5891 5.479394 2.348835 390.8709 52 57
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 62 67 61 63 122 120 118 112 60 60 60 60
b2 63 64 67 65 106 108 104 108 60 60 68 70 24.8 29
w2 70 71 70 71 110 116 116 116 70 74 74 74
w3a 65 62 58 63 116 108 110 104 72 72 72 68 24.5 39
w3b 72 66 68 112 114 70 80
w4a 67 66 68 70 106 102 106 108 70 70 68 66 24.75 38.3
w4b 63 61 62 60 106 100 110 110 74 74 70 70 24.9 41.7
w5a 64 64 62 62 108 98 98 100 72 64 70 70 24.85
w5b 61 64 68 66 112 104 106 106 68 66 72 70 24.6 38.33
end 51 53 54 51 108 112 112 116 84 80 82 80
Subject 15 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.882378 3.407116 3.697833 3.593282 78.28338 50.69083 171.0348 106.3807 88.11181 -4.75339 -7.44635 237.4078 59 62
b2 3.794989 3.707679 3.845827 3.783032 77.94055 83.79381 164.147 120.5175 102.0742 1.339621 -0.31505 95.89392 70 68
w2 3.665825 3.353971 3.753846 3.549544 97.58923 47.936 157.4259 106.0418 101.5618 2.401142 -3.17203 228.4086 81 71
w3a 3.962651 3.680661 3.965715 3.762247 94.31346 62.42237 154.4835 101.036 113.7944 0.077324 -5.05731 147.481 61 64
w3b 72 69
w4a 4.121513 3.843866 4.058003 4.026973 89.65584 61.89855 174.4858 115.8646 97.59014 -1.54095 -2.29381 181.89 73 78
w4b 3.840727 3.753099 4.082676 4.011258 92.07221 51.89952 144.3145 95.52001 98.80317 6.299584 4.440089 178.0651 65 59
w5a 3.937819 3.767049 4.108304 4.049118 65.52313 35.52145 154.8317 112.2427 106.3818 4.329427 2.826418 335.8823 61 63
w5b 3.594283 3.379698 4.097222 3.984644 87.24206 54.31269 176.3815 120.8671 104.1451 13.99274 10.8606 224.7519 84 72
end 3.636294 3.566296 3.903993 3.787244 71.38096 50.0051 139.8315 109.8289 91.38737 7.361859 4.151225 179.6344 61 56
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 71 62 61 72 106 110 110 110 70 68 70 70
b2 64 58 67 64 100 100 102 98 70 70 70 70 25.7 34.67
w2 65 68 67 65 104 110 106 104 82 80 82 82
w3a 58 57 66 70 100 100 100 104 70 68 70 74 25.55 38.67
w3b 81 61 78 62 106 108 78 78
w4a 65 67 69 72 100 100 100 104 72 70 70 70 25.8 41
w4b 57 62 61 61 106 102 104 102 76 68 72 66 25.65 43
w5a 65 62 61 63 98 98 98 96 72 68 72 70 25.9  
w5b 68 64 70 71 112 106 106 104 70 74 72 74 25.65 44.67
end 52 52 52 54 110 112 100 108 84 84 84 80
225
Subject 16 ND Left
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.32406 3.274896 3.700142 3.478681 117.2502 114.8328 175.5353 135.3574 127.9332 11.31395 4.651565 52.86171 60 61
b2 3.448636 3.533701 3.875009 3.725923 116.9028 123.9703 191.065 151.212 141.0398 12.36355 8.040477 54.12162 68 65
w2 3.475787 3.419624 3.92513 3.705724 119.6564 101.0375 164.8512 128.4541 127.4168 12.9278 6.61539 63.1584 68 64
w3a 3.447038 3.560535 4.154752 4.03577 123.9778 103.9669 156.3909 131.3811 121.3906 20.53107 17.07934 50.42369 73 72
w3b 3.43366 4.123752 3.858136 124.489 130.5209 194.3312 158.7978 139.4896 20.09786 12.3622 48.88898 67 67
w4a 3.547751 3.467939 3.910365 3.631957 126.897 109.8471 175.3668 141.56 132.7622 10.22096 2.373484 59.64629 65 64
w4b 3.460382 3.405741 4.165597 4.014922 126.8987 89.49965 205.7467 166.3896 145.8655 20.37971 16.02543 129.8855 70 66
w5a 3.538087 3.310165 4.07286 4.129832 115.3474 64.65749 154.1404 146.3812 129.1473 15.11475 16.725 138.3953 67 69
w5b
end 3.456018 3.386308 3.765655 3.729818 115.0003 111.2079 173.4487 133.1037 121.2074 8.959343 7.922411 55.96791 62 61
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 61 61 64 60 112 114 110 110 70 72 70 70
b2 67 67 65 67 112 112 110 110 62 64 70 70 26.2 42.6
w2 61 62 63 64 110 114 108 110 68 70 68 70 26.55 34
w3a 68 68 65 66 120 118 112 108 72 72 72 70 26.25 38
w3b 67 69 68 76 122 110 110 110 64 60 60 60 26.75 44.6
w4a 60 63 64 63 120 110 106 110 68 70 68 66
w4b 68 65 70 67 110 110 110 110 70 70 70 70 27.15 38.3
w5a 71 68 70 69 106 114 114 114 64 66 70 68 27.25 34.6
w5b
end 62 64 62 62 116 116 114 114 70 70 70 70
Subject 16 D Right
diambase diampre diam60 diam90 velbase velpre velrel vel60 vel90 basev60 basev90 prev/relv Hrbase HRpre180
b1 3.466095 3.284462 3.491444 3.303866 78.1103 86.21618 152.5991 110.5199 98.10841 0.731324 -4.68046 76.99591 60 58
b2 3.601851 3.35575 3.653288 3.45581 87.24993 87.93137 163.9746 132.4195 128.7973 1.428084 -4.0546 86.48019 64 64
w2 3.758476 3.536919 95.87108 108.4505 -5.89487 56 59
w3a 3.811275 3.677658 3.677503 3.499341 92.41921 92.76439 154.8311 109.6731 111.3865 -3.5099 -8.18452 66.90785 68 73
w3b 3.752567 3.612544 3.731299 3.769604 116.2102 106.3804 145.8741 116.3826 114.4848 -0.56675 0.454017 37.12497 71 69
w4a 3.628568 3.381354 3.909257 3.690542 100.6911 112.9336 157.0932 137.2512 151.0488 7.73552 1.707947 39.10226 61 80
w4b 3.736951 3.512594 3.92534 3.703065 97.41531 83.10805 150.8732 125.5196 109.8321 5.04124 -0.90677 81.53857 74 67
w5a 3.738849 3.621449 4.140314 4.222019 92.42409 97.58771 174.8345 136.7294 125.6897 10.73766 12.92294 79.15632 71 71
w5b
end 3.60741 3.61631 4.194567 3.8931 84.14146 85.86276 173.97 118.9688 116.3875 16.27641 7.919533 102.614 61 62
HRpre30 Hrrel HR60 HR90 SBPbaseSBPpre180SBPpre30 SBP60 DBPbaseDBPpre180DBPpre30 DBP60 forecirc HG
b1 64 59 64 64 110 112 114 112 72 74 74 72
b2 64 68 68 68 110 110 110 110 68 70 68 68 26.5 45
w2 61 73 65 70 110 114 116 112 72 72 72 72 27 33
w3a 61 65 95 72 110 116 110 120 66 76 70 78 27 36
w3b 70 71 68 74 110 112 110 110 74 68 68 70 27.56 42.3
w4a 68 66 68 72 108 120 120 120 68 84 70 72
w4b 68 70 67 74 112 110 112 110 70 70 70 68 27.45 41.33
w5a 71 68 72 68 110 108 110 106 78 68 68 68 28 42
w5b
end 62 65 65 64 114 116 118 116 72 72 74 74
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